Prof. Dr. ERDEM TÜZÜN

Avesis Araştırma Alanları: Tıp, Sağlık Bilimleri, Temel Tıp Bilimleri, Dahili Tıp Bilimleri, Nöroloji, Yaşam Bilimleri, Nörobiyoloji, Temel Bilimler

WoS Araştırma Alanları: Klinik Tıp (Med), Yaşam Bilimleri (Life), Klinik Tıp, Sinirbilim Ve Davranış, İmmünoloji, Klinik Nöroloji, Sinir Bilimi, İmmünoloji

Scopus Araştırma Alanları: İnsan Bilgisayar Etkileşimi, Genel İmmünoloji ve Mikrobiyoloji, Nöroloji (klinik), Genel Sinirbilim

Akademik Faaliyetlere Dayalı Araştırma Alanları

Avesis Araştırma Alanları

WoS Araştırma Alanları

Scopus Araştırma Alanları

Akademik Ünvanlar / Görevler

2015 - Devam Ediyor

Prof. Dr.

İstanbul Üniversitesi, Aziz Sancar Deneysel Tıp Araştırma Enstitüsü, Sinir Bilimi Ana Bilim Dalı

2011 - 2015

Doç. Dr.

İstanbul Üniversitesi, Aziz Sancar Deneysel Tıp Araştırma Enstitüsü, Sinir Bilimi Ana Bilim Dalı

Yönetimsel Görevler

2025 - Devam Ediyor

Senato Üyesi

İstanbul Üniversitesi, Aziz Sancar Deneysel Tıp Araştırma Enstitüsü, Sinir Bilimi Ana Bilim Dalı

2025 - Devam Ediyor

Enstitü Müdürü

İstanbul Üniversitesi, Aziz Sancar Deneysel Tıp Araştırma Enstitüsü, Sinir Bilimi Ana Bilim Dalı

2025 - Devam Ediyor

BAP Koordinatörü

İstanbul Üniversitesi, Aziz Sancar Deneysel Tıp Araştırma Enstitüsü, Sinir Bilimi Ana Bilim Dalı

2021 - Devam Ediyor

Neuro-oncology Board

EAN - European Academy of Neurology, Scientific Boards

2019 - 2022

Uluslararası İşbirliği Projeleri Araştırma Destek Grubu (UPAG)

TÜBİTAK

2012 - 2022

Anabilim/Bilim Dalı Başkanı

İstanbul Üniversitesi, Aziz Sancar Deneysel Tıp Araştırma Enstitüsü, Sinir Bilimi Ana Bilim Dalı

2007 - 2011

Klinik Araştırmacı

İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

Makaleler

2026

1. Anti-Neuronal Antibodies in Patients with Sjögren's Syndrome and Acute Cerebellar Ataxia: Two Case Reports.

Şanlı E., Elkoca P., Akbaş H., Yurddaş G., Şahin E., Samancı B., et al.

Acta neurologica Taiwanica , 2026 (Scopus)

2026

2. Effect of immunotherapy on seizure severity and spike-wave index in epileptic encephalopathy with spike-wave activation in sleep: The value of EEG spikes in monitoring treatment response

Topaloğlu P., Dörtkol O., Emekli A. S., Elmalı Yazıcı A. D., Tüzün E., Yılmaz V., et al.

Epilepsy Research , cilt.226, ss.107861, 2026 (Hakemli Dergi)

2026

3. Impact of Intravenous Immunoglobulin on Neuroinflammation Markers in Patients With Electrical Status Epilepticus During Slow Sleep.

Koral G., Tuzun E., Emekli A. S., Dortkol S. O., Savas M., Oz F., et al.

In vivo (Athens, Greece) , cilt.40, sa.4, ss.2014-2024, 2026 (SCI-Expanded, Scopus)

2026

4. [Increased serum transferrin receptor 1 levels are associated with severity of acute ischemic stroke in patients with Covid-19 pneumonia].

Memiş Z., Soylu S., Duran Bayar M., Büşra Şişman A., Sancar N., Tüzün E., et al.

Ideggyogyaszati szemle , cilt.79, sa.5-6, ss.181-188, 2026 (SCI-Expanded, Scopus)

2026

5. Immune-driven mechanisms in idiopathic intracranial hypertension: a critical synthesis.

Yetimler B., Tüzün E.

Reviews in the neurosciences , cilt.37, sa.5, ss.519-534, 2026 (SCI-Expanded, Scopus)

2026

6. Expression Levels of Intracellular Pathway Factors of B Lymphocytes in Patients with Multiple Sclerosis with and without Optic Neuritis Onset

Fırat Z., Özkan Yaşargün D., Yılmaz V., Türkoğlu R., Tüzün E., Arsoy E.

Journal of Multiple Sclerosis Research , cilt.6, sa.1, ss.39-45, 2026 (Hakemli Dergi)

2026

7. NLRP3 and RANK-RANKL-OPG Pathway-related Gene Expression Levels in Children With Autism Spectrum Disorder.

Kara B., Savaş M., Özer T., Şişmanlar Ş. G., Akarsu R., Öztürk S. Y., et al.

In vivo (Athens, Greece) , cilt.40, sa.3, ss.1680-1695, 2026 (SCI-Expanded, Scopus)

2026

8. Polyclonal glycine receptor aAbs: a challenge for personalized epitope characterization

Wiessler A., Stahl I., Schaefer N., Rauschenberger V., Talucci I., Maric H. M., et al.

Frontiers in Molecular Neuroscience , cilt.19, ss.1747209, 2026 (Hakemli Dergi)

2026

9. A Comprehensive Overview of the Clinical, Electrophysiological, and Neuroimaging Features of BPAN: Insights From a New Case Series

Susgun S., Kizek O., Ugur Iseri S. A., Kamaci I., Elmali A. D., Iscen P., et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY , cilt.13, sa.3, ss.453-465, 2026 (SCI-Expanded, Scopus)

2026

10. Possible association between immunoglobulin A vasculitis and the development of schizophrenia: A case study

Tüzün E., Uzun E., Sağır F.

Turkish Journal of clinical psychiatry , cilt.29, sa.1, ss.63-67, 2026 (Hakemli Dergi)

2026

11. Aquaporin-1 Antibodies in Autoimmune Inflammatory Demyelinating Disorders with Predominant Optic Nerve & Spinal Cord Involvement

Tüzün E., Karachalıou E., Pechlıvanıdou M., Tzanetakos D., Küçükali C. İ., Yılmaz V., et al.

Archives of Neuropsychiatry , cilt.63, sa.1, ss.375-379, 2026 (Hakemli Dergi)

2026

12. Involvement of SWAP-70 in proteolipid protein-induced experimental autoimmune encephalomyelitis

Ulusoy C. A., Koral G., Akpunar Salman F., Şen M., Şekerdağ Kılıç E., Türkoğlu R., et al.

Turkish Journal of Medical Sciences , cilt.56, sa.", ss.274-281, 2026 (Hakemli Dergi)

2026

13. Neurofilament Light Chain as a Potential Serum-Based Biomarker for Monitoring Disease Activity in Neuro-Behcet's Disease

Tezel M., KARPUZOĞLU F. H., Toz H. T., EMEKLİ A. S., DİLSİZ E., GÜNDÜZ T., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.63, ss.479-481, 2026 (SCI-Expanded, Scopus, TRDizin)

2025

14. Cognitive Outcome in a Case of Herpes Simplex Virus Encephalitis-induced Anti-N-methyl-D-aspartate Receptor Encephalitis

Şişman Bayar A. B., Bayar M. D., Savaş M., Atacan Yaşgüçlükal M., Şen Ö., Tüzün E.

Neurological Sciences and Neurophysiology , cilt.42, sa.4, ss.190-193, 2025 (Hakemli Dergi)

2025

15. MOG and GFAP Antibodies are not Present in Headache with Neurological Deficits and Cerebrospinal Fluid Lymphocytosis (HaNDL)

Pechlivanidou M., Şanlı E., Kürtüncü M., Tzartos J., Tzartos S., Tüzün E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.62, sa.4, ss.293-294, 2025 (SCI-Expanded, Scopus, TRDizin)

2025

16. Peripheral cytokine levels in patients with idiopathic parkinson's disease undergoing subthalamic nucleus deep brain stimulation.

Kocabıcak E., Sen S., Uzun H., Ozturk S., Yildiz M. O., Tuzun E., et al.

Scientific reports , cilt.15, sa.1, ss.36719, 2025 (SCI-Expanded, Scopus)

2025

17. Diagnostic Value of Serum Humanin-Like 3 Levels in Multiple Sclerosis Patients with Predominant Optic Nerve and Spinal Cord Involvement: A Preliminary Study.

Küçükali C. İ., Sancar N., Korkmaz H. Y., Gündüz T., Kürtüncü M., Tüzün E.

Noro psikiyatri arsivi , cilt.63, sa.1, ss.242-245, 2025 (SCI-Expanded, Scopus, TRDizin)

2025

18. Short and Long-Term Effects of Intravenous Methylprednisolone and Plasma Exchange Combination in NMOSD Attacks.

Yaşargün D. Ö., Ersöz A. S., Türkoğlu R., Tüzün E.

Noro psikiyatri arsivi , cilt.62, sa.4, ss.354-359, 2025 (SCI-Expanded, Scopus, TRDizin)

2025

19. Investigation of symptom-specific functional connectivity patterns in Parkinson's disease

Kicik A., Bayram A., Erdogdu E., Kurt E., Saridede D. B., Cengiz S., et al.

NEUROLOGICAL SCIENCES , cilt.46, sa.9, ss.4385-4396, 2025 (SCI-Expanded, Scopus)

2025

20. Hock immunization, a refined alternative for developing experimental autoimmune myasthenia gravis (EAMG) in mice.

Mané-Damas M., Schöttler A. K., Mohile T., Arets B., Tüzün E., Losen M., et al.

Scientific reports , cilt.15, sa.1, ss.31893, 2025 (SCI-Expanded, Scopus)

2025

21. Binding patterns of glycine receptor autoantibodies are related to clinical syndromes.

Piro I., Wiessler A., Kakavela E., Baykan B., Tüzün E., Villmann C., et al.

Acta neuropathologica communications , cilt.13, sa.1, ss.166, 2025 (SCI-Expanded)

2025

22. Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms.

van de Burgt N. A., Kulsvehagen L., Mané-Damas M., Lutz L., Lecourt A., Monserrat C., et al.

Frontiers in neurology , cilt.16, ss.1593042, 2025 (SCI-Expanded, Scopus)

2025

23. Early Electrodiagnostic Study in Guillain-Barré Syndrome Requires a Second One for Accurate Electrodiagnosis

Tasdemir V., Sirin N. G., Oge A. E., Cakar A., Culha A., Soysal A., et al.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY , cilt.42, sa.5, ss.470-471, 2025 (SCI-Expanded, Scopus)

2025

24. Clinical characteristics and prognostic clinical factors of anti-gamma-aminobutyric acid-B receptor (GABAB-R) encephalitis in Türkiye: a multicenter study

Gozubatik-Celik R. G., Baykan B., Emekli A. S., Tuzun E., Soysal A., Uzunkopru C., et al.

NEUROLOGICAL RESEARCH , cilt.47, sa.7, ss.612-625, 2025 (SCI-Expanded, Scopus)

2025

25. Active Immunization for Inducing Autoimmune Muscle-Specific Kinase (MuSK) Myasthenia Gravis in Mice

Koral G., Yılmaz V., Ulusoy C. A., Lazaridis K., Tüzün E.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS , cilt.2025, sa.221, 2025 (SCI-Expanded, Scopus)

2025

26. Investigating the Effects of NMDAR and LGI1 Antibodies on Absence Seizures: Insights from Genetic Absence Epilepsy Rats and Acute Pharmacological Model of Absence Seizures.

Çarçak N., Korkmaz H. Y., Pişkin Ş. A., Yalçın B., Çırak S., Ulusoy C., et al.

Noro psikiyatri arsivi , cilt.62, sa.3, ss.279-285, 2025 (SCI-Expanded, Scopus, TRDizin)

2025

27. Pediatric case of Kelch-like protein 11 (KLHL11) encephalitis with long-term follow-up: pitfalls in diagnosis of pediatric autoimmune encephalitis.

Şanlı E., Pechlivanidou M., Akbeyaz H., Savaş M., Takış G., Tzartos J., et al.

Noro psikiyatri arsivi , cilt.62, sa.2, ss.97-99, 2025 (SCI-Expanded, Scopus, TRDizin)

2025

28. Effects of NMDAR and LGI1 antibodies on absence seizures: Insights from genetic and pentylenetetrazol-induced models

Yilmaz N. C., TÜZÜN E., Akat S., Kucukali C., ONAT F.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.32, 2025 (SCI-Expanded, Scopus)

2025

29. Failure to suppress effector B cells is associated with resistance to ocrelizumab treatment in multiple sclerosis

Tuerkoglu R., TÜZÜN E., Akbayir E., Kizilay T., Erol R., Yilmaz V.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.32, 2025 (SCI-Expanded, Scopus)

2025

30. Treatment-resistant patients with focal epilepsy of unknown cause display reduced neurogranin levels: a preliminary study

Aysel Ş. B., Merve S., Gizem K., Muhammet B. D., Oğuz Y., Aytül M., et al.

IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE , cilt.78, sa.5-6, 2025 (SCI-Expanded, Scopus)

2025

31. Renal Expression Levels of C5a Receptor and Autophagy-related Beclin-1 and LC3A/B Are Simultaneously Enhanced Under Immunoglobulin Treatment in a Rat Model of Sepsis

Polat Ö., Orhun G., Anakli I., Yilmaz V., Koral G., Ulusoy C., et al.

IN VIVO , cilt.39, sa.2, ss.810-818, 2025 (SCI-Expanded, Scopus)

2025

32. Impaired Presynaptic Function Contributes Significantly to the Pathology of Glycine Receptor Autoantibodies.

Wiessler A., Zheng F., Werner C., Habib M., Tuzun E., Alzheimer C., et al.

Neurology(R) neuroimmunology & neuroinflammation , cilt.12, sa.2, 2025 (SCI-Expanded, Scopus)

2025

33. Longitudinal Investigation of Brain and Spinal Cord Pericytes After Inducible PDGFRβ+ Cell Ablation in Adult Mice

Atak D., Yıldız E., Özkan E., Yousefi M., Özkan A., Yılmaz A. B., et al.

Journal of Neurochemistry , cilt.169, sa.3, ss.70035, 2025 (Hakemli Dergi)

2025

34. B-Cell and T-Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis

Akbayır E., Kizilay T., Erol R., Ozkan Yasargun D., Erdem Tuzun T., Vuslat Yılmaz Y., et al.

IN VIVO , cilt.39, sa.2, ss.1162-1172, 2025 (SCI-Expanded, Scopus)

2025

35. Reparixin as a Potential Antiepileptogenic Agent: Modulation of the CXCL1–CXCR1/2 Axis and Seizure Activity in a Kindling Rat Model of Temporal Lobe Epilepsy

Çarçak Yılmaz N., Mutlu N., Erdeve E. T., Turan T. T., Sarıyıldız Ö., Ulusoy C. A., et al.

International Journal of Molecular Sciences , cilt.26, sa.7, ss.2831, 2025 (Scopus)

2025

36. Effects of immune modulatory treatment on language and psychiatric profile in patients with electrical status epilepticus in sleep (ESES)

Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., İşcen P., Topaloğlu P., et al.

EPILEPSY & BEHAVIOR , cilt.163, 2025 (SCI-Expanded, Scopus)

2025

37. Differentiating multiple sclerosis with predominant spinal cord and optic nerve involvement from other autoimmune demyelinating diseases using B cell immunophenotyping and gene expression profiling.

Yilmaz V., Karaaslan Z., Sanli E., Yuceer-Korkmaz H., Ulusoy C. A., Timirci-Kahraman Ö., et al.

Multiple sclerosis and related disorders , cilt.93, ss.106238, 2025 (SCI-Expanded, Scopus)

2025

38. N-Methyl-D-Aspartate Receptor (NMDAR) Antibodies Induce Diverse Calcium Activity Patterns on Cultured Astrocytes and Astrocyte–Neuron Cocultures

AYŞİT N., BOSTAN S., ULUSOY C. A., TÜZÜN E., BAYAT F. K.

Acta Neurologica Scandinavica , cilt.2025, sa.1, 2025 (SCI-Expanded, Scopus)

2025

39. Baseline eronufilmniaet light chain and brain-derived neurotrophic factor levels predict development of aggressive multiple sclerosis

Erol Yildiz R., Akbayir E., Kizilay T., Ersöz A. S., Özkan Yaşargün D., Süer D., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.55, sa.5, 2025 (SCI-Expanded, Scopus, TRDizin)

2025

40. Sodium/Potassium-transporting ATPase Subunit Alpha-3 Antibody is not Present in Patients with Idiopathic Intracranial Hypertension

KÜÇÜKALİ C. İ., Soylu S., Ulusoy C., TÜZÜN E.

Haseki Tip Bulteni , cilt.63, sa.1, ss.6-11, 2025 (ESCI, Scopus, TRDizin)

2024

41. Cognitive Dysfunction in Multiple Sclerosis Patients with Hippocampal Antibodies.

Arsoy E., Yüceer H., Yalçın B., Günbek S., Tezel M., Türkoğlu R., et al.

Noro psikiyatri arsivi , cilt.61, sa.4, ss.293-295, 2024 (SCI-Expanded, Scopus, TRDizin)

2024

42. The Fibrotic Response in Pericyte Culture Upon Exposure to Multiple Sclerosis Sera.

Şekerdağ-Kılıç E., Özkan E., Ulusoy C., Uçar E. A., Shomalizadeh N., Sapancı S., et al.

Noro psikiyatri arsivi , cilt.62, sa.1, ss.69-76, 2024 (SCI-Expanded, Scopus, TRDizin)

2024

43. Distinctive sleep complaints and polysomnographic findings in antibody subgroups of autoimmune limbic encephalitis

Küçükali C. İ., Yılmaz V., Karadeniz D., Akyıldız U. O., İlhan Algın D., Sarıtaş A. Ş., et al.

NEUROLOGICAL SCIENCES , cilt.45, sa.11, ss.5429-5439, 2024 (SCI-Expanded, Scopus)

2024

44. Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study

Kızılay T., Akbayir E., Erol R., Demir A. S., Özkan Yaşargün D., Yilmaz V., et al.

EUROPEAN NEUROLOGY , cilt.87, sa.4, ss.203-210, 2024 (SCI-Expanded, Scopus)

2024

45. Patients with restless legs syndrome exhibit reduced serum colony-stimulating factor-1, humanin-like 3 and 10 levels

Gülçiçek A., Şanlı E., Şenel G. B., Karadeniz D., Timirci-Kahraman Ö., Küçükali C. İ., et al.

ACTA NEUROLOGICA BELGICA , cilt.124, sa.5, ss.1561-1568, 2024 (SCI-Expanded, Scopus)

2024

46. Gene Expression Levels Related to Histone Acetylation are Altered in Parkinson Disease Patients Parkinson Hastalarında Histon Asetilasyonu ile İlgili Gen İfade Düzeylerinin Değişimi

Tunoğlu S., Yalçin B., Yenilmez Tunoğlu E. N., KARAASLAN Z., BİLGİÇ B., Hanağasi H. A., et al.

Noropsikiyatri Arsivi , cilt.61, sa.3, ss.271-274, 2024 (SCI-Expanded, Scopus, TRDizin)

2024

47. The Association Between Serum Levels of Glial Biomarkers, Clinical Severity and Electro-encephalography Features in Idiopathic West and Lennox-Gastaut Syndromes

Charkazzade M., Soylu S., Tüzün E., Yılmaz V., Sezgin M., Yapıcı Z., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.61, sa.2, ss.128-134, 2024 (SCI-Expanded, Scopus, TRDizin)

2024

48. Autoimmune Encephalitis with Antibodies Against A-Amino-3hydroxy-5Methyl-4-Isoxazolepropionic Acid Receptor and γ-Aminobutyric Acid-Beta Receptor: Case Report

Doğan F. U., Samanci B., YILMAZ V., Hanağasi H. A., Gürvit İ. H., TÜZÜN E., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.61, sa.1, ss.94-96, 2024 (SCI-Expanded, Scopus, TRDizin)

2024

49. Electrodiagnostic methods to verify Guillain-Barré syndrome subtypes in Istanbul: A prospective multicenter study

Tasdemir V., Sirin N. G., Cakar A., Culha A., Soysal A., Elmali A. D., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.29, sa.1, ss.72-81, 2024 (SCI-Expanded, Scopus)

2024

50. Glycine Receptor β-Targeting Autoantibodies Contribute to the Pathology of Autoimmune Diseases.

Wiessler A., Talucci I., Piro I., Seefried S., Hörlin V., Baykan B. B., et al.

Neurology(R) neuroimmunology & neuroinflammation , cilt.11, sa.2, 2024 (SCI-Expanded, Scopus)

2024

51. Peripheral blood regulatory B and T cells are decreased in patients with focal epilepsy

ŞANLI E., ŞİRİN İNAN N. G., KÜÇÜKALİ C. İ., Baykan B., ULUSOY C. A., BEBEK N., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.387, 2024 (SCI-Expanded, Scopus)

2024

52. Seronegative NMOSD patients display distinctive peripheral blood T-cell subset frequencies

Sanli E., Karaaslan Z., Yilmaz V., Gunduz T., Kurtuncu M., Turkoglu R., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , cilt.219, sa.1, 2024 (SCI-Expanded, Scopus)

2024

53. Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause.

Tzartos J., Pechlivanidou M., Bosveli D., Ninou E., Yuceer H., Yalcin B., et al.

In vivo (Athens, Greece) , cilt.38, sa.1, ss.351-357, 2024 (SCI-Expanded, Scopus)

2024

54. Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders

Pechlivanidou M., Vakrakou A. G., Karagiorgou K., Tüzün E., Karachaliou E., Chroni E., et al.

FRONTIERS IN IMMUNOLOGY , cilt.15, 2024 (SCI-Expanded, Scopus)

2024

55. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes

Ozdag Acarli A. N., Tuzun E., Sanli E., Koral G., Akbayir E., Cakar A., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , cilt.215, sa.1, ss.65-78, 2024 (SCI-Expanded, Scopus)

2023

56. [Cerebellar antibodies in post-stroke sera of acute ischemic stroke patients].

Atmaca M. M., Erdağ E., Demir S., Yüceer H., Atmaca M. Ç., Küçükali C. İ., et al.

Ideggyogyaszati szemle , cilt.76, sa.11-12, ss.394-398, 2023 (SCI-Expanded, Scopus)

2023

57. Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice

Koral G., Ulusoy C., Cossins J., Lazaridis K., Türkoğlu R., Dong Y. Y., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.383, 2023 (SCI-Expanded, Scopus)

2023

58. Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement

KARAASLAN Z., Şengül-Yediel B., Yüceer-Korkmaz H., ŞANLI E., GEZEN AK D., DURSUN E., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.78, 2023 (SCI-Expanded, Scopus)

2023

59. Distribution of peripheral blood mononuclear cell subtypes in patients with West syndrome: Impact of synacthen treatment

Soylu S., Cherkezzade M., Akbayır E., Korkmaz H., Koral G., Şanlı E., et al.

IMMUNOLOGY LETTERS , cilt.261, ss.17-24, 2023 (SCI-Expanded, Scopus)

2023

60. Demyelinating Inflammatory Disorders of the Central Nervous System in the Era of COVID-19: Cases with Mild Infectious Symptoms.

Yaşargün D. Ö., Türkoğlu R., Tüzün E.

Noro psikiyatri arsivi , cilt.60, sa.3, ss.191-193, 2023 (SCI-Expanded, Scopus, TRDizin)

2023

61. Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination

Pechlivanidou M., Xenou K., Tzanetakos D., Koutsos E., Stergiou C., Andreadou E., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.24, sa.16, 2023 (SCI-Expanded, Scopus)

2023

62. Generalized Peripheric Nerve Hyperexcitability with Neuropathy: Case Series with Long-Term Outcome.

Akan O., Baysal L., Uzunhan T. A., Tüzün E.

Noro psikiyatri arsivi , cilt.61, sa.2, ss.184-188, 2023 (SCI-Expanded)

2023

63. Autoimmune Mechanisms in Focal Epilepsy of Unknown Cause

ŞANLI E., YILMAZ V., TÜZÜN E.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , cilt.40, sa.3, ss.113-121, 2023 (SCI-Expanded)

2023

64. Serum IgG of patients with relapsing inflammatory optic neuropathy immunoreacts with Sox2-positive glial cells of the optic nerve

Erdağ E., Emekli A. S., Gündüz T., Küçükali C. İ., Kürtüncü M., Tüzün E.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.73, 2023 (SCI-Expanded, Scopus)

2023

65. Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis

Ho S., Oswald E., Wong H. K., Vural A., Yilmaz V., Tüzün E., et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , cilt.10, sa.2, 2023 (SCI-Expanded, Scopus)

2023

66. Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus.

Kilic H., Sahin S., Toprak M. F., Hatay G. H., Yilmaz K., Adrovic A., et al.

Clinical and experimental rheumatology , cilt.41, sa.3, ss.753-757, 2023 (SCI-Expanded, Scopus)

2023

67. The Effect of Lidocaine on the Experimental Model of Streptozotocin-Induced Alzheimer's Disease.

Tamam Y., Yokuş B., Tamam C., Yüceer H., Karahan S., Em B., et al.

Noro psikiyatri arsivi , cilt.60, sa.1, ss.68-72, 2023 (SCI-Expanded, Scopus, TRDizin)

2023

68. Glycine receptor autoantibody binding to the extracellular domain is independent from receptor glycosylation.

Rauschenberger V., Piro I., Kasaragod V. B., Hörlin V., Eckes A., Kluck C. J., et al.

Frontiers in molecular neuroscience , cilt.16, ss.1089101, 2023 (SCI-Expanded)

2023

69. Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy

ORHUN G., ESEN F., YILMAZ V., Ulusoy C., ŞANLI E., Yildirim E., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.133, sa.3, ss.327-333, 2023 (SCI-Expanded, Scopus)

2023

70. Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder

KARAASLAN Z., YILMAZ V., YÜCEER H., ŞANLI E., Akcay H. I., Kurtuncu M., et al.

Northern Clinics of Istanbul , cilt.10, sa.3, ss.341-344, 2023 (ESCI, Scopus, TRDizin)

2023

71. Perivascular PDGFRB+ cells accompany lesion formation and clinical evolution differentially in two different EAE models.

Şekerdağ-Kılıç E., Ulusoy C., Atak D., Özkan E., Gökyüzü A. B., Seyaj S., et al.

Multiple sclerosis and related disorders , cilt.69, sa.1, ss.104428, 2023 (SCI-Expanded, Scopus)

2023

72. Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis

Pişkin Ş. A., Korkmaz H., Ulusoy C. A., Şanlı E., Küçükali C. İ., Onat F., et al.

FRONTIERS IN IMMUNOLOGY , cilt.14, 2023 (SCI-Expanded, Scopus)

2023

73. Effect of telerehabilitation on verbal and visual memory in multiple sclerosis patients: A 12-month follow-up study

Arsoy E., Pamuk S., Tüzün E., Türkoğlu R.

Journal of Multiple Sclerosis Research , cilt.3, sa.2, ss.30-36, 2023 (Hakemli Dergi)

2023

74. Immunoreactivity against SLC3A2 in high grade gliomas displays positive correlation with glioblastoma patient survival: Potential target for glioma diagnosis and therapy

Karakaş N., Topçu O., Tüzün E., Timirci Kahraman Ö., Sabancı P. A., Aras Y., et al.

Biorxiv , cilt.26, ss.525653, 2023 (Hakemsiz Dergi)

2023

75. Increased neuropil antibody prevalence in COVID-19 patients with acute ischemic stroke

Baştan B., ERDAĞ TURGEON E., ŞANLI E., Bayar M. D., Şişman A. B., Atacan Yaşgüçlükal M., et al.

Neurological Research , cilt.45, sa.11, ss.988-993, 2023 (SCI-Expanded)

2023

76. Cerebrospinal fluid and serum autoantibodies in drug-resistant temporal lobe epilepsies: case series

Canbaz Kabay S., Tüzün E., Akdağ G., Çetiner M., Ayas S., Özişik Karaman H., et al.

Osmangazi Tıp Dergisi , cilt.45, sa.1, ss.125-129, 2023 (TRDizin)

2022

77. Neuropsychiatry in the Century of Neuroscience

Marangozoğlu Samanci B., Yildizhan E., Tüzün E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.59, ss.1-2, 2022 (SCI-Expanded, Scopus, TRDizin)

2022

78. Permanent Impairment of Language Functions in an Adolescent Case of Autoimmune Encephalitis Adölesan Bir Otoimmün Ensefalit Vakasında Kalıcı Dil Fonksiyon Bozukluğu

ŞANLI E., Savaş M., Öztürk G., Findik O. T. P., Başoğlu S., Akbeyaz H., et al.

Noropsikiyatri Arsivi , cilt.59, sa.4, ss.338-341, 2022 (SCI-Expanded, Scopus, TRDizin)

2022

79. The modulatory action of C-Vx substance on the immune system in COVID-19

Tahrali I., Akdeniz N., Yilmaz V., Kucuksezer U. C., Oktelik F. B., Ozdemir O., et al.

EMERGING MICROBES & INFECTIONS , cilt.11, sa.1, ss.2698-2710, 2022 (SCI-Expanded, Scopus)

2022

80. Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios

Oezguen N., Yılmaz V., Horvath T. D., Akbayir E., Haidacher S. J., Hoch K. M., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.68, 2022 (SCI-Expanded, Scopus)

2022

81. Cutaneous allodynia and thermal thresholds in chronic migraine: The effect of onabotulinumtoxinA.

Ozarslan M., Matur Z., Tuzun E., Oge A. E.

Clinical neurology and neurosurgery , cilt.220, ss.107357, 2022 (SCI-Expanded, Scopus)

2022

82. Reduced expression of inflammasome complex components in cluster headache.

Şahin E., Karaaslan Z., Şanlı E., Timirci Kahraman Ö., Ulusoy C., Kocasoy Orhan E., et al.

Headache , cilt.62, sa.8, ss.967-976, 2022 (SCI-Expanded, Scopus)

2022

83. Immune modulation as a consequence of SARS-CoV-2 infection

Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz V., Küçüksezer U. C., Akdeniz N., et al.

FRONTIERS IN IMMUNOLOGY , cilt.13, 2022 (SCI-Expanded, Scopus)

2022

84. Do the neurologists recognize autoimmune epilepsy well enough? What is the effect of the pandemic on this matter?

Yavuz E. N. V., Altindag E., Tuzun E., Baykan B.

NEUROLOGICAL SCIENCES , cilt.43, sa.8, ss.5029-5037, 2022 (SCI-Expanded, Scopus)

2022

85. Classical complement pathway factor alterations in narcolepsy.

Yüceer H., Gezen Ak D., Benbir Şenel G., Dursun E., Yilmaz V., Karadeniz D., et al.

Acta neuropsychiatrica , cilt.34, sa.4, ss.212-219, 2022 (SCI-Expanded, Scopus)

2022

86. Blood-brain barrier targeted delivery of lacosamide-conjugated gold nanoparticles: Improving outcomes in absence seizures.

Temizyürek A., Yılmaz C. U., Emik S., Akcan U., Atış M., Orhan N., et al.

Epilepsy research , cilt.184, ss.106939, 2022 (SCI-Expanded, Scopus)

2022

87. Kv5.1 antibody in epilepsy patients with unknown etiology

KÜÇÜKALİ C. İ., Sengul B., Gezen-Ak D., Dursun E., ERDAĞ E., AKPINAR G., et al.

EPILEPSY RESEARCH , cilt.182, 2022 (SCI-Expanded, Scopus)

2022

88. Posterior Reversible Encephalopathy in Sepsis-Associated Encephalopathy: Experience from a Single Center.

Orhun G., Sencer S., Tüzün E., Bebek N., Ergin Özcan P., Barburoğlu M., et al.

Neurocritical care , cilt.36, ss.372-386, 2022 (SCI-Expanded, Scopus)

2022

89. IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.

Koneczny I., Tzartos J., Mané-Damas M., Yilmaz V., Huijbers M. G., Lazaridis K., et al.

Frontiers in immunology , cilt.13, sa.13, ss.834342, 2022 (SCI-Expanded, Scopus)

2022

90. CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

KARAASLAN Z., KÜRTÜNCÜ M., Akcay H. I., GÜNDÜZ T., Altunrende B., Turkoglu R., et al.

EUROPEAN NEUROLOGY , cilt.85, sa.1, ss.69-71, 2022 (SCI-Expanded, Scopus)

2022

91. Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.

Türkoğlu R., Baliç N., Kızılay T., Erol R., Akbayır E., Yılmaz V., et al.

Multiple sclerosis and related disorders , cilt.58, ss.103524, 2022 (SCI-Expanded, Scopus)

2022

92. Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behcet's disease

Karaaslan Z., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Akbayır E., Koral G., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.4, ss.1266-1273, 2022 (SCI-Expanded, Scopus, TRDizin)

2022

93. Biomarker Value of Neurofilaments and Glial Fibrillary Acidic Protein in Central Nervous System Lymphoma and Tumors Merkezi Sinir Sistemi Lenfoma ve Tümörlerinde Nörofilamentlerin ve Glial Fibriler Asidik Proteinin Biyobelirteç Değeri

YÜCEER H., TÜZÜN E.

Noropsikiyatri Arsivi , cilt.59, sa.4, ss.253-254, 2022 (SCI-Expanded, Scopus, TRDizin)

2022

94. INCREASED SERUM CITRULLINATED HISTONE H3 LEVELS IN COVID-19 PATIENTS WITH ACUTE ISCHEMIC STROKE AKUT ISCHAEMIÁS STROKE-BAN SZENVEDÔ COVID-19-BETEGEK KÖRÉBEN MEGNÔ A SZÉRUM CITRULLINÁLT HISZTON H3-SZINTJE

Bayar M. D., Şişman A. B., Koral G., Çirak S., TÜZÜN E., Günaydin S., et al.

Ideggyogyaszati Szemle , cilt.75, sa.5-6, ss.191-198, 2022 (SCI-Expanded, Scopus)

2022

95. The effects of demographic, clinical, and radiological parameters of multiple sclerosis on quality of life and fatigue

Arsoy E., Delipoyraz I., Bulut N., Tüzün E., Türkoğlu R.

Haydarpaşa Numune Hastanesi Tıp Dergisi , cilt.62, sa.2, ss.206-212, 2022 (Hakemli Dergi)

2022

96. Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination

Oktelik F. B., Yilmaz V., Gelmez M. Y., Akdeniz N., Pamukcu C., Sutlu T., et al.

CANADIAN JOURNAL OF MICROBIOLOGY , cilt.68, ss.543-550, 2022 (SCI-Expanded, Scopus)

2021

97. Phosphorylated Neurofilament Heavy Chain (pNFH) in Clinically Isolated Syndrome and Multiple Sclerosis

TÜZÜN E., ŞANLI E., Akbayir E., Turkoglu R.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.58, sa.4, ss.255-256, 2021 (SCI-Expanded, Scopus, TRDizin)

2021

98. Expression of Akt1 and p-Akt1 in peripheral T cell subsets of multiple sclerosis patients.

Oktelik F. B., Yilmaz V., Turkoglu R., Akbayir E., Tuzun E., Deniz G., et al.

Acta neurologica Belgica , cilt.121, sa.6, ss.1777-1782, 2021 (SCI-Expanded, Scopus)

2021

99. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study

SAĞIR F., Tunali N. E., TOMBUL T., Koral G., Cirak S., YILMAZ V., et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS , sa.11, ss.720-726, 2021 (SCI-Expanded, Scopus)

2021

100. Cerebrospinal fluid level of phosphorylated neurofilament heavy chain is higher in converting clinically isolated syndrome and correlates with CAMP response element-binding protein concentration

Gencer M., Koral G., ŞANLI E., Cirak S., Akbayir E., YÜCEER H., et al.

Neurological Sciences and Neurophysiology , cilt.38, sa.4, ss.256-261, 2021 (SCI-Expanded, Scopus, TRDizin)

2021

101. Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause.

Savaş M., Tzartos J., Küçükali C., Dursun E., Karagiorgou K., Gezen-Ak D., et al.

Acta neurologica Belgica , cilt.121, sa.5, ss.1275-1280, 2021 (SCI-Expanded, Scopus)

2021

102. Leucine-Rich Glioma-Inactivated Protein 1 Antibody-Positive Polyradiculopathy Associated with Epstein-Barr Virus Infection.

Uzunalimoğlu B. P., Sağlam A., Şişman B., Günaydın S., Uzuner E. G., Aysal F., et al.

Case reports in neurology , cilt.13, sa.2, ss.549-554, 2021 (ESCI, Scopus)

2021

103. Paraneoplastic cerebellar degeneration in a patient with multiple myeloma

KÜRTÜNCÜ M., TÜZÜN E.

LEUKEMIA & LYMPHOMA , cilt.62, sa.10, ss.2556-2557, 2021 (SCI-Expanded, Scopus)

2021

104. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis

YILMAZ V., Ulusoy C., Hajtovic S., Turkoglu R., Kurtuncu M., Tzartos J., et al.

Immunological Investigations , cilt.50, ss.671-684, 2021 (SCI-Expanded, Scopus)

2021

105. Serum glial fibrillary acidic protein (GFAP)-antibody in idiopathic intracranial hypertension.

Yetimler B., Tzartos J., Şengül B., Dursun E., Ulukan Ç., Karagiorgou K., et al.

The International journal of neuroscience , cilt.131, sa.8, ss.775-779, 2021 (SCI-Expanded, Scopus)

2021

106. Peripheral blood B cell subset ratios and expression levels of B cell-associated genes are altered in benign multiple sclerosis

Turkoglu R., YILMAZ V., ÖZDEMİR Ö., Akbayir E., Benbir G., Arsoy E., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.52, 2021 (SCI-Expanded, Scopus)

2021

107. Impact of Autoimmune Demyelinating Brain Disease Sera on Pericyte Survival

Ulusoy C., Şekerdağ E., YILMAZ V., Yilmaz A. B., Atak D., Vural A., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.2, ss.83-86, 2021 (SCI-Expanded, Scopus, TRDizin)

2021

108. Aquaporin-4 Gene Polymorphisms in Relapsing Inflammatory Optic Neuropathy and RANKL in Glioblastoma: Research and Progress on Biomarkers.

Şanli E., Tüzün E.

Noro psikiyatri arsivi , cilt.58, sa.2, ss.81-82, 2021 (SCI-Expanded, Scopus, TRDizin)

2021

109. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings

Noyan H., ERDAĞ E., TÜZÜN E., YAYLIM İ., KÜÇÜKHÜSEYİN Ö., HAKAN M. T., et al.

Schizophrenia Research , cilt.229, ss.27-37, 2021 (SCI-Expanded, SSCI, Scopus)

2021

110. Tumefactive demyelinating lesions: A case series of 11 patients and review of the literature

Efendioğlu M., Kızılay T., Erol Yıldız R., Süer D., Karaaslan Z., Mısırlı C., et al.

Haydarpaşa Numune Hastanesi Tıp Dergisi , cilt.61, sa.3, ss.245-255, 2021 (Hakemli Dergi)

2021

111. Adaptive immunity cells are differentially distributed in the peripheral blood of glycine receptor antibody-positive patients with focal epilepsy of unknown cause.

Sanli E., Akbayir E., Kuçukali C. İ., Baykan B., Sirin N. G., Bebek N., et al.

Epilepsy research , cilt.170, ss.106542, 2021 (SCI-Expanded, Scopus)

2021

112. CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.

Tamam Y., Gunes B., Akbayir E., Kizilay T., Karaaslan Z., Koral G., et al.

Multiple sclerosis and related disorders , cilt.48, sa.1, ss.102697, 2021 (SCI-Expanded, Scopus)

2021

113. The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigens.

Hoffmann C., Zong S., Mané-Damas M., Stevens J., Malyavantham K., Küçükali C. İ., et al.

Schizophrenia research , cilt.228, ss.462-471, 2021 (SCI-Expanded, SSCI, Scopus)

2021

114. Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients.

Karaaslan Z., Kahraman Ö. T., Şanlı E., Ergen H. A., Ulusoy C., Bilgiç B., et al.

Scientific reports , cilt.11, sa.1, ss.2316, 2021 (SCI-Expanded, Scopus)

2021

115. Central Role of T Follicular Helper Cells in Myasthenia Gravis.

Wu N., Tüzün E., Cheng Y., Yan L., Wu Y., Rao J., et al.

Noro psikiyatri arsivi , cilt.58, sa.1, ss.68-72, 2021 (SCI-Expanded, Scopus, TRDizin)

2021

116. Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

Koneczny I., YILMAZ V., Lazaridis K., Tzartos J., Lenz T. L., Tzartos S., et al.

FRONTIERS IN IMMUNOLOGY , cilt.11, 2021 (SCI-Expanded, Scopus)

2021

117. Expression levels of B cell receptor (BCR) signaling pathway factors are associated with conversion from clinically isolated syndrome to multiple sclerosis

Karaaslan Z., Akbayır E., Şanlı E., Şen M., Yüceer H., Türkoğlu R., et al.

EXPERIMED , cilt.11, sa.1, ss.33-37, 2021 (TRDizin)

2021

118. Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis

Culha Oktar A., Selcuk O., Elmas Tunc C., IŞILDAK Ş., ŞANLI E., YILMAZ V., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2570-2574, 2021 (SCI-Expanded, Scopus, TRDizin)

2021

119. Impact of calcitriol and an AKT inhibitor, AT7867, on survival of rat C6 glioma cells

KÜÇÜKHÜSEYİN Ö., ÇAKİRİS A., HAKAN M. T., Horozoglu C., TÜZÜN E., YAYLIM İ.

BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT , cilt.35, sa.1, ss.730-738, 2021 (SCI-Expanded, Scopus)

2021

120. The effect of cognitive rehabilitation on peripheral blood B cell distribution and specific gene expression levels in MS patients

Akbayır E., Şen M., Arsoy E., Türkoğlu R., Yılmaz V., Tüzün E.

Journal of Multiple Sclerosis Research , cilt.1, sa.2, ss.32-39, 2021 (Hakemli Dergi)

2020

121. The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients

YILMAZ V., TÜZÜN E., DURMUŞ TEKÇE H., Oflazer P., Aysal F., Parman Y., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.349, 2020 (SCI-Expanded, Scopus)

2020

122. Peripheral blood expression levels of inflammasome complex components in two different focal epilepsy syndromes

Ulusoy C., Vanlı-Yavuz E., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Bebek N., et al.

Journal of Neuroimmunology , cilt.347, 2020 (SCI-Expanded, Scopus)

2020

123. A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain

Sisman A. B., Bayar M. D., İçöz S., YILMAZ V., Kürtüncü M., TÜZÜN E., et al.

Case Reports in Neurology , cilt.12, sa.3, ss.334-338, 2020 (ESCI, Scopus)

2020

124. Determination of Paraneoplastic neuropathy in newly diagnosed breast tumor patients

Sayman C., Tireli H., Tüzün E., Günay Gürleyik M., Vardar Aker F.

eNeurologicalSci , cilt.21, ss.100265, 2020 (Scopus)

2020

125. The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.

Arslan D. B., Gurvit H., Genc O., Kicik A., Eryurek K., Cengiz S., et al.

Journal of neural transmission (Vienna, Austria : 1996) , cilt.127, ss.1285-1294, 2020 (SCI-Expanded, Scopus)

2020

126. Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease

Gündüz T., Kürtüncü M., Matur Z., Tüzün E., Limon U., Tanyildiz B., et al.

Journal of the Neurological Sciences , cilt.414, 2020 (SCI-Expanded, Scopus)

2020

127. Aquaporin-4 Gene Polymorphisms in Neuromyelitis Optica and Recurrent Optic Neuritis

Çakar A., Ulusoy C. A., İplik E. S., Küçükali C. İ., Tüzün E., Kürtüncü M.

Turkish Journal of Neurology , cilt.26, sa.2, ss.127-130, 2020 (Hakemli Dergi)

2020

128. Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature.

Gulec B., Kurucu H., Bozbay S., Dikmen Y., Sayman H., Tuzun E., et al.

Multiple sclerosis and related disorders , cilt.42, ss.102075, 2020 (SCI-Expanded, Scopus)

2020

129. Nivolumab-induced autoantibody negative limbic encephalitis in a patient with Hodgkin lymphoma

Erol-Yıldız R., Kızılay T., TÜZÜN E., Mısırlı H., Türkoğlu R.

Leukemia and Lymphoma , cilt.61, sa.6, ss.1519-1521, 2020 (SCI-Expanded, Scopus)

2020

130. [Episodes with goose bumps caused by anti-LGI-1 encephalitis].

Johansson L., Esbjörnsson M., Tüzün E., van W., Baureder R., Sahin G.

Lakartidningen , cilt.117, sa.117, 2020 (Scopus)

2020

131. Small ubiquitin-related modifier (SUMO) 3 and SUMO4 gene polymorphisms in Parkinson's disease

Küçükali C. İ., Salman B., Yüceer H., Ulusoy C. A., Abacı N., Ekmekci S., et al.

NEUROLOGICAL RESEARCH , cilt.42, sa.6, ss.451-457, 2020 (SCI-Expanded, Scopus)

2020

132. Plasma levels of inflammatory mediators in vestibular migraine.

Karaaslan Z., Ozcelik P., Ulukan Ç., Ulusoy C. A., Orhan K. S., Orhan E., et al.

The International journal of neuroscience , cilt.130, sa.4, ss.330-335, 2020 (SCI-Expanded, Scopus)

2020

133. NLRP1-Mediated Antidepressant Effect of Ketamine in Chronic Unpredictable Mild Stress Model in Rats.

Aricioğlu F., Yalcinkaya C., Ozkartal C., Tuzun E., Sirvanci S., Kucukali C. İ., et al.

Psychiatry investigation , cilt.17, ss.283-291, 2020 (SCI-Expanded, SSCI, Scopus)

2020

134. Serum immunoglobulin G of neuro-Behçet's Disease patients reduce cerebral expression levels of survival pathway factors

Erdağ E., Şahin Özkartal C., Küçükali C. İ., Arıcıoğlu F., Tüzün E.

Neurological Sciences and Neurophysiology , cilt.37, sa.3, ss.118-123, 2020 (Hakemli Dergi)

2020

135. Absence of Autoantibodies Against Neuronal Surface Antigens in Sera of Patients With Psychotic Disorders

Hoffmann C., Zong S., Mané-Damas M., Molenaar P. C., Losen M., Titulaer M. J., et al.

JAMA Psychiatry , cilt.77, sa.3, ss.322-325, 2020 (Hakemli Dergi)

2020

136. Diagnosing acute brain dysfunction due to sepsis

Esen F., Orhun G., Özcan P. E., Brenes Bastos A. R., TÜZÜN E.

Neurological Sciences , cilt.41, sa.1, ss.25-33, 2020 (SCI-Expanded, Scopus)

2020

137. Sleep disturbance and cognitive decline in multiple sclerosis patients with isolated optic neuritis as the first demyelinating event

Türkoğlu R., Benbir G., Özyurt S., Arsoy E., Akbayır E., Turan S., et al.

International Ophthalmology , cilt.40, sa.1, ss.151-158, 2020 (SCI-Expanded, Scopus)

2020

138. Investigation of IL-10 gene expression and rs1554286 SNP in Behçet's disease

Şehitoğlu Taşar E., Uğurel E., Tüzün E., Vural B.

EXPERIMED , cilt.10, sa.1, ss.25-29, 2020 (TRDizin)

2020

139. Neurocognitive decline caused by L-methionine: A mouse model of neurodegeneration

Altun Y., Tüzün E., Mehler M., Gökhan Ş.

EXPERIMED , cilt.10, sa.2, ss.59-66, 2020 (TRDizin)

2020

140. Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study

Tamam Y., Yuceer H., Duzel B., Sen M., Ulusoy C., Tuzun E.

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.45, sa.2, ss.237-240, 2020 (SCI-Expanded, Scopus)

2020

141. Impact of epilepsy on language and discourse: Two self-limited focal epileptic syndromes of childhood

Savas M., TUNÇER A. M., Cokar A. O., Demirbilek A. V., Tuzun E.

EPILEPSY & BEHAVIOR , cilt.102, 2020 (SCI-Expanded, Scopus)

2020

142. Neuroimmunology of COVID-19

Ekizoğlu Turgut E., Tüzün E.

Türkiye Klinikleri Journal of Medical Research , cilt.1, sa.1, ss.1-5, 2020 (Hakemli Dergi)

2019

143. Antidepressant-like effects of agmatine and NOS inhibitors in chronic unpredictable mild stress model of depression in rats: The involvement of NLRP inflammasomes

Ozkartal C. S., Tuzun E., Kucukali C. I., Ulusoy C. A., Giris M., ARICIOĞLU F.

BRAIN RESEARCH , cilt.1725, 2019 (SCI-Expanded, Scopus)

2019

144. Impact of fingolimod on CD4+T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients

Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Cinar S., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.337, 2019 (SCI-Expanded, Scopus)

2019

145. Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement

Sen M., Akbayir E., Mercan O., Arsoy E., Gencer M., Yilmaz V., et al.

JOURNAL OF SPINAL CORD MEDICINE , 2019 (SCI-Expanded, Scopus)

2019

146. Inflammatory biomarkers in epilepsy

Karaaslan Z., Tuzun E.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , cilt.36, sa.3, ss.129-135, 2019 (SCI-Expanded, Scopus, TRDizin)

2019

147. Expression Levels of Inflammasome Complexes in Experimental Autoimmune Myasthenia Gravis Mouse Model (EAMG).

Baltacı C. N., YILMAZ V., ULUSOY C. A., TÜZÜN E., VURAL B.

Experimed , cilt.9, sa.3, ss.79-85, 2019 (TRDizin)

2019

148. Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behcet's Disease

UGUREL E., ERDAG E., KUCUKALI C. İ., OLCAY A., Sanli E., AKBAYIR E., et al.

IN VIVO , cilt.33, sa.5, ss.1493-1497, 2019 (SCI-Expanded, Scopus)

2019

149. Neuroinflammation Mediators are Reduced in Sera of Parkinson's Disease Patients with Mild Cognitive Impairment.

Kıçık A., Tüzün E., Erdoğdu E., Bılgıç B., Tüfekçıoğlu Z., Öztürk-Işik E., et al.

Noro psikiyatri arsivi , cilt.57, ss.15-17, 2019 (SCI-Expanded, Scopus, TRDizin)

2019

150. Inflammation and Neurodegeneration in Patients with Early-Stage and Chronic Bipolar Disorder

Karabulut S., Tasdemir I., Akcan U., Kucukali C. I., Tuzun E., Cakir S.

TURK PSIKIYATRI DERGISI , cilt.30, sa.2, ss.75-81, 2019 (SSCI, Scopus, TRDizin)

2019

151. Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats

ARICIOĞLU F., Ozkartal C. S., Bastaskin T., Tuzun E., Kandemir C., ŞİRVANCI S., et al.

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , cilt.17, sa.2, ss.261-272, 2019 (SCI-Expanded, Scopus)

2019

152. Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis

Gencer M., Akbayir E., Sen M., Arsoy E., Yilmaz V., Bulut N., et al.

NEUROLOGICAL SCIENCES , cilt.40, sa.5, ss.1067-1070, 2019 (SCI-Expanded, Scopus)

2019

153. Association Between Inflammatory Markers and Cognitive Outcome in Patients with Acute Brain Dysfunction Due to Sepsis

Orhun G., Tuzun E., Ergin Ozcan P., Ulusoy C., Yildirim E., Kucukerden M., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.56, ss.63-70, 2019 (SCI-Expanded, Scopus, TRDizin)

2019

154. Follow-up of patients with epilepsy harboring antiglycine receptor antibodies

EKIZOĞLU E., Baykan B., SEZGIN M., ERDAG E., GUNDOGDU-UNVERENGIL G., VANLı-YAVUZ E., et al.

EPILEPSY & BEHAVIOR , ss.103-107, 2019 (SCI-Expanded, Scopus)

2019

155. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid

Timirci-Kahraman O., Karaaslan Z., Tuzun E., Kurtuncu M., Baykal A. T., Gunduz T., et al.

ACTA NEUROLOGICA BELGICA , sa.1, ss.101-111, 2019 (SCI-Expanded, Scopus)

2019

156. Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation

Duzel B., Tamam Y., Coban A., Tuzun E.

IMMUNOLOGICAL INVESTIGATIONS , cilt.48, sa.2, ss.190-197, 2019 (SCI-Expanded, Scopus)

2019

157. Neuroimaging Findings in Sepsis-Induced Brain Dysfunction: Association with Clinical and Laboratory Findings

Orhun G., Esen F., Ozcan P. E., Sencer S., Bilgic B., Ulusoy C., et al.

NEUROCRITICAL CARE , cilt.30, ss.106-117, 2019 (SCI-Expanded, Scopus)

2019

158. B cell immunophenotyping and expression analysis of B cell specific molecules of patients with benign multiple sclerosis

Şen M., Akbayır E., Türkoğlu R., Tüzün E., Yılmaz V.

EXPERIMED , cilt.9, sa.3, ss.105-112, 2019 (Hakemli Dergi)

2019

159. Insomnia and Dysautonomia with Contactin-Associated Protein 2 and Leucine-Rich Glioma Inactivated Protein 1 Antibodies: A "Forme Fruste" of Morvan Syndrome?

Bakircioglu-Duman E., Acar Z., Benbir G., Yuceer H., Acar H., Bastan B., et al.

CASE REPORTS IN NEUROLOGY , cilt.11, sa.1, ss.80-86, 2019 (ESCI, Scopus)

2019

160. Microbiota stratification identifies disease-specific alterations in neuro-Behcet's disease and multiple sclerosis

Oezguen N., Yalcinkaya N., Kucukali C. I., Dahdouli M., Hollister E. B., Luna R. A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.58-66, 2019 (SCI-Expanded, Scopus)

2019

161. Brain Volume Changes in Patients with Acute Brain Dysfunction Due to Sepsis

Orhun G., TÜZÜN E., Bilgiç B., Ergin Özcan P., Sencer S., Barburoğlu M., et al.

Neurocritical Care , 2019 (SCI-Expanded, Scopus)

2019

162. Immunopathogenesis in neuromuscular junction disorders

Tüzün E.

Türkiye Klinikleri Journal of Medical Research , cilt.12, sa.1, ss.6-14, 2019 (Hakemli Dergi)

2018

163. Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder

Hoffmann C., Stevens J., Zong S., van Kruining D., Saxena A., Kucukali C. I., et al.

PLOS ONE , cilt.13, sa.12, 2018 (SCI-Expanded, Scopus)

2018

164. Intracranial hypertension related to cerebral venous thrombosis; and acute ischemic stroke with micro-infarcts associated with IgG4-related disease

Ekizoglu E., Coban O., Ulukan C., Ak D. G., Dursun E., Tuzun E., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.128, sa.11, ss.1097-1099, 2018 (SCI-Expanded, Scopus)

2018

165. Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause

Tekturk P., Baykan B., Erdag E., Peach S., Sezgin M., Yapici Z., et al.

BRAIN & DEVELOPMENT , cilt.40, sa.10, ss.909-917, 2018 (SCI-Expanded, Scopus)

2018

166. LRP4 antibody positive amyotrophic lateral sclerosis patients display neuropil-reactive IgG and enhanced serum complement levels

Tuzun E., Gezen-Ak D., Tzartos J., Dursun E., Giris M., Zisimopoulou P., et al.

IMMUNOLOGY LETTERS , cilt.203, ss.54-56, 2018 (SCI-Expanded, Scopus)

2018

167. A SOD2 Polymorphism is Associated with Abnormal Quantitative Sensory Testing in Type 2 Diabetic Patients

Isikli A., Kubat-Uzum A., Satman I., Matur Z., Oge A. E., Kucukali M. I., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.55, sa.3, ss.276-279, 2018 (SCI-Expanded, Scopus, TRDizin)

2018

168. Evidence of linkage to chromosome 5p13.2-q11.1 in a large inbred family with genetic generalized epilepsy

Kinay D., Oliver K. L., Tuzun E., Damiano J. A., Ulusoy C., Andermann E., et al.

EPILEPSIA , cilt.59, sa.8, 2018 (SCI-Expanded, Scopus)

2018

169. Effect of LGI1 antibody-positive IgG on hippocampal neuron survival: a preliminary study

Aysit-Altuncu N., Ulusoy C., ÖZTÜRK G., Tuzun E.

NEUROREPORT , cilt.29, sa.11, ss.932-938, 2018 (SCI-Expanded, Scopus)

2018

170. Delta Brush Pattern Is Not Unique to NMDAR Encephalitis: Evaluation of Two Independent Long-Term EEG Cohorts

Baykan B., Tuncer O. G., Vanli-Yavuz E. N., Kirac L. B., Gundogdu G., Bebek N., et al.

CLINICAL EEG AND NEUROSCIENCE , cilt.49, sa.4, ss.278-284, 2018 (SCI-Expanded, Scopus)

2018

171. Peripheral blood memory B cell frequency predicts conversion from clinically isolated syndrome to multiple sclerosis

Aktura S. D., Yilmaz V., Ozkan-Yasargun D., Ulusoy C., Tuzun E., Turkoglu R.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.23, ss.9-14, 2018 (SCI-Expanded, Scopus)

2018

172. Prognostic Factors in Anti-Neurona Antibody Positive Patients

Aydin C., Celik S. Y., Icoz S., Ulusoy C. A., Gunduz T., Akman Demir G., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.55, sa.2, ss.189-194, 2018 (SCI-Expanded, Scopus, TRDizin)

2018

173. The psychiatric profiles of patients with temporal lobe epilepsy associated with neuronal auto-antibodies

Sezgin M., Cikrikcili U., Kulaksizoglu I. B., Vanli-Yavuz E. N., Bebek N., Tuzun E., et al.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , cilt.35, sa.2, ss.84-90, 2018 (SCI-Expanded, Scopus, TRDizin)

2018

174. Mechanisms of action of intravenous immunoglobulin in septic encephalopathy

Esen F., Ozcan P. E., Tuzun E., Boone M. D.

REVIEWS IN THE NEUROSCIENCES , cilt.29, sa.4, ss.417-423, 2018 (SCI-Expanded, Scopus)

2018

175. Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels

Akcan U., Karabulut S., Kucukali C. I., Cakir S., Tuzun E.

ACTA NEUROPSYCHIATRICA , cilt.30, sa.2, ss.70-78, 2018 (SCI-Expanded, Scopus)

2018

176. Reduced Peripheral Blood Mononuclear Cell ROCK1 and ROCK2 Levels in Obstructive Sleep Apnea Syndrome

Aydin S., Ozdemir C., Kucukali C. I., Sokucu S. N., Giris M., Akcan U., et al.

IN VIVO , cilt.32, sa.2, ss.319-325, 2018 (SCI-Expanded, Scopus)

2018

177. Comparison of the expression of levels of PI3K/Akt pathway factors in Parkinson’s disease and lung cancer

Şanlı E., Yalçınkaya N., Tüzün E.

EXPERIMED , cilt.8, sa.2, ss.52-57, 2018 (Hakemli Dergi)

2018

178. Immunopathological Factors Associated with Disability in Multiple Sclerosis.

Tüzün E.

Noro psikiyatri arsivi , cilt.55, sa.Suppl 1, 2018 (SCI-Expanded)

2018

179. Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis

TEZER FİLİK F. İ., FIRAT A., Tuzun E., Unal I., Soylemezoglu F., BİLGİNER B., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.128, sa.5, ss.421-428, 2018 (SCI-Expanded, Scopus)

2018

180. Effects of computer-assisted cognitive rehabilitation in benign multiple sclerosis

Arsoy E., Tuzun E., Turkoglu R.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.48, sa.5, ss.999-1005, 2018 (SCI-Expanded, Scopus, TRDizin)

2018

181. Transcriptional repressor Blimp1 regulates follicular regulatory T-cell homeostasis and function

Yang G., Yang X., Zhang J., Li G., Zheng D., Peng A., et al.

IMMUNOLOGY , cilt.153, sa.1, ss.105-117, 2018 (SCI-Expanded, Scopus)

2018

182. Chronic mild stress-induced anhedonia in rats is coupled with the upregulation of inflammasome sensors: a possible involvement of NLRP1

Ozkartal C. S., ARICIOĞLU F., Tuzun E., Kucukali C. I.

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , cilt.28, sa.3, ss.236-244, 2018 (SCI-Expanded, Scopus)

2017

183. Investigation of anti-neuronal antibodies in status epilepticus of unknown etiology: a prospective study

Atmaca M. M., Tuzun E., Erdag E., Bebek N., Baykan B., Gurses C.

ACTA NEUROLOGICA BELGICA , cilt.117, sa.4, ss.841-848, 2017 (SCI-Expanded, Scopus)

2017

184. Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis.

Esen F., Orhun G., Ozcan P., Senturk E., Kucukerden M., Gırıs M., et al.

Intensive care medicine experimental , cilt.5, ss.1, 2017 (ESCI, Scopus)

2017

185. A NMOSD case with multifocal nervous system involvement in a single attack

Tanyel T., Karaaslan Z., Misirli H., Gencer M., Tuzun E., Turkoglu R.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.18, ss.82-84, 2017 (SCI-Expanded, Scopus)

2017

186. Investigation of DNA repair genes in patients with obsessive-compulsive disorder

Celik R., Iplik E. S., Kucukali C. İ., Tuzun E., Cakmakoglu B.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE , cilt.26, sa.8, ss.1269-1273, 2017 (SCI-Expanded, Scopus)

2017

187. Glial and neuronal antibodies in patients with idiopathic intracranial hypertension

Altiokka-Uzun G., Erdag E., Baykan B., TZARTOS J., Gezen-Ak D., Samanci B., et al.

NEUROLOGICAL SCIENCES , sa.10, ss.1817-1822, 2017 (SCI-Expanded, Scopus)

2017

188. Neuron-specific enolase levels as a marker for possible neuronal damage in idiopathic intracranial hypertension

Samanci Y., Samanci B., Sahin E., Altiokka-Uzun G., Kucukali C. I., Tuzun E., et al.

ACTA NEUROLOGICA BELGICA , cilt.117, sa.3, ss.707-711, 2017 (SCI-Expanded, Scopus)

2017

189. Anti-Neuronal Autoantibodies in Both Drug Responsive and Resistant Focal Seizures with Unknown Cause

Gozubatik-Celik G., Ozkara C., Ulusoy C. A., Gunduz A., Delil S., Yeni N., et al.

EPILEPSY RESEARCH , cilt.135, ss.131-136, 2017 (SCI-Expanded, Scopus)

2017

190. Impact of Topiramate on Rat Phrenic Nerve-Hemidiaphragm Preparations

Kucukali C. I., Tuzun E., NURTEN A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.54, sa.3, ss.202-204, 2017 (SCI-Expanded)

2017

191. Recurrent tumefactive demyelinating lesions: a pathological study

Turkoglu R., Lassmann H., Aker F. V., Tzartos J., Tzartos S., Tuzun E.

CLINICAL NEUROPATHOLOGY , cilt.36, sa.4, ss.195-198, 2017 (SCI-Expanded, Scopus)

2017

192. Investigation of the prognostic value of adipokines in multiple sclerosis

Coban A., Duzel B., Tuzun E., Tamam Y.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.15, ss.11-14, 2017 (SCI-Expanded, Scopus)

2017

193. Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

Giris M., Durmus H., Yetimler B., Tasli H., Parman Y., Tuzun E.

IN VIVO , sa.4, ss.657-660, 2017 (SCI-Expanded, Scopus)

2017

194. Clinical, Electrophysiological, and Serological Evaluation of Patients with Cramp-Fasciculation Syndrome

Poyraz M., Matur Z., Aysal F., Tuzun E., Hanoglu L., Oge A. E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.54, sa.2, ss.183-186, 2017 (SCI-Expanded, Scopus, TRDizin)

2017

195. Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension

Samanci B., Samancı Y., Tuzun E., Altiokka-Uzun G., Ekizoglu E., Icoz S., et al.

CEPHALALGIA , cilt.37, sa.6, ss.525-531, 2017 (SCI-Expanded, Scopus)

2017

196. Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG

Erdag E., Sahin C., Kucukali C. İ., Bireller S., Kucukerden M., Kurtuncu M., et al.

NEUROLOGICAL SCIENCES , sa.5, ss.833-843, 2017 (SCI-Expanded, Scopus)

2017

197. Impact of Neuro-Behcet Disease Immunoglobulin G on Neuronal Apoptosis

Giris M., Bireller S., Kucukali C. I., Hanagasi H. A., Degirmencioglu S., Tuzun E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.54, sa.1, ss.67-71, 2017 (SCI-Expanded, Scopus, TRDizin)

2017

198. Neurodegenerative diseases and SUMO

Ay U., Şen M., Akbayır E., Tüzün E., Küçükali C. İ.

EXPERIMED , cilt.7, sa.13, ss.59-70, 2017 (Hakemli Dergi)

2017

199. VIABILITY OF SH-SY5Y CELLS IS ASSOCIATED WITH PURINERGIC P2 RECEPTOR EXPRESSION ALTERATIONS

Orcen A., Yilmaz V., Giris M., Akcan U., Tuzun E., Erten G.

ACTA BIOLOGICA HUNGARICA , cilt.68, sa.1, ss.22-34, 2017 (SCI-Expanded, Scopus)

2017

200. Etiopathogenesis of Parkinson’s disease

Akbayır E., Şen M., Ay U., Şenyer S., Tüzün E., Küçükali C. İ.

EXPERIMED , cilt.7, sa.13, ss.1-23, 2017 (Hakemli Dergi)

2017

201. Neuronal nitric oxide synthase polymorphisms in obsessive-compulsive disorder

TOPALOGLU M., Tuzun E., GULEC H., Bireller E. S., Cakmakoglu B., Kucukali C. İ.

NORDIC JOURNAL OF PSYCHIATRY , cilt.71, sa.2, ss.115-119, 2017 (SCI-Expanded, SSCI, Scopus)

2017

202. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?

Wu X., Tuzun E.

MEDICAL HYPOTHESES , cilt.99, ss.26-28, 2017 (SCI-Expanded, Scopus)

2017

203. A Case of Seronegative Limbic Encephalitis with Multiple Sclerosis: A Possible Overlapping Syndrome

Karaaslan Z., Mercan O., Tuzun E., Misirli H., Turkoglu R.

AMERICAN JOURNAL OF CASE REPORTS , cilt.18, ss.64-66, 2017 (ESCI, Scopus)

2017

204. Agmatine produces antidepressant effect via modulation of neuroinflammation in chronic unpredictable mild stress model of rats: Implication in inflammatory perspective of depression

Şahin-Özkartal C., Arıcıoğlu F., Tüzün E., Keleş R., Kandemir C., Şirvancı S., et al.

Psychiatry and Clinical Psychopharmacology , cilt.27, sa.1, ss.184-188, 2017 (Hakemli Dergi)

2017

205. The antibody and cytokine profile in MuSK-associated myasthenia gravis

Yüceer Korkmaz H., Ulusoy C. A., Tüzün E.

EXPERIMED , cilt.7, sa.14, ss.39-49, 2017 (Hakemli Dergi)

2017

206. The role of DNA repair mechanisms in neurodegenerative diseases

Şen M., Ay U., Tüzün E., Küçükali C. İ.

EXPERIMED , cilt.7, sa.13, ss.47-58, 2017 (Hakemli Dergi)

2017

207. NF-B, SUMO and ubiquitination relationship

Şen M., Ay U., Akbayır E., Şenyer S., Tüzün E., Küçükali C. İ.

EXPERIMED , cilt.7, sa.13, ss.35-46, 2017 (Hakemli Dergi)

2017

208. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice

Ulusoy C. A., Cavus F., Yilmaz V., Tuzun E.

IMMUNOLOGICAL INVESTIGATIONS , cilt.46, sa.5, ss.490-499, 2017 (SCI-Expanded, Scopus)

2017

209. Investigation of neuronal auto-antibodies in systemic lupus erythematosus patients with epilepsy

Karaaslan Z., Ekizoglu E., Tekturk P., Erdag E., Tuzun E., Bebek N., et al.

EPILEPSY RESEARCH , ss.132-137, 2017 (SCI-Expanded, Scopus)

2017

210. The role of NF-B in neuronal plasticity and neurodegenerative diseases

Yağmur E., Yıldız N., Adıgüzel S., Femir B., Şenyer S., Şen M., et al.

EXPERIMED , cilt.7, sa.13, ss.71-85, 2017 (Hakemli Dergi)

2016

211. Brain Infiltration of Immune Cells in CASPR2-Antibody Associated Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis

Unverengil G., Vanli Yavuz E. N., Tuzun E., Erdag E., Kabadayi S., Bilgic B., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.53, sa.4, ss.344-347, 2016 (SCI-Expanded, Scopus, TRDizin)

2016

212. NMDA receptor encephalitis with cancer of unknown primary origin

Çoban A., GÜNDOGDU G., Poyraz M., Yegen G., DEMIRTAŞ-TATLIDEDE A., Bilgiç B., et al.

TUMORI , cilt.102, 2016 (SCI-Expanded, Scopus)

2016

213. 36th International Symposium on Intensive Care and Emergency Medicine

Orhun G., Şentürk E., Ergin Özcan P., Sencer N. S., Ulusoy C. A., Tüzün E., et al.

Critical Care , cilt.20, ss.347, 2016 (Hakemli Dergi)

2016

214. Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder

Tokaç D., Tuzun E., GULEC H., Yilmaz V., Bireller E. S., Cakmakoglu B., et al.

PSYCHIATRY INVESTIGATION , cilt.13, sa.5, ss.541-548, 2016 (SCI-Expanded, SSCI, Scopus)

2016

215. Reduced fecal GABA levels in multiple sclerosis patients

Yalcinkaya N., Akcan U., Orcen A., Kucukali C. İ., Tuzun E., TURKOGLU R., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , ss.60-61, 2016 (SCI-Expanded, Scopus)

2016

216. Expression of switch-associated protein 70 is associated with lymphocyte activation and reduced disability in multiple sclerosis

Türkoğlu R., özyurt S., Ulusoy C. A., ERDAG E., Tuzun E.

IMMUNOLOGY LETTERS , cilt.177, ss.75-77, 2016 (SCI-Expanded, Scopus)

2016

217. Chemokine gene variants in schizophrenia

Dasdemir S., Kucukali C. I., Bireller E. S., Tuzun E., Cakmakoglu B.

NORDIC JOURNAL OF PSYCHIATRY , cilt.70, sa.6, ss.407-412, 2016 (SCI-Expanded, SSCI, Scopus)

2016

218. Are There Any Specific EEG Findings in Autoimmune Epilepsies?

Baysal-Kirac L., Tuzun E., ALTINDAG E., Ekizoglu E., KINAY D., Bilgic B., et al.

CLINICAL EEG AND NEUROSCIENCE , sa.3, ss.224-234, 2016 (SCI-Expanded, Scopus)

2016

219. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis

Vanli-Yavuz E. N., Erdag E., Tuzun E., Ekizoglu E., Baysal-Kirac L., Ulusoy C. A., et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , cilt.87, sa.7, ss.684-692, 2016 (SCI-Expanded, Scopus)

2016

220. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS

Oeckl P., Jardel C., Salachas F., Lamari F., Andersen P. M., Bowser R., et al.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION , cilt.17, ss.404-413, 2016 (SCI-Expanded, Scopus)

2016

221. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK

Kucukerden M., Huda R., Tuzun E., Yilmaz A., Skriapa L., Trakas N., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.295, ss.84-92, 2016 (SCI-Expanded, Scopus)

2016

222. The Owner and Responsible Manager on behalf of Turkish Neuropsychiatric Society (President)

Atbasoglu E. C., Tuzun E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.53, sa.2, 2016 (SCI-Expanded, Scopus, TRDizin)

2016

223. Neuronal autoantibodies in patients with Rasmussen's encephalitis

Samanci B., Tekturk P., Tuzun E., Erdag E., KINAY D., Yapici Z., et al.

EPILEPTIC DISORDERS , sa.2, ss.204-210, 2016 (SCI-Expanded, Scopus)

2016

224. Behcet's Disease and Nervous System Involvement

Kurtuncu M., Tuzun E., AKMAN-DEMIR G.

CURRENT TREATMENT OPTIONS IN NEUROLOGY , cilt.18, sa.5, 2016 (SCI-Expanded, Scopus)

2016

225. Autoantibodies to Neurotransmitter Receptors and Ion Channels in Psychotic Disorders

Tuzun E.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.26, sa.1, ss.75-82, 2016 (SCI-Expanded, Scopus, TRDizin)

2016

226. Increased complexin-1 and decreased miR-185 expression levels in Beh‡et's disease with and without neurological involvement

Ugurel E., Sehitoglu E., Tuzun E., Kurtuncu M., Coban A., Vural B.

NEUROLOGICAL SCIENCES , sa.3, ss.411-416, 2016 (SCI-Expanded, Scopus)

2016

227. First-episode psychotic disorder improving after immunotherapy

Gungor I., Derin S., Tekturk P., Tuzun E., Bilgic B., Cakir S.

ACTA NEUROLOGICA BELGICA , cilt.116, sa.1, ss.113-114, 2016 (SCI-Expanded, Scopus)

2016

228. Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings

Baysal-Kirac L., Tuzun E., Erdag E., Ulusoy C., Vanli-Yavuz E. N., Ekizoglu E., et al.

JOURNAL OF NEUROLOGY , cilt.263, sa.3, ss.455-466, 2016 (SCI-Expanded)

2016

229. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease

Yalcinkaya N., Haytural H., Bilgic B., Ozdemir O., Hanagasi H. A., Kucukali C. I., et al.

NEUROSCIENCE LETTERS , cilt.615, ss.72-77, 2016 (SCI-Expanded, Scopus)

2016

230. Obturator mononeuropathy due to adenocarcinoma of unknown primary origin

TURKOGLU R., GENCER M., AKER F. V., MERIC K., GOKCEER S. Y., Coban A., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , sa.6, ss.882-883, 2016 (SCI-Expanded, Scopus)

2016

231. Association Between Polymorphisms of DNA Repair Genes and Risk of Schizophrenia

ODEMIS S., Tuzun E., GULEC H., SEMIZ U. B., Dasdemir S., Kucuk M., et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS , sa.1, ss.11-17, 2016 (SCI-Expanded, Scopus)

2016

232. Epilepsy and Autoimmunity: Basic Physiopathological Mechanisms

Vanli Yavuz E. N., Tuzun E.

EPILEPSI , cilt.22, ss.1-6, 2016 (ESCI)

2016

233. Voltage-Gated Potassium Channel Antibodies is a Sign of Limbic Encephalitis

Bican Demir A., Uzun P., TAŞKAPILIOĞLU Ö., Bora I., Tuzun E.

EPILEPSI , cilt.22, ss.72-75, 2016 (ESCI, TRDizin)

2016

234. Editorial

Tüzün E.

EPILEPSI , cilt.22, sa.1, ss.5, 2016 (Hakemli Dergi)

2016

235. Limbic Encephalitis Associated with Sjogren's Syndrome: Report of Three Cases

Coban A., Ozyurt S., Meric K., Misirli H., Tuzun E., Turkoglu R.

INTERNAL MEDICINE , cilt.55, sa.16, ss.2285-2289, 2016 (SCI-Expanded, Scopus)

2016

236. Anti-Neuronal Autoantibodies Associated with Epilepsy and Related Neurological Syndromes

Coban A., Tuzun E.

EPILEPSI , cilt.22, ss.7-13, 2016 (ESCI, TRDizin)

2015

237. Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.

Ulusoy C. A., Zibandeh N., Yildirim S., TRAKAS N., ZISIMOPOULOU P., Kucukerden M., et al.

Journal of neuroinflammation , cilt.12, ss.231, 2015 (SCI-Expanded, Scopus)

2015

238. Ocular myasthenia gravis induced by human acetylcholine receptor epsilon subunit immunization in HLA DR3 transgenic mice

WU X., Tuzun E., SAINI S. S., WANG J., LI J., AGUILERA-AGUIRRE L., et al.

IMMUNOLOGY LETTERS , cilt.168, sa.2, ss.306-312, 2015 (SCI-Expanded, Scopus)

2015

239. Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice.

Ozkok E., Durmus H., Yetimler B., Tasli H., TRAKAS N., Ulusoy C. A., et al.

Clinical neuropathology , cilt.34, sa.6, ss.359-63, 2015 (SCI-Expanded, Scopus)

2015

240. Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension

Altiokka-Uzun G., Tuzun E., Ekizoglu E., Ulusoy C. A., Yentur S., Kurtuncu M., et al.

CEPHALALGIA , sa.13, ss.1153-1161, 2015 (SCI-Expanded, Scopus)

2015

241. Behcet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria

AKMAN-DEMIR G., Mutlu M. O., KIYAT-ARAMER A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)

2015

242. A case of hyperkinetic movement disorder associated with LGI1 antibodies

Erer-Ozbek S., Yapici Z., Tuzun E., Giris M., Duran S., Taskapilioglu O., et al.

TURKISH JOURNAL OF PEDIATRICS , cilt.57, sa.5, ss.514-517, 2015 (SCI-Expanded, Scopus, TRDizin)

2015

243. The association between obesity and oligoclonal band formation in multiple sclerosis patients

Coban A., çevik D., özyurt S., Gencer M., Tuzun E., TURKOGLU R.

OBESITY RESEARCH & CLINICAL PRACTICE , sa.5, ss.533-535, 2015 (SCI-Expanded, Scopus)

2015

244. Reduced serum vitamin D levels in neuromyelitis optica

Tuzun E., Kucukhuseyin Ö., Kurtuncu M., TURKOGLU R., Yaylim I.

NEUROLOGICAL SCIENCES , sa.9, ss.1701-1702, 2015 (SCI-Expanded, Scopus)

2015

245. Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization

Tuzun E., BERRIH-AKNIN S., Brenner T., Kusner L. L., LE PANSE R., YANG H., et al.

EXPERIMENTAL NEUROLOGY , cilt.270, ss.11-17, 2015 (SCI-Expanded, Scopus)

2015

246. Epigenetics of Multiple Sclerosis: An Updated Review

Kucukali C. İ., Kurtuncu M., Coban A., Cebi M., Tuzun E.

NEUROMOLECULAR MEDICINE , sa.2, ss.83-96, 2015 (SCI-Expanded, Scopus)

2015

247. Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients

Erdag E., ÇELEBİSOY N., YÜCEYAR A. N., Kurtuncu M., Vural B., Tuzun E.

ACTA NEUROLOGICA BELGICA , cilt.115, sa.2, ss.137-140, 2015 (SCI-Expanded, Scopus)

2015

248. Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis

PETEK-BALCI B., Coban A., Shugaiv E., TURKOGLU R., Ulusoy C., Icoz S., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.5, ss.352-356, 2015 (SCI-Expanded, Scopus)

2015

249. Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK

Yilmaz V., Oflazer P., AYSAL F., Durmus H., Poulas K., Yentur S. P., et al.

PLoS ONE , cilt.10, sa.4, 2015 (SCI-Expanded, Scopus)

2015

250. IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice

HUDA R., STRAIT R. T., Tuzun E., FINKELMAN F. D., CHRISTADOSS P.

JOURNAL OF NEUROIMMUNOLOGY , cilt.281, ss.68-72, 2015 (SCI-Expanded, Scopus)

2015

251. Peripheral nerve hyperexcitability syndromes

Kucukali C. İ., Kurtuncu M., Akcay H. I., Tuzun E., Oge A. E.

REVIEWS IN THE NEUROSCIENCES , sa.2, ss.239-251, 2015 (SCI-Expanded, Scopus)

2015

252. Evaluation of Paraoxonase 1 Polymorphisms in Patients with Bipolar Disorder

Kucukali C. İ., Ulusoy C., OZKAN O., Orhan N., GULEC H., Erdag E., et al.

IN VIVO , cilt.29, sa.1, ss.103-108, 2015 (SCI-Expanded, Scopus)

2015

253. Inflammation and autoimmunity in epilepsy pathogenesis

Vanlı Yavuz E. N., Tüzün E., Baykan B.

EXPERIMED , cilt.3, sa.9, ss.7-14, 2015 (Hakemli Dergi)

2015

254. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., Tuzun E., Kurtuncu M., Kiyat-Atamer A., Coban A., Akman-Demir G., et al.

MULTIPLE SCLEROSIS JOURNAL , sa.1, ss.105-107, 2015 (SCI-Expanded, Scopus)

2015

255. Febrile Infection Related Epilepsy Syndrome (FIRES) in Adults Imitating Limbic Encephalitis

Tekturk P., Baykan B., Tuzun E.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , cilt.32, sa.1, ss.243-249, 2015 (SCI-Expanded, Scopus, TRDizin)

2014

256. Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients

Kucukali C. İ., Haytural H., Benbir G., Coban A., Ulusoy C., Giris M., et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES , sa.1-2, ss.353-355, 2014 (SCI-Expanded, Scopus)

2014

257. Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study

Sehitoglu E., Cavus F., Ulusoy C., Kucukerden M., Orcen A., Akbas-Demir D., et al.

INFLAMMATION RESEARCH , sa.10, ss.799-801, 2014 (SCI-Expanded, Scopus)

2014

258. Guillain-Barre Syndrome in a Patient with Primary Extranodal Intestinal Non-Hodgkin's Lymphoma: Paraneoplastic, Drug Induced or Coincidental?

Atamer A. K., Okutur K., Tuzun E., Hasbal B., BOYACIYAN A., Krespi Y., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.51, sa.3, ss.288-292, 2014 (SCI-Expanded, Scopus, TRDizin)

2014

259. Targeting complement system to treat myasthenia gravis

HUDA R., Tuzun E., CHRISTADOSS P.

REVIEWS IN THE NEUROSCIENCES , cilt.25, sa.4, ss.575-583, 2014 (SCI-Expanded, Scopus)

2014

260. Increased IL-23 receptor, TNF-alpha and IL-6 expression in individuals with the IL23R-IL12R132 locus polymorphism

Cavus F., Ulusoy C., Orcen A., Gül A., Tuzun E., Vural B.

IMMUNOLOGY LETTERS , cilt.160, sa.1, ss.96-98, 2014 (SCI-Expanded, Scopus)

2014

261. Calcium channel antibodies in patients with absence epilepsy

Tekturk P., Baykan B., Ekizoglu E., Ulusoy C., Aydin-Ozemir Z., Icoz S., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.124, sa.7, ss.486-490, 2014 (SCI-Expanded, Scopus)

2014

262. The relationship between mitochondrial, oxidative, apoptotic parameters and PI3K/Akt pathway in animal model of Parkinson’s disease

Haytural H., Tüzün E.

EXPERIMED , cilt.3, sa.7, ss.28-37, 2014 (Hakemli Dergi)

2014

263. Anti NMDA receptor encephalitis associated with thymic hyperplasia: A case report

Yilmaz B., Mastanzade T., Ozkara C., Erkol O., Tuzun E.

NEUROLOGY INDIA , cilt.62, sa.3, ss.331-332, 2014 (SCI-Expanded, Scopus)

2014

264. Encephalomyelitis

Tüzün E.

Türkiye Klinikleri Journal of Medical Research , cilt.7, sa.3, ss.26-31, 2014 (Hakemli Dergi)

2014

265. Investigation of neuronal autoantibodies in two different focal epilepsy syndromes

Ekizoglu E., Tuzun E., Woodhall M., Lang B., Jacobson L., Icoz S., et al.

EPILEPSIA , cilt.55, sa.3, ss.414-422, 2014 (SCI-Expanded, Scopus)

2014

266. Pathogenesis of paraneoplastic neurological syndromes

Tüzün E., Akman Demir G.

Türkiye Klinikleri Journal of Medical Research , cilt.7, sa.3, ss.4-14, 2014 (Hakemli Dergi)

2014

267. Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice

Ulusoy C. A., KIM E., Tuzun E., HUDA R., Yilmaz V., Poulas K., et al.

Clinical Immunology , cilt.151, sa.2, ss.155-163, 2014 (SCI-Expanded, Scopus)

2014

268. Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression

TURKOGLU R., Gencer M., EKMEKCI D., Ulusoy C., Erdag E., Sehitoglu E., et al.

MEDICAL PRINCIPLES AND PRACTICE , sa.3, ss.239-245, 2014 (SCI-Expanded, Scopus)

2014

269. Aquaporin-1 Antibody in Neuromyelitis Optica Patients

Tuzun E., TZARTOS J., Ekizoglu E., STERGIOU C., ZISIMOPOULOU P., Coban A., et al.

EUROPEAN NEUROLOGY , sa.5-6, ss.271-272, 2014 (SCI-Expanded, Scopus)

2014

270. Evaluation of incidence and clinical features of antibody-Associated autoimmune encephalitis mimicking dementia

Coban A., Kucukali C. I., Bilgic B., Yalcinkaya N., Haytural H., Ulusoy C., et al.

Behavioural Neurology , cilt.2014, 2014 (SCI-Expanded, Scopus)

2013

271. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica

Woodhall M., Coban A., Waters P., Eldzoglu E., Kurtuncu M., Shugaiv E., et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES , sa.1-2, ss.221-223, 2013 (SCI-Expanded, Scopus)

2013

272. Expression analysis and clinical correlation of aquaporin 1 and 4 genes in human hippocampal sclerosis

Bebek N., Özdemir Ö., Sayitoglu M., Hatirnaz O., Baykan B., Gurses C., et al.

JOURNAL OF CLINICAL NEUROSCIENCE , cilt.20, sa.11, ss.1564-1570, 2013 (SCI-Expanded, Scopus)

2013

273. GUILLAIN-BARRE-LIKE SYNDROME ASSOCIATED WITH LUNG ADENOCARCINOMA AND CASPR2 ANTIBODIES

Tuzun E., Kinay D., Hacohen Y., Aysal F., Vincent A.

MUSCLE & NERVE , cilt.48, sa.5, ss.836-837, 2013 (SCI-Expanded, Scopus)

2013

274. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behcet's disease

Vural B., Sehitoglu E., Cavus F., Yalcinkaya N., Haytural H., Kucukerden M., et al.

JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.139-144, 2013 (SCI-Expanded, Scopus)

2013

275. Reduced Orexin-A Levels in Frontotemporal Dementia: Possible Association With Sleep Disturbance

Coban A., Bilgic B., Lohmann E., Kucukali C. I., Benbir G., Karadeniz D., et al.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS , cilt.28, sa.6, ss.606-611, 2013 (SCI-Expanded, Scopus)

2013

276. Experimental autoimmune myasthenia gravis in the mouse

Wu B., Goluszko E., Huda R., TÜZÜN E., Christadoss P.

Current Protocols in Immunology , sa.SUPPL.100, 2013 (Scopus)

2013

277. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis

Coban A., Ulusoy C. A., Giris M., Turan S., TUERKOGLU R., Tuzun E., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.8, ss.557-562, 2013 (SCI-Expanded, Scopus)

2013

278. Non-Convulsive Status Epilepticus Associated With Glutamic Acid Decarboxylase Antibody

Cikrikcili U., Ulusoy C. A., Turan S., Yildiz S., Bilgic B., Hanagasi H. A., et al.

CLINICAL EEG AND NEUROSCIENCE , cilt.44, sa.3, ss.232-236, 2013 (SCI-Expanded, Scopus)

2013

279. Impact of cigarette smoking on conversion from clinically isolated syndrome to clinically definite multiple sclerosis

Arikanoglu A., Shugaiv E., Tuzun E., Erakso M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.123, sa.7, ss.476-479, 2013 (SCI-Expanded, Scopus)

2013

280. Complement associated pathogenic mechanisms in myasthenia gravis

Tuzun E., CHRISTADOSS P.

AUTOIMMUNITY REVIEWS , cilt.12, sa.9, ss.904-911, 2013 (SCI-Expanded, Scopus)

2013

281. Coexistence of Guillain-Barre syndrome and Behcet's disease

Shugaiv E., Kiyat-Atamer A., Tuzun E., Deymeer F., Oflazer P., Parman Y., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.3, 2013 (SCI-Expanded, Scopus)

2013

282. Peripheral Neuropathy Associated With Antiglutamic Acid Decarboxylase Antibodies

Saltik S., Turkes M., Tuzun E., Cakir A., Ulusoy C.

PEDIATRIC NEUROLOGY , cilt.48, sa.5, ss.403-406, 2013 (SCI-Expanded, Scopus)

2013

283. Complement C2 siRNA mediated therapy of myasthenia gravis in mice

HUDA R., Tuzun E., CHRISTADOSS P.

JOURNAL OF AUTOIMMUNITY , cilt.42, ss.94-104, 2013 (SCI-Expanded, Scopus)

2013

284. Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients

KIYAT-ATAMER A., Ekizoglu E., Tuzun E., Kurtuncu M., Shugaiv E., AKMAN-DEMIR G., et al.

EUROPEAN JOURNAL OF NEUROLOGY , sa.5, ss.781-787, 2013 (SCI-Expanded, Scopus)

2013

285. Aquaporin-4 antibody seropositivity in myasthenia gravis patients with thymoma

Ekizoglu E., Yilmaz V., Icoz S., Birisik O., Tuzun E., Akman-Demir G., et al.

Muscle and Nerve , cilt.47, sa.2, ss.306-307, 2013 (SCI-Expanded, Scopus)

2013

286. Epilepsy and Autoimmunity

ÇOBAN A., EKİZOĞLU TURGUT E., TÜZÜN E.

EPILEPSI , cilt.19, sa.2, ss.39-47, 2013 (ESCI, TRDizin)

2013

287. CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL)

Kurtuncu M., KAYA D., Zuliani L., Erdag E., Icoz S., Ugurel E., et al.

CEPHALALGIA , cilt.33, sa.2, ss.123-129, 2013 (SCI-Expanded, Scopus)

2013

288. Anti-N-methyl-D-aspartate receptor encephalitis with minimal cortical impairment

Tuzun E., TURKOGLU R., Yumerhodzha S. M., Erdag E., Eraksoy M., Akman-Demir G.

NEUROLOGICAL SCIENCES , cilt.34, sa.1, ss.111-113, 2013 (SCI-Expanded, Scopus)

2013

289. Syndrome of Headache Accompanied with Transient Neurologic Deficits and Cerebrospinal Fluid Lymphocytosis

Coban A., Shugaiv E., Tuzun E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , ss.52-55, 2013 (SCI-Expanded, Scopus, TRDizin)

2013

290. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures

Durmus H., Kurtuncu M., Tuzun E., Pehlivan M., Akman-Demir G., Yapici Z., et al.

Acta Neurologica Belgica , cilt.113, sa.4, ss.421-426, 2013 (SCI-Expanded, Scopus)

2013

291. Progressive Encephalomyelitis with Rigidity and Myoclonus: A Syndrome with Diverse Clinical Features and Antibody Responses

Shugaiv E., Leite M. I., Sehitoglu E., Woodhall M., Cavus F., Waters P., et al.

EUROPEAN NEUROLOGY , sa.5, ss.257-262, 2013 (SCI-Expanded, Scopus)

2013

292. Kleptomania in Patients with Neuro-Behcet's Disease

Shugaiv E., Kiyat-Atamer A., Tuzun E., Kurtuncu M., Baral-Kulaksizoglu I., Demir G. A.

MEDICAL PRINCIPLES AND PRACTICE , sa.6, ss.550-554, 2013 (SCI-Expanded, Scopus)

2012

293. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

Tuezuen E., ALLMAN W., Ulusoy C. A., YANG H., CHRISTADOSS P.

Annals of the New York Academy of Sciences , cilt.1274, ss.133-9, 2012 (SCI-Expanded, Scopus)

2012

294. Isolated dysphagia due to aquaporin-4 autoimmunity

TURKOGLU R., Kiyat-Atamer A., Tuzun E., Akman-Demir G.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.23, sa.6, ss.804-805, 2012 (SCI-Expanded, Scopus, TRDizin)

2012

295. Cognitive Impairment in Neuro-Behcet's Disease and Multiple Sclerosis: A Comparative Study

Gunduz T., Emir O., Kurtuncu M., Mutlu M., Tumac A., Akca S., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.11, ss.650-656, 2012 (SCI-Expanded, Scopus)

2012

296. Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse

Erdag E., Tuzun E., Ugurel E., Cavus F., Sehitoglu E., Giris M., et al.

INFLAMMATION RESEARCH , cilt.61, sa.9, ss.927-930, 2012 (SCI-Expanded, Scopus)

2012

297. CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis

ALLMAN W., QI H., SAINI S. S., LI J., Tuzun E., CHRISTADOSS P.

JOURNAL OF NEUROIMMUNOLOGY , cilt.249, ss.1-7, 2012 (SCI-Expanded, Scopus)

2012

298. Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23

Kurtuncu M., Tuzun E., TURKOGLU R., PETEK-BALCI B., Icoz S., Pehlivan M., et al.

CYTOKINE , cilt.59, sa.2, ss.400-402, 2012 (SCI-Expanded, Scopus)

2012

299. Evaluation of Glutathione S-Transferase P1 Polymorphisms (Ile105Val and Ala114Val) in Patients with Small Cell Lung Cancer

Vural B., Yakar F., Derin D., Saip P., Yakar A., Demirkan A., et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS , cilt.16, sa.7, ss.701-706, 2012 (SCI-Expanded, Scopus)

2012

300. Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: Favorable response to cancer treatment

Armagan H., Tuzun E., Icoz S., Birisik O., Ulusoy C., Demir G., et al.

JOURNAL OF SPINAL CORD MEDICINE , cilt.35, sa.4, ss.267-269, 2012 (SCI-Expanded, Scopus)

2012

301. Comparison of the Cytokine Profiles of Patients With Neuronal-Antibody-Associated Central Nervous System Disorders

Ulusoy C., Tuzun E., Kurtuncu M., TURKOGLU R., Akman-Demir G., Eraksoy M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.6, ss.284-289, 2012 (SCI-Expanded, Scopus)

2012

302. Investigation of Swap70 antibody in patients with Behcet’s disease

Uğurel E., Karabulut A., Gül A., Güre A., Shugaiv E., Tüzün E., et al.

EXPERIMED , cilt.2, sa.4, ss.22-29, 2012 (Hakemli Dergi)

2012

303. Prevalence of glutamic acid decarboxylase antibody in autoimmune encephalitis and its clinical spectrum

Ulusoy C. A., Turan S., Tüzün E.

EXPERIMED , cilt.2, sa.3, ss.23-27, 2012 (Hakemli Dergi)

2012

304. Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension

Ekizoglu E., Icoz S., Tuzun E., Birisik O., Kocasoy-Orhan E., Akman-Demir G., et al.

CEPHALALGIA , cilt.32, sa.3, ss.198-202, 2012 (SCI-Expanded, Scopus)

2012

305. Ocular and generalized myasthenia gravis induced by human acetylcholine receptor ? subunit immunization

WU X., Tuzun E., LI J., XIAO T., SAINI S. S., QI H., et al.

MUSCLE & NERVE , cilt.45, sa.2, ss.209-216, 2012 (SCI-Expanded, Scopus)

2011

306. The Role of B Cells in Multiple Sclerosis Pathogenesis and Monoclonal Antibody Treatments Targeting B Cells

Tuzun E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.48, ss.73-78, 2011 (SCI-Expanded, Scopus, TRDizin)

2011

307. Experimental autoimmune myasthenia gravis in the mouse.

Wu B., Goluszko E., Huda R., Tüzün E., Christadoss P.

Current protocols in immunology , sa.15, 2011 (Scopus)

2011

308. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behcet's disease

Vural B., Ugurel E., Tuzun E., Kurtuncu M., Zuliani L., Cavus F., et al.

JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.91-97, 2011 (SCI-Expanded, Scopus)

2011

309. Increased complement consumption in musk-antibody-positive myasthenia gravis patients

Tuzun E., Yilmaz V., Parman Y., Oflazer P., Deymee F., Saruhan-Direskeneli G.

Medical Principles and Practice , cilt.20, sa.6, ss.581-583, 2011 (SCI-Expanded, Scopus)

2011

310. Increased Alcohol Consumption Rates of Multiple Sclerosis Patients and Their Parents

Pehlivan M., Kurtuncu M., Yargic I., Tuzun E.

AMERICAN JOURNAL ON ADDICTIONS , cilt.20, sa.5, ss.488-489, 2011 (SSCI, Scopus)

2011

311. Complement and cytokine based therapeutic strategies in myasthenia gravis

Tuezuen E., Huda R., Christadoss P.

JOURNAL OF AUTOIMMUNITY , cilt.37, sa.2, ss.136-143, 2011 (SCI-Expanded, Scopus)

2011

312. Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis

ALLMAN W., SAINI S. S., Tuzun E., CHRISTADOSS P.

Cellular Immunology , cilt.271, sa.2, ss.292-298, 2011 (SCI-Expanded, Scopus)

2011

313. Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behcet's disease with parenchymal involvement: presentation of four cases

Shugaiv E., Tuzun E., Mutlu M. O., Kiyat-Atamer A., Kurtuncu M., Akman-Demir G.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.4, 2011 (SCI-Expanded, Scopus)

2011

314. The comparison of socio-economic conditions and personal hygiene habits of neuro-Behcet's disease and multiple sclerosis patients

Pehlivan M., Kurtuncu M., Tuzun E., Shugaiv E., Mutlu M., Eraksoy M., et al.

INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH , cilt.214, sa.4, ss.335-337, 2011 (SCI-Expanded, Scopus)

2011

315. Steroid-responsive recurrent limbic encephalitis associated with small cell lung cancer and neuropil antibodies

Tuzun E., Yaka E., Zuliani L., Icoz S., Baklan B., Birisik O., et al.

ACTA NEUROLOGICA BELGICA , cilt.111, sa.2, ss.139-142, 2011 (SCI-Expanded, Scopus)

2011

316. Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis

QI H., LI J., ALLMAN W., SAINI S. S., Tuezuen E., WU X., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.234, ss.165-167, 2011 (SCI-Expanded, Scopus)

2011

317. Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients

Tuzun E., Kurtuncu M., TURKOGLU R., Icoz S., Pehlivan M., Birisik O., et al.

JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.211-215, 2011 (SCI-Expanded, Scopus)

2011

318. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients

Akman-Demir G., Tuzun E., Waters P., Icoz S., Kurtuncu M., Jarius S., et al.

JOURNAL OF NEUROLOGY , sa.3, ss.464-470, 2011 (SCI-Expanded)

2011

319. Association of systemic autoantibody positivity with the presence of oligoclonal bands and disability in multiple sclerosis

Tüzün E., Türkoğlu R.

EXPERIMED , cilt.1, sa.1, ss.34-39, 2011 (Hakemli Dergi)

2011

320. Seizures associated with amphiphysin antibody

Tüzün E., Bebek N., Gürses R. C., Akman-Demir G., Gökyiğit A.

Mediterranean Oncology Journal , cilt.1, sa.1, ss.52-53, 2011 (Hakemli Dergi)

2011

321. Antineuronal Antibodies in Migraine Patients With White Matter Lesions

TURKOGLU R., Tuzun E., Icoz S., Birisik O., Erdag E., Kurtuncu M., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.1, ss.33-36, 2011 (SCI-Expanded, Scopus)

2011

322. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis

Tuzun E., Erdag E., Durmus H., Brenner T., Turkoglu R., Kurtuncu M., et al.

NEUROLOGY INDIA , cilt.59, sa.1, ss.47-50, 2011 (SCI-Expanded, Scopus)

2010

323. Bickerstaff's encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies

Tuzun E., Kurtuncu M., Lang B., Icoz S., Akman-Demir G., Eraksoy M., et al.

EUROPEAN JOURNAL OF NEUROLOGY , sa.10, ss.1304-1307, 2010 (SCI-Expanded, Scopus)

2010

324. Unihemispheric acute disseminated encephalomyelitis: A case report Tek hemisferi tutan akut dissemine ensefalomiyelit: Olgu sunumu

Durmus H., TURKOGLU R., Tuzun E.

Noropsikiyatri Arsivi , cilt.47, sa.2, ss.166-168, 2010 (SCI-Expanded, Scopus, TRDizin)

2010

325. Amphiphysin Autoimmunity: Associated Neurological Syndromes and Tumors in The Turkish Population

Tuzun E., Bebek N., Icoz S., Durmus H., Kurtuncu M., Gurses C., et al.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , cilt.27, sa.2, ss.121-126, 2010 (SCI-Expanded, TRDizin)

2010

326. Steroid-Responsive Myeloneuropathy Associated With Antithyroid Antibodies

TURKOGLU R., Tuzun E.

JOURNAL OF SPINAL CORD MEDICINE , cilt.33, sa.3, ss.278-280, 2010 (SCI-Expanded, Scopus)

2010

327. A rare case of multiple sclerosis and cerebral hemorrhage associated with osteopetrosis

Kaya D., Tüzün E., Dinçer A., Pamir M. N., Kürtüncü M.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , sa.1, ss.16-19, 2010 (SCI-Expanded, Scopus)

2010

328. Erdheim-Chester disease presented with bilateral carotid artery occlusion: Case Report

Çelik Y., Balcı K., Asil T., Tüzün E., Hamamcioglu M., Temizöz O., et al.

TURK NOROLOJI DERGISI , cilt.16, sa.2, ss.110-113, 2010 (Scopus, TRDizin)

2010

329. Peripheral nerve hyperexcitability syndromes

Tüzün E., Öge A. E.

Türkiye Klinikleri Journal of Medical Research , cilt.3, sa.2, ss.91-98, 2010 (Hakemli Dergi)

2010

330. Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients

Icoz S., Tuzun E., Kurtuncu M., Durmus H., Mutlu M., Eraksoy M., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , sa.1, ss.71-75, 2010 (SCI-Expanded, Scopus)

2010

331. Rare Neurological Syndromes Associated with Systemic Lupus Erythematosus

Durmus H., Tuzun E., Alpay N., Icoz S., Kurtuncu M., Demir G. A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.47, sa.1, ss.81-82, 2010 (SCI-Expanded, Scopus, TRDizin)

2010

332. Paraneoplastic syndromes presenting with neurological involvement

Tüzün E.

Klinik Gelişim , cilt.23, sa.1, ss.71-77, 2010 (Hakemli Dergi)

2010

333. Sensorimotor neuropathy associated with endometrioid endometrial carcinoma

Durmus H., Tuzun E., Icoz S., Akman-Demir G., Parman Y.

European Journal of Obstetrics and Gynecology and Reproductive Biology , cilt.150, sa.2, ss.216-217, 2010 (SCI-Expanded, Scopus)

2010

334. Impact of Earthquake on Multiple Sclerosis Attacks

Tuzun E., Polat A., Akman-Demir G., Kurtuncu M., Mutlu M., Aksay B., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.4, ss.324-327, 2010 (SCI-Expanded)

2009

335. Brainstem encephalitis following influenza vaccination: Favorable response to steroid treatment

TURKOGLU R., Tuzun E.

VACCINE , cilt.27, sa.52, ss.7253-7256, 2009 (SCI-Expanded, Scopus)

2009

336. Primary cerebral lymphoma with a 5-year remission to single-agent corticosteroids

Kurtuncu M., Tuzun E., Durmus H., Mutlu M., Akman-Demir G., Eraksoy M.

Leukemia and Lymphoma , cilt.50, sa.9, ss.1552-1553, 2009 (SCI-Expanded, Scopus)

2009

337. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma

Tuezuen E., Zhou L., Baehring J. M., Bannykh S., Rosenfeld M. R., Dalmau J.

ACTA NEUROPATHOLOGICA , cilt.118, sa.6, ss.737-743, 2009 (SCI-Expanded, Scopus)

2009

338. Antinuclear antibodies in juvenile myoclonic epilepsy

Altindag E., Icoz S., Tuzun E., Durmus H., Uludokumaci A., Demir G. A., et al.

Journal of Neurological Sciences , cilt.26, sa.1, ss.43-48, 2009 (Scopus, TRDizin)

2009

339. Anti-Yo-associated cerebellar syndrome presenting with a brain mass

Tuzun E., BEKTAS H. M., Icoz S., Kurtuncu M., SAIP P., Akman-Demir G.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , sa.2, ss.183-184, 2009 (SCI-Expanded, Scopus)

2009

340. Pregnancy-Induced Atypic Demyelinating Inflammatory Disease

Durmus H., Tuzun E., Kurtuncu M., Mutlu M., Demir G. A., Eraksoy M.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , sa.2, ss.80-83, 2009 (SCI-Expanded, Scopus, TRDizin)

2009

341. Paraneoplastic neurological syndromes

Tüzün E.

Türkiye Klinikleri Journal of Medical Research , cilt.2, sa.4, ss.67-74, 2009 (Hakemli Dergi)

2009

342. Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis

LI J., QI H., Tuzun E., ALLMAN W., Yilmaz V., SAINI S. S., et al.

Journal of Neuroimmunology , cilt.208, ss.40-45, 2009 (SCI-Expanded, Scopus)

2009

343. Development of Multiple Sclerosis in Patients with Optic Neuritis: Analysis of Predictive Factors

Durmuş Tekçe H., Kürtüncü M., Tüzün E., Akalın B., Mutlu M., Akman-Demir G., et al.

Turkish Journal of Neurology , cilt.15, sa.3, ss.119-123, 2009 (Hakemli Dergi)

2008

344. Interleukin-6 in neuro-Behcet's disease: Association with disease subsets and long-term outcome

Akman-Demir G., Tuezuen E., Icoez S., Yesilot N., Yentuer S. P., Kuertuencue M., et al.

CYTOKINE , sa.3, ss.373-376, 2008 (SCI-Expanded, Scopus)

2008

345. Multiple sclerosis: Could it be an epigenetic disease?

Kurtuncu M., Tuzun E.

MEDICAL HYPOTHESES , cilt.71, sa.6, ss.945-947, 2008 (SCI-Expanded, Scopus)

2008

346. Targeting classical complement pathway to treat complement mediated autoimmune diseases

TÜZÜN E., LI J., SAINI S. S., YANG H., CHRISTADOSS P.

Advances in Experimental Medicine and Biology , cilt.632, ss.265-272, 2008 (SCI-Expanded, Scopus)

2008

347. Anti-neuronal antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis

Kurtuncu M., Tuzun E., KAYA D., Icoz S., Baslo M. B., Ertas M., et al.

JOURNAL OF HEADACHE AND PAIN , cilt.9, sa.5, ss.333-335, 2008 (SCI-Expanded, Scopus)

2008

348. C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis

QI H., Tüzün E., ALLMAN W., SAINI S. S., PENABAD Z. R., PIERANGELI S., et al.

Journal of Neuroimmunology , cilt.196, ss.101-106, 2008 (SCI-Expanded, Scopus)

2008

349. Inhibitory IgG receptor Fc gamma RIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

LI J., Tuzun E., WU X. R., BIN QI H., ALLMAN W., SAINI S. S., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.194, ss.44-53, 2008 (SCI-Expanded, Scopus)

2008

350. Anti-neuronal antibodies in small cell lung cancer patients without paraneoplastic disorders

İçöz S., Tüzün E., Oflazer P., Akman Demir G.

NOROPSIKIYATRI ARSIVI , cilt.45, sa.1, ss.6-8, 2008 (TRDizin)

2008

351. Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesis

CHRISTADOSS P., Tuzun E., LI J., SAINI S. S., YANG H.

MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE , cilt.1132, ss.210-219, 2008 (SCI-Expanded, Scopus)

2007

352. A new mouse model of autoimmune ocular myasthenia gravis

Yang H., Wu B., Tuezuen E., Saini S. S., Li J., Allman W., et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.48, sa.11, ss.5101-5111, 2007 (SCI-Expanded, Scopus)

2007

353. Limbic encephalitis and variants: Classification, diagnosis and treatment

Tuzun E., DALMAU J.

NEUROLOGIST , cilt.13, sa.5, ss.261-271, 2007 (SCI-Expanded, Scopus)

2007

354. A patient with encephalitis associated with NMDA receptor antibodies

SANSING L. H., Tuzun E., KO M. W., BACCON J., LYNCH D. R., DALMAU J.

NATURE CLINICAL PRACTICE NEUROLOGY , cilt.3, sa.5, ss.291-296, 2007 (SCI-Expanded, Scopus)

2007

355. Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis

Tuzun E., ROSSI J. E., KARNER S. F., CENTURION A. F., DALMAU J.

JOURNAL OF NEUROIMMUNOLOGY , cilt.186, ss.177-180, 2007 (SCI-Expanded, Scopus)

2007

356. Limbic encephalitis associated with antibodies to cell membrane antigens

Tüzün E.

NOROPSIKIYATRI ARSIVI , cilt.44, sa.3, ss.101-107, 2007 (Hakemli Dergi)

2007

357. Isolated Deep Infarcts: Which Size Indicates Single Penetrating Artery Disease?

Yeşilot N., Krespi Y., Tüzün E., Çoban O., Tuncay R., Bahar S.

Turkish Journal of Neurology , cilt.13, sa.3, ss.189-200, 2007 (Hakemli Dergi)

2007

358. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis

YAPICI Z., Tuezuen E., ALTUNAYOGLU V., ERDOGAN A., ERAKSOY M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.117, sa.11, ss.1505-1512, 2007 (SCI-Expanded, Scopus)

2007

359. Pros and cons of treating murine myasthenia gravis with anti-C1q antibody

Tuzun E., LI J., SAINI S. S., YANG H., CHRISTADOSS P.

JOURNAL OF NEUROIMMUNOLOGY , cilt.182, ss.167-176, 2007 (SCI-Expanded, Scopus)

2007

360. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

Dalmau J., Tuzun E., Wu H., Masjuan J., Rossı J. E., Voloschın A., et al.

ANNALS OF NEUROLOGY , cilt.61, ss.25-36, 2007 (SCI-Expanded, Scopus)

2006

361. Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis

Tuzun E., SAINI S. S., MORGAN B. P., CHRISTADOSS P.

JOURNAL OF NEUROIMMUNOLOGY , cilt.181, ss.29-33, 2006 (SCI-Expanded, Scopus)

2006

362. Autoimmune thyroid encephalopathy presenting with epilepsia partialis continua

AYDIN-OEZEMIR Z., Tuezuen E., BAYKAN B., Akman-Demir G., OEZBEY N., GUERSES C., et al.

CLINICAL EEG AND NEUROSCIENCE , cilt.37, sa.3, ss.204-209, 2006 (SCI-Expanded, Scopus)

2006

363. Immunization of mice with T cell-dependent antigens promotes IL-6 and TNF-alpha production in muscle cells

Tuzun E., LI J., WANASEN N., SOONG L., CHRISTADOSS P.

CYTOKINE , cilt.35, ss.100-106, 2006 (SCI-Expanded, Scopus)

2006

364. Genetic evidence for the involvement of Fc gamma receptor III in experimental autoimmune myasthenia gravis pathogenesis

Tuzun E., Saini S. S., Yang H., Alagappan D., Higgs S., Christadoss P.

JOURNAL OF NEUROIMMUNOLOGY , cilt.174, ss.157-167, 2006 (SCI-Expanded, Scopus)

2006

365. Unraveling myasthenia gravis immunopathogenesis using animal models

Tüzün E., Christadoss P.

DRUG DISCOVERY TODAY: DISEASE MODELS , cilt.3, sa.1, ss.15-20, 2006 (Scopus)

2006

366. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis

Tuzun E., SAINI S., GHOSH S., ROWIN J., MERIGGIOLI M., CHRISTADOSS P.

NEUROMUSCULAR DISORDERS , cilt.16, sa.2, ss.137-143, 2006 (SCI-Expanded, Scopus)

2006

367. Neuronal acetylcholine receptor alpha 9-subunit: A possible central nervous system autoantigen

Tuzun E.

MEDICAL HYPOTHESES , cilt.67, sa.3, ss.561-565, 2006 (SCI-Expanded, Scopus)

2005

368. The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit

SAINI S., Tuzun E., CHRISTADOSS P.

JOURNAL OF NEUROIMMUNOLOGY , cilt.169, ss.177-179, 2005 (SCI-Expanded, Scopus)

2005

369. IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1

Yang H., Tuzun E., Alagappan D., Yu X., Scott B., Ischenko A., et al.

JOURNAL OF IMMUNOLOGY , cilt.175, sa.3, ss.2018-2025, 2005 (SCI-Expanded, Scopus)

2005

370. Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment

Tuzun E., MERIGGIOLI M., ROWIN J., YANG H., CHRISTADOSS P.

JOURNAL OF AUTOIMMUNITY , cilt.24, sa.3, ss.261-268, 2005 (SCI-Expanded, Scopus)

2004

371. Etanercept treatment in corticosteroid-dependent myasthenia gravis

ROWIN J., MERIGGIOLI M., Tuzun E., LEURGANS S., CHRISTADOSS P.

NEUROLOGY , cilt.63, sa.12, ss.2390-2392, 2004 (SCI-Expanded, Scopus)

2004

372. ICOS is essential for the development of experimental autoimmune myasthenia gravis

SCOTT B., YANG H., Tuzun E., DONG C., FLAVELL R., CHRISTADOSS P.

JOURNAL OF NEUROIMMUNOLOGY , cilt.153, ss.16-25, 2004 (SCI-Expanded, Scopus)

2004

373. Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS/J mice

Tuzun E., SCOTT B., YANG H., WU B., GOLUSZKO E., GUIGNEAUX M., et al.

JOURNAL OF IMMUNOLOGY , cilt.172, sa.9, ss.5743-5752, 2004 (SCI-Expanded, Scopus)

2003

374. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis

Tuzun E., SCOTT B., GOLUSZKO E., HIGGS S., CHRISTADOSS P.

JOURNAL OF IMMUNOLOGY , cilt.171, sa.7, ss.3847-3854, 2003 (SCI-Expanded, Scopus)

2003

375. B7-1 costimulatory molecule is critical-for the development of experimental autoimmune myasthenia gravis

POUSSIN M., Tuzun E., GOLUSZKO E., SCOTT B., YANG H., FRANCO J., et al.

JOURNAL OF IMMUNOLOGY , cilt.170, sa.8, ss.4389-4396, 2003 (SCI-Expanded, Scopus)

2003

376. Autoimmune disorders of neuronal potassium channels

Newsom-Davis J., BUCKLEY C., CLOVER L., Hart I., MADDISON P., Tuzum E., et al.

MYASTHENIA GRAVIS AND RELATED DISORDERS , cilt.998, ss.202-210, 2003 (SCI-Expanded, Scopus)

2002

377. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production

DENG C., GOLUSZKO E., Tuzun E., YANG H., CHRISTADOSS P.

JOURNAL OF IMMUNOLOGY , cilt.169, sa.2, ss.1077-1083, 2002 (SCI-Expanded, Scopus)

2001

378. Paroxysmal attacks in multiple sclerosis

Tuzun E., AKMAN-DEMIR G., ERAKSOY M.

MULTIPLE SCLEROSIS , cilt.7, sa.6, ss.402-404, 2001 (SCI-Expanded, Scopus)

2001

379. F wave parameters and F tacheodispersion in mild diabetic neuropathy.

TÜZÜN E., Oge A. E., ERTAŞ M., BOYACÍYAN A., DINÇÇAĞ N., YAZÍCÍ J.

Electromyography and clinical neurophysiology , cilt.41, sa.5, ss.273-9, 2001 (Hakemli Dergi)

2001

380. Potassium channel antibodies in two patients with reversible limbic encephalitis

BUCKLEY C., OGER J., CLOVER L., Tuzun E., CARPENTER K., JACKSON M., et al.

ANNALS OF NEUROLOGY , cilt.50, sa.1, ss.73-78, 2001 (SCI-Expanded, Scopus)

2001

381. Clinical and laboratory features of cases with isolated acute behavioral changes

Tüzün E., Kıyat Atamer A., Özdemir Ö., Gürvit İ. H.

NOROPSIKIYATRI ARSIVI , cilt.38, sa.4, ss.223-227, 2001 (Hakemli Dergi)

2001

382. Morvan's syndrome: New insights into the mechanisms of thalamic insomnia

Tüzün E.

JOURNAL OF NEUROLOGICAL SCIENCES , cilt.18, sa.1, ss.14801, 2001 (Hakemli Dergi)

2001

383. Lafora body-like inclusions in a case of progressive myoclonic ataxia associated with coeliac disease

Tuzun E., GURSES C., BAYKAN B., BUYUKBABANI N., OZTURK A., GOKYIGIT A. Z.

EUROPEAN NEUROLOGY , cilt.46, sa.3, ss.157-158, 2001 (SCI-Expanded, Scopus)

2000

384. Out cold

Tuzun E.

NEW SCIENTIST , cilt.168, sa.2259, ss.56, 2000 (SCI-Expanded)

2000

385. Longterm follow-up of electroencephalographic and clinical findings of a case with Gaucher's disease type 3a

Tuzun E., Baykan B., GURSES C., GOKYIGIT A. Z.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , cilt.9, sa.7, ss.469-472, 2000 (SCI-Expanded, Scopus)

2000

386. Possible role of gangliosides in salivary gland complications of diabetes

Tuzun E., HATEMI A., MEMISOGLU K.

MEDICAL HYPOTHESES , cilt.54, sa.6, ss.910-912, 2000 (SCI-Expanded, Scopus)

2000

387. Amyotrophic lateral sclerosis and frontal lobe dementia

Tüzün E., Hanağası H. A., Kaptanoğlu G., Gürvit İ. H.

Turkish Journal of Neurology , cilt.1, sa.1, ss.67-74, 2000 (Hakemli Dergi)

1999

388. A case of intracranial granulocytic sarcoma (chloroma)

Tüzün E., Krespi Y., Tuncay R., Çoban O., Bahar S.

NOROPSIKIYATRI ARSIVI , cilt.36, sa.1, ss.23-26, 1999 (Hakemli Dergi)

1998

389. Intracavernosal endothelin levels of impotent men before and after papaverine induced penile erection.

Kadioǧlu A., Memişoǧlu K., Sazoya O., Tüzün E.

Archivos espanoles de urologia , cilt.51, sa.7, ss.739-40, 1998 (Scopus)

1998

390. Anterior choroidal artery territory infarction: A case report and review

Tuzun E.

ARCHIVES OF MEDICAL RESEARCH , cilt.29, sa.1, ss.83-87, 1998 (SCI-Expanded, Scopus)

1997

391. Serum sialic acid levels are not altered in streptozotocin (STZ) induced diabetic rats

Tuzun E., HATEMI A., MEMISOGLU K., SAZOVA O.

Turkish Journal of Medical Sciences , cilt.27, sa.6, ss.531-533, 1997 (SCI-Expanded)

1997

392. Impotence due to reduced central nitric oxide synthase activity in hypogonadal males

Tuzun E.

ARCHIVES OF MEDICAL RESEARCH , cilt.28, sa.3, ss.431, 1997 (SCI-Expanded)

1994

393. Treatment of congenital SST deformity with a new technique

Babacan S., Kadıoğlu A., Tüzün E., Doğruer K., Erdoğru T., Memişoğlu K., et al.

TURKISH JOURNAL OF UROLOGY , cilt.20, sa.4, ss.451-455, 1994 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

2026

1. Evaluation of anti-NfL in multiple sclerosis

Dilsiz E., Yilmaz V., Tuzun E., Ulusoy C., Kefeli M., Emekli S., et al.

12th Congress of the European-Academy-of-Neurology (EAN), Geneva, İsviçre, 27 - 30 Haziran 2026, cilt.33, (Özet Bildiri)

2026

2. Serum neurofilament light chain levels are associated with increased disability and impairment of specific cognitive domains in neuro-Behcet disease

Tuzun E., Tezel M., Karpuzoglu H., Emekli A., Gunduz T., Yilmaz V., et al.

12th Congress of the European-Academy-of-Neurology (EAN), Geneva, İsviçre, 27 - 30 Haziran 2026, cilt.33, (Özet Bildiri)

2025

3. The effect of lidocaine on the experimental model of streptozotocin-induced Alzheimer's disease

Tamam Y., YOKUŞ B., Tamam C., Yuceer H., Karahan S., Em B., et al.

ISN World Congress of Nephrology (WCN), New Delhi, Hindistan, 6 - 09 Şubat 2025, cilt.480, (Özet Bildiri)

2025

4. Memory Impairment and Synaptic Alterations Induced by Anti-GABABR Antibodies in a Rat Model of Autoimmune Encephalitis.

Sancar N., Yüceer Korkmaz H., Yalcın Celıkel B., Soylu S., Yıldız N., Ulusoy C. A., et al.

International Society of Neuroimmunology Congress 2025 (ISNI 2025), Chiba, Japonya, 5 - 08 Ekim 2025, ss.1, (Özet Bildiri)

2025

5. Patient-derived polyclonal NMDAR antibodies cause epileptic seizures and sleep–wake disturbances in a passive transfer rat model

Çarçak Yılmaz N., Yüceer Korkmaz H., Yalcın B., Yıldız N., Ulusoy C. A., Şanlı E., et al.

36th International Epilepsy Congress, Lisbon, Portekiz, 30 Ağustos - 03 Eylül 2025, ss.1, (Özet Bildiri)

2025

6. Characterizing Immune Cell Dynamics in Anti-NMDAR Encephalitis via Single-Cell Transcriptomics

Şanlı E., Karaaslan Z., Yılmaz V., Uygunoğlu U., Uğur İşeri S. A., Tüzün E.

IMMUNOLOGY2025, Hawaii, Amerika Birleşik Devletleri, 3 - 07 Mayıs 2025, (Yayınlanmadı)

2025

7. Effects of IL-4Rα shRNA Lentiviral Particles Treatment in Experimental Autoimmune MuSK Myasthenia Gravis Model

Koral G., Mountadir I., Lazaridis K., Tüzün E., Yılmaz V.

15th International Conference on Myasthenia and Related Disorders, The Hague, Hollanda, 13 - 15 Mayıs 2025, (Yayınlanmadı)

2025

8. DENEYSEL OTOİMMÜN MUSK MİYASTENİA GRAVİS MODELİNDE IL-4Rα SHRNA TEDAVİSİNİN ETKİSİ

ULUSOY C. A., Koral G., Sancar N., Mountadir I. F., Lazaridis K., TÜZÜN E., et al.

12.Nöroimmünoloji Okulu, 8 - 11 Mayıs 2025, (Özet Bildiri)

2024

9. Agresif Seyirli Multiple Skleroz Hastalarında Biyobelirteçlerin Klinik Ve Radyolojik Bulgularla İlişkisi.

Erol Yıldız R., Akbayır E., Ersöz A. S., Yılmaz V., Tüzün E., Türkoğlu R.

13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Türkiye, 13 - 18 Mayıs 2024, (Yayınlanmadı)

2024

10. Aterosklerotik Karotis Hastalığında Doğal İmmün Sistemin Rolü.

Koral G., Günbek S., Yalçın B., Yusifli S., Sezgin M., Yeşilot N., et al.

13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Türkiye, 13 - 18 Mayıs 2024, (Yayınlanmadı)

2024

11. Otoimmün Ensefalitlerde Antikor Varlığının Hücre Temelli Yöntem ile Doğrulanması

Şanlı E., Karaaslan Z., Yılmaz V., Özkara Ç., Terzi M., Baykal B., et al.

13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Türkiye, 13 - 18 Mayıs 2024, (Yayınlanmadı)

2024

12. İVİG Tedavisinin Uykuda Elektriksel Status Epileptikus Hastalarındaki İmmün Cevap ile İlişkisi.

Koral G., Soylu S., Topaloğlu P., Emekli A. S., Karaaslan Z., Yüceer Korkmaz H., et al.

13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Türkiye, 13 - 18 Mayıs 2024, (Yayınlanmadı)

2024

13. Okrelizumab Tedavisi Alan RRMS Hastalarında BOS Nörofilaman Hafif Zincir Ve Nörogranin Seviyelerindeki Değişiklik Tedaviye Yanıtı Ve Hastalık Aktivitesini Öngördürebilir Mi?

Kızılay T., Akbayır E., Erol Yıldız R., Ersöz A. S., Özkan Yaşargün D., Yılmaz V., et al.

Klinik Nöroimmunoloji Sempozyumu, Antalya, Türkiye, 13 - 18 Mayıs 2024, ss.1-5, (Özet Bildiri)

2024

14. Anti-CD20 Tedavisi Altındaki MS Hastalarının Hücre Gruplarının Dağılımı Ve Serum Sitokin Seviyeleri.

Akbayır E., Ulusoy C. A., Koral G., Erol R., Demir A. S., Kızılay T., et al.

13. Klinik Nöroimmünoloji Sempozyumu, Antalya, Türkiye, 13 - 18 Mayıs 2024, (Yayınlanmadı)

2024

15. Neuronal-glial mechanisms and electrophysiological insights into spatial memory impairments in the anti-NMDAR encephalitis mouse model.

Yüceer Korkmaz H., Yılmaz V., Tüzün E., Hussaını A.

Society for Neuroscience (SfN), Illinois, Amerika Birleşik Devletleri, 5 - 09 Ekim 2024, ss.1, (Özet Bildiri)

2024

16. Aquaporin-1 antibodies in autoimmune inflammatory demyelinating disorders with predominant optic nerve & spinal cord involvement

TÜZÜN E., Kaptov E., YILMAZ V., Pechlivanidou M., KÜRTÜNCÜ M., GÜNDÜZ T., et al.

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.885, (Özet Bildiri)

2024

17. Baseline cerebrospinal fluid levels of BDNF predict disease activity in MS: A Prospective Study

Yildiz R. E., Qkbayir E., Ersoz A. S., YILMAZ V., TÜZÜN E., Turkoglu R.

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.592-593, (Özet Bildiri)

2024

18. Distribution of immune cell groups and cytokine levels in MS patients under ocrelizumab treatment

Turkoglu R., Akbayir E., ULUSOY C. A., Koral G., YILMAZ V., TÜZÜN E.

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.1013-1014, (Özet Bildiri)

2023

19. Uykuda elektriksel status epileptikus hastalarında immün tedavilerin nöropsikiyatrik ve dil bozuklukları üzerine etkisi

Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., Topaloğlu P., Çırak S., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, ss.19, (Özet Bildiri)

2023

20. Otoimmün Ensefalit Hastalarinda Uyku Şikayetleri, Polisomnografi Bulgulari Ve Hastalik Seyri İle İlişkisi

Tüzün E., Yılmaz V., Karadeniz D., Akyıldız U. O., İlhan Algın D., Sarıtaş A. Ş., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, ss.109, (Özet Bildiri)

2023

21. Nadir Nörogenetik Bir Hastalik Modeli Olarak Epileptik Ensefelopatilerde Trio Ekzom Dizileme Analizleri

Karaaslan Z., Salman B., Ovamigyan S. A., Kılıç M., Çırak S., Uğur İşeri S. A., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, ss.25, (Özet Bildiri)

2023

22. Otoimmün Demiyelizan Hastalıkların Ayırıcı Tanısında CCL4L2’nin B Hücre Temelli Biyobelirteç Olarak Değeri

Koral G., Akpunar F., Şanlı E., Karaaslan Z., Yüceer H., Özkan E., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, ss.89, (Özet Bildiri)

2023

23. Genetik Absans Epilepsili Sıçanlarda İntraserebroventriküler LGI1 Antikor Uygulamasının Spontan Diken-Yavaş-Dalga Deşarjlar Üzerine Etkisi

Çarçak Yilmaz N., Akat Ş., Yalçin B., Yüceer Korkmaz H., Ulusoy C. A., Küçükali C. I., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, (Yayınlanmadı)

2023

24. Nedeni Belirlenemeyen Nöbeti Olan Çocuklarda Kelch Benzeri Protein 11 (Klhl11) Antikoru

Günbek S., Tzartos J., Pechlivanidou M., Despoina B., Ninou E., Yüceer Korkmaz H., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, (Yayınlanmadı)

2023

25. Akut İskemik İnmeli Hastaların İnme Sonrası Serumlarında Serebellar Antikorlar

Atmaca M. M., Erdağ E., Demir S., Yüceer Korkmaz H., Çolak Atmaca M., Küçükali C. I., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 - 18 Aralık 2023, (Yayınlanmadı)

2023

26. Unraveling Neuronal and Glial Mechanisms in Anti-NMDAR Encephalitis: Perspectives from Mouse, Rat, and Zebrafish Models

Yüceer Korkmaz H., Bhattarai P., Yilmaz V., Kizil Ç., Tüzün E., Hussaini S. A.

13th Annual Taub Institute Research Retreat, New York, Amerika Birleşik Devletleri, 08 Kasım 2023, (Yayınlanmadı)

2023

27. The Effect of Multiple Sclerosis Sera on Pericyte Survival

Akbayir E., Turkoglu R., Ulusoy C. A., Yılmaz V., Kürtüncü M., Küçükali C. İ., et al.

9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.825-826, (Özet Bildiri)

2023

28. Possible Diagnostic Biomarkers in The Differential Diagnosis of Autoimmune Demyelinating Central Nervous System Diseases: Sorcin and CLIC1

Karaaslan Z., Şengül Yediel B., Şanlı E., Yüceer H., Dursun E., Gezen Ak D., et al.

9th Joint ECTRIMS-ACTRIMS Meeting, Milan, İtalya, 11 - 13 Ekim 2023, cilt.29, sa.3, ss.574-575, (Özet Bildiri)

2023

29. Patients with epileptic seizures in the intensive care unit is distinguished from other diseases by IL-1beta and IL-8 levels but not markers of glial activation.

Şanlı E., Altundağ E., İlgen Uslu F., Karaaslan Z., Akbayır E., Koral G., et al.

XVII Workshop on Neurobiology of Epilepsy – WONOEP 2023, Dublin, İrlanda, 28 - 31 Ağustos 2023, ss.24, (Özet Bildiri)

2022

30. WEST Sendromunda Periferik Kan Hücrelerinin Dağılımının Tedaviye Yanıt ile İlişkisi

Yılmaz V., Soylu S., Cherkazzade M., Akbayır E., Yüceer H., Koral G., et al.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, ss.121, (Özet Bildiri)

2022

31. Epilepsia Parsiyalis Kontinua Olgularında Kompleman Aracılı Nöroinflamasyonun Olası Rolü

Altındağ E., Şanlı E., Ilgen Uslu F., Yılmaz V., Ekizoğlu Turgut E., Küçükali C. İ., et al.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, ss.128, (Özet Bildiri)

2022

32. Epileptik Ensefalopati: Glial Aktivite Faktörleri Biyobelirteç Olarak Kullanılabilir Mi?

Charkazzade M., Soylu S., Tüzün E., Yılmaz V., Sezgin M., Yapıcı Z., et al.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, ss.196, (Özet Bildiri)

2022

33. MS Hasta Serumlarında Bulunan Faktörler In Vitroda Perisit Sağkalımını Etkiler Mi?

Akbayır E., Ulusoy C. A., Yılmaz V., Kürtüncü M., Küçükali C. İ., Tüzün E.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, ss.212, (Özet Bildiri)

2022

34. Multipl Skleroz Hastalarında Beyin Omurilik Sıvısı Nörofilament Hafif Zincir Seviyesinin Prognostik Değeri

Demirel A., Şahin E., Gündüz T., Yılmaz V., Tüzün E., Öztürk Erden S., et al.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, ss.63, (Özet Bildiri)

2022

35. Silencing KCNS3 and FCRLB Genes in Experimental Model of MuSK Myasthenia Gravis: Two Novel Molecules in MG Pathogenesis

Koral G., Ulusoy C. A., Şahin H., Soylu S., Akbayır E., Tüzün E., et al.

5th International Molecular Immunology and Immunogenetics Congress (MIMIC V), İzmir, Türkiye, 20 - 22 Ekim 2022, ss.14, (Özet Bildiri)

2022

36. West sendromunda periferik kan hücre dağılımı ve inflamazom aktivitesinin immünopatogeneze ve tedaviye yanıta etkisi

SOYLU S., CHERKEZZADE M., AKBAYIR E., YÜCEER H., KORAL G., ŞANLI E., et al.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, (Özet Bildiri)

2022

37. Otoimmün ensefalit sıçan modelinde intraserebroventriküler NMDAR ve LGI1 antikoru uygulaması sonrasında artan nöbet duyarlılığı ve bozulan bellek işlevi

YÜCEER H., AKAT PİŞKİN Ş., ULUSOY C. A., KARAASLAN Z., SOYLU S., ERDAĞ E., et al.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, (Özet Bildiri)

2022

38. Otoimmün demiyelinizan santral sinir sistemi hastalıkları ayırıcı tanısında olası biyobelirteçler: Sorcin, CLIC1 ve Src substrate cortactin

Karaaslan Z., Şengül Yediel B., Şanlı E., Yüceer H., Dursun E., Gezen Ak D., et al.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 18 - 24 Kasım 2022, ss.200, (Özet Bildiri)

2022

39. Evaluation of SARS-CoV-2 Specific Antibody Responses in Asymptomatic and Symptomatic Cases

Öktelik F. B., Yılmaz V., Gelmez M. Y., Akdeniz N., Köse M., Tüzün E., et al.

5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V), İzmir, Türkiye, 20 - 22 Ekim 2022, ss.251, (Özet Bildiri)

2022

40. MuSK Myasthenia Gravis fare modelinde KCNS3 ve FCRLB genlerinin susturulması

Koral G., Ulusoy C. A., Soylu S., Şanlı E., Tüzün E., Yılmaz V.

20. Ulusal Sinirbilim Kongresi, İstanbul, Türkiye, 19 - 23 Ekim 2022, ss.98, (Özet Bildiri)

2022

41. West sendromunda periferik kan hücrelerinin dağılımının tedaviye yanıt ile ilişkisi

SOYLU S., CHERKEZZADE M., AKBAYIR E., YÜCEER H., KORAL G., ŞANLI E., et al.

20. Ulusal Sinirbilim Kongresi, İstanbul, Türkiye, 19 - 23 Ekim 2022, (Özet Bildiri)

2022

42. Sıçanlarda LGI1 antikorunun intraserebroventriküler uygulanması ile artan nöbet şiddeti ve bozulan bellek işlevi

AKAT PİŞKİN Ş., YÜCEER H., ULUSOY C. A., SOYLU S., KARAASLAN Z., ERDAĞ E., et al.

20. Ulusal Sinirbilim Kongresi, İstanbul, Türkiye, 19 - 23 Ekim 2022, (Özet Bildiri)

2022

43. Silencing KCNS3 And FCRLB Genes İn The Experimental Model Of Musk Myasthenia Gravis: Two Novel Molecules in MG Pathogenesis

Koral G., ULUSOY C. A., Şahin H., Soylu S., Akbayır E., TÜZÜN E., et al.

5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V), İzmir, Türkiye, 20 - 22 Ekim 2022, (Tam Metin Bildiri)

2022

44. B cell gene expression profile in different demyelinating diseases

Karaaslan Z., Şanlı E., Yüceer H., Timirci Kahraman Ö., Gündüz T., Kürtüncü M., et al.

International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Türkiye, 20 - 22 Ekim 2022, (Özet Bildiri)

2022

45. Intracerebroventricular injection of LGI1 antibody increase seizure susceptibility and disrupts cognitive performance in autoimmune encephalitis rat model

Yüceer H., Akat Pişkin Ş., Ulusoy C. A., Soylu S., Karaaslan Z., Erdağ E., et al.

International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Türkiye, 20 - 22 Ekim 2022, (Özet Bildiri)

2022

46. Evaluation of SARS-CoV-2 Specific Antibody Responses in Asymptomatic and Symptomatic Cases.

Öktelik F. B., Yılmaz V., Gelmez M. Y., Akdeniz N., Köse M., Tüzün E., et al.

5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V), İzmir, Türkiye, 20 - 22 Ekim 2022, ss.1, (Özet Bildiri)

2022

47. Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios

Tuzun E., Turkoglu R., Oezguen N., Yilmaz V., Akbayir E., Horvath T. D., et al.

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, ss.778, (Özet Bildiri)

2022

48. Increased seizure susceptibility and disturbed cognitive performence after intracerebroventricular injections of NMDAR antibody in passive transfer rat model of autoimmune encephalitis

AKAT PİŞKİN Ş., YÜCEER H., ULUSOY C. A., KÜÇÜKALİ C. İ., ONAT F., TÜZÜN E., et al.

14th European Epilepsy Congress, Geneva, İsviçre, 9 - 13 Temmuz 2022, (Özet Bildiri)

2022

49. Increased seizure susceptibility and disturbed cognitive performance after intracerebroventricular injections of NMDAR antibody in passive transfer rat model of autoimmune encephalitis

Akat Pişkin Ş., Yüceer H., Küçükali C. I., Onat F., Tüzün E., Çarçak Yılmaz N.

14th European Epilepsy Congress, Geneve, İsviçre, 9 - 13 Temmuz 2022, (Yayınlanmadı)

2022

50. Diagnostic and Theraputic Autoantibody Discovery Studies for Brain Tumors

Topçu O., Timirci Kahraman Ö., Sabancı P. A., Aras Y., Yetimler B., Mohr T., et al.

5th Annual Meeting New Diagnostic and Therapeautic Tools Against Multidrug Resistance Tumors, Coimbra, Portekiz, 29 Haziran - 01 Temmuz 2022, ss.50-51, (Özet Bildiri)

2022

51. Pasif Transfer Sıçan Otoimmün Ensefalit Modelinde İntraserebroventriküler NMDAR Antikoru Uygulaması Sonrasında Artan Nöbet Duyarlılığı ve Bozulmuş Bilişsel Performans

Yüceer H., Akat Pişkin Ş., Ulusoy C. A., Karaaslan Z., Çırak S., Çarçak Yılmaz N., et al.

13. Ulusal Epilepsi Kongresi, Muğla, Türkiye, 26 - 29 Mayıs 2022, (Yayınlanmadı)

2022

52. NSC-87877, Inhibıtor Of Src Homology 2 Domain-Containing Phosphotyrosine Phosphatase 2, Ameliorates Experimental Autoimmune Myasthenia Gravis Induced By Musk Immunizatıon

YILMAZ V., Koral G., Cao M., Liu W., Maxwell S., Webster R., et al.

14th MGFA International Conference On Myasthenia And Related Disorders, Amerika Birleşik Devletleri, 10 - 12 Mayıs 2022, (Tam Metin Bildiri)

2022

53. NSC-87877, Inhibıtor Of Src Homology 2 Domain-Containing Phosphotyrosine Phosphatase 2, Ameliorates Experimental Autoimmune Myasthenia Gravis Induced By Musk Immunization

Yılmaz V., Koral G., Cao ., Liu W. W., Maxwell S., Webster R., et al.

14th MGFA International Conference On Myasthenia And Related Disorders, Florida, Amerika Birleşik Devletleri, 10 - 12 Mayıs 2022, cilt.65, ss.45, (Özet Bildiri)

2021

54. COVID-19 Pnömonisi Eş Zamanlı İskemik İnmede İmmünotrombotik Belirteçler

Duran Bayar M., Şişman A. B., Çırak S., Erdağ E., Yılmaz V., Tüzün E., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Yayınlanmadı)

2021

55. SWAP-70 ve FCRL2 moleküllerinin multipl skleroz fizyopatolojisindeki rolü ve biyobelirteç olarak değeri

Akbayır E., Şekerdağ E., Erdağ E., Şanlı E., Ulusoy C. A., Koral G., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Yayınlanmadı)

2021

56. Pandemi Öncesi ve Pandemi Döneminde Guillain-Barré Sendromunun Klinik ve Elektrofizyolojik Özellikleri: Çok Merkezli İstanbul Çalışması

Taşdemir V., Şirin İnan N. G., Çakar A., Çulha A., Soysal A., Elmalı Yazıcı A. D., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Yayınlanmadı)

2021

57. Glisin Reseptör Antikoru Pozitif Nedeni Bilinmeyen Fokal Epilepsi ile Süpresif T Hücre İlişkisi

Şanlı E., Yılmaz V., Şirin Inan N. G., Koral G., Küçükali C. I., Bebek N., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Yayınlanmadı)

2021

58. Narkolepsi ile İlişkili İmmün Mekanizmaların Mikroarray Yöntemi ile İncelenmesi

Yüceer H., Timirci Kahraman Ö., Benbir Şenel G., Karadeniz D., Tüzün E., Küçükali C. İ.

57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, ss.77, (Tam Metin Bildiri)

2021

59. Wistar Sıçanlarda İntraventriküler Anti-NMDAR Antikoru Pozitif Otoimmün Ensefalit Hasta Serum IgG Uygulamasının Epileptik Nöbet ve Davranış Üzerine Etkileri

Yüceer H., Akat Ş., Ulusoy C. A., Karaaslan Z., Çırak S., Çarçak Yılmaz N., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, ss.43, (Tam Metin Bildiri)

2021

60. Periferik Kan İmmünfenotiplemesi OSMS'yi NMOSH'den Ayırabilir mi?

KARAASLAN Z., ŞANLI E., YÜCEER H., ULUSOY C. A., KÜÇÜKALİ C. İ., TİMİRCİ KAHRAMAN Ö., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 01 Aralık 2021, (Özet Bildiri)

2021

61. The role of SWAP-70 and FCRL2 in the pathophysiology of multiple sclerosis and their value as a biomarker.

Şanlı E., Şekerdağ-Yılmaz E., Erdağ Turgeon E., Akbayır E., Ulusoy C. A., Koral G., et al.

15th International Society of Neuroimmunology (ISNI) Congress, Antibes, Fransa, 8 - 12 Kasım 2021, ss.45, (Özet Bildiri)

2021

62. The role of SWAP-70 and FCRL2 in the pathophysiology of multiple sclerosis and their value as a biomarker

ŞANLI E., Şekerdağ Yılmaz E., ERDAĞ E., Akbayır E., ULUSOY C. A., Koral G., et al.

15th International Society of Neuroimmunology (ISNI) Congress, France (Virtual)., 8 - 12 Kasım 2021, (Tam Metin Bildiri)

2021

63. Serum IgG of NMDAR Antibody Positive Encephalitis Patients Delays Absence Seizure Onset and Prolongs Seizure Duration in Rats

Yüceer H., Akat Ş., Ulusoy C. A., Karaaslan Z., Çırak S., Çarçak Yılmaz N., et al.

15th International Society of Neuroimmunology (ISNI) Congress, Nice, Fransa, 8 - 12 Kasım 2021, (Yayınlanmadı)

2021

64. Can OSMS be differentiated from NMOSD and MS by peripheral blood immunophenotyping?

Şanlı E., Karaaslan Z., Yüceer H., Ulusoy C. A., Küçükali C. İ., Timirci Kahraman Ö., et al.

15th International Society of Neuroimmunology (ISNI) Congress, Nice, Fransa, 8 - 12 Kasım 2021, (Yayınlanmadı)

2021

65. Benign multipl skleroz hastaları, değişmiş periferik kan B hücresi alt küme oranları ve B hücresi gen ekspresyon seviyeleri gösterir.

Akbayır E., Şanlı E., Ulusoy C. A., Özdemir Ö., Benbir Şenel G., Arsoy E., et al.

European Congress of Immunology, 1 - 04 Eylül 2021, (Yayınlanmadı)

2020

66. Parkinson Hastalığı: SUMO Gen Varyantları Etiyopatojenezde Rol Oynuyor Mu?

Yüceer H., Küçükali C. İ., Tüzün E., Bilgiç B., Ergen H. A., Hanağası H. A.

31. Ulusal Biyokimya Kongresi, İstanbul, Türkiye, 18 - 20 Aralık 2020, ss.80, (Özet Bildiri)

2019

67. Küme Başağrısı Patofizyolojisinde İnflamasyonun Olası Rolünün İnflamazom Kompleksiyle Değerlendirilmesi

Küçükali C. İ., Ulusoy C. A., Ekizoğlu Turgut E., Kocasoy Orhan E., Tüzün E., Baykal B.

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2019, (Yayınlanmadı)

2019

68. Glioblastoma Multiforme Erken Tanı ve Tedavisine İmkan Sağlayabilecek Otoantikorların Tanımlanması

Timirci Kahraman Ö., Topçu O., Sabancı P. A., Aras Y., Bilgiç M. B., Ünverengil G., et al.

55. Ulusal Nöroloji Kongresi , Antalya, Türkiye, 15 - 21 Kasım 2019, ss.1, (Özet Bildiri)

2019

69. Hippokampal Sklerozla İlişkili Mezyal Temporal Lob Epilepsisi ve Nedeni Bilinmeyen Fokal Epilepsilerde İnflamazom ve İnflamatuvar Faktörlerin Rolü

Ulusoy C. A., Vanlı Yavuz E. N., Şanlı E., Timirci Kahraman Ö., Yılmaz V., Bebek N., et al.

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2019, (Yayınlanmadı)

2019

70. Narkolepsiye Özgü Otoantikorların İmmünopresipitasyon ve Kütle Spektrofotometre ile Tanımlanması ve Validasyonu

YÜCEER H., KÜÇÜKALİ C. İ., YILMAZ V., GEZEN AK D., DURSUN E., BENBİR ŞENEL G., et al.

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2019, (Özet Bildiri)

2019

71. Glisin Reseptör Antikoru Pozitif Kriptojenik Fokal Epilepsi Hastalarının Periferik Kan Hücrelerinin İmmünfenotipik Değerlendirmesi

Şanlı E., Küçükali C. İ., Baykal B., Yılmaz V., Tüzün E.

55.Ulusal Nöroloji Kongresi, Antalya, Türkiye, 15 - 21 Kasım 2019, ss.71, (Özet Bildiri)

2019

72. NARKOLEPSİYE ÖZGÜ OTOANTİKORLARIN İMMÜNOPRESİPİTASYON VE KÜTLE SPEKTROFOTOMETREİLE TANIMLANMASI VE VALİDASYONU

YÜCEER H., BENBİR ŞENEL G., KARADENİZ D., TÜZÜN E., YILMAZ V.

55. Ulusal Nöroloji Kongresi, Türkiye, 16 - 20 Kasım 2019, (Tam Metin Bildiri)

2019

73. Narkolepsiye Özgü Otoantikorların İmmünopresipitasyon ve Kütle-Spektrofotometresi ile Tanımlanması ve Validasyonu

Yüceer H., Küçükali C. İ., Yılmaz V., Gezen Ak D., Dursun E., Benbir Şenel G., et al.

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2019, (Özet Bildiri)

2019

74. Hippokampal Sklerozla İlişkili Mezyal Temporal Lob Epilepsi ve Nedeni Bilinmeyen Fokal Epilepsilerde İnflamazom ve İnflamatuvar Faktörlerin Rolü

ULUSOY C. A., VANLI YAVUZ E. N., ŞANLI E., TİMİRCİ KAHRAMAN Ö., YILMAZ V., BEBEK N., et al.

55. Ulusal Nöroloji Kongresi (Uluslararası Katılımlı), Türkiye, 15 - 21 Kasım 2019, (Tam Metin Bildiri)

2019

75. Parkinson Hastalığı Patogenezinde Rol Alan Olası Moleküler Mekanizmalar: PI3K-Akt ve P53 Sinyal Yolakları

Karaaslan Z., Şanlı E., Timirci Kahraman Ö., Ergen H. A., Bilgiç B., Tüzün E., et al.

55.Ulusal Nöroloji Kongresi,, Antalya, Türkiye, 15 - 19 Kasım 2019, ss.78, (Özet Bildiri)

2019

76. Cognitive assessment and cytokine profile of multiple sclerosis patients presenting with only optic neuritis and myelitis

TÜZÜN E., ARSOY E., AKBAYIR E., ŞEN M., MERCAN Ö., GENCER M., et al.

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, İsveç, 11 - 13 Eylül 2019, cilt.25, ss.849, (Özet Bildiri)

2019

77. Immunophenotyping and investigation of antigenic responses of peripheral blood cells in glycine receptor antibody positive cryptogenic focal epilepsy

Şanlı E., Küçükali C. İ., Baykal B., Yılmaz V., Tüzün E.

VII. International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 07 Eylül 2019, ss.50-53, (Tam Metin Bildiri)

2019

78. Glisin Reseptör Antikoru Pozitif Kriptojenik Fokal Epilepside Periferik Kan Hücrelerinin İmmünfenotiplendirilmesi ve Antijenik Yanıtlarının Araştırılması

ŞANLI E., Akbayır E., KÜÇÜKALİ C. İ., BAYKAL B., YILMAZ V., TÜZÜN E.

VII. Uluslararası Moleküler Tıp Kongresi, İstanbul, Türkiye, 5 - 07 Eylül 2019, ss.1, (Özet Bildiri)

2019

79. Identification and validation of narcolepsy-spesific autoantibodies with immunoprecipitation and mass spectrophotometry

Küçükali C. İ., Yüceer H., Yılmaz V., Gezen Ak D., Dursun E., Benbir Şenel G., et al.

VII. International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 07 Eylül 2019, (Yayınlanmadı)

2019

80. Low prevalence of autoantibodies related to neuronal and rheumatic autoimmune disease in sera of patients with psychotic disorders

hoffmann c., Zong S., Mané-Damas M., , Stevens J. ,., Nogales-Gadea G., KÜÇÜKALİ C. İ., et al.

FENS Regional Meeting (FRM) (2019, Belgrade, Serbia), Belgrade, Sırbistan, 10 - 13 Temmuz 2019, ss.29, (Özet Bildiri)

2019

81. COGNITIVE IMPAIRMENT IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: EARLY DETECTION WITH MR SPECTROSCOPY AND ITS ASSOCIATION WITH MOG ANTIBODIES

Kilic H., Sahin S., Toprak M. F., Hatay G. H., YILMAZ K., ADROVIC YILDIZ A., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.982, (Özet Bildiri)

2019

82. DECREASED LEVELS OF Akt AND p-Akt1 IN PERIPHERAL CD4+CD25+CD127-/LOW REGULATOR T CELLS OF MULTIPLE SCLEROSIS PATIENTS

Öktelik F. B., YILMAZ V., Türkoğlu R., TÜZÜN E., DENİZ G., ÇINAR S.

International Molecular Immunology & Immunogenetics Congress IV ( MIMIC IV), Bursa, Türkiye, 27 - 29 Nisan 2019, cilt.PA119, ss.118, (Tam Metin Bildiri)

2019

83. The role of pericytes in MS pathophysiology.

Küçükali C. İ., Tüzün E., Ulusoy C. A., Özdemir Y.

VII. International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 07 Eylül 2019, ss.92-15, (Özet Bildiri)

2019

84. Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis

Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Ulusoy C., et al.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri)

2019

85. The Role of Pericytes in the Pathophysiology Multiple of Sclerosis

Tuzun E., Sekerdag E., Atak D., Yilmaz A., Ulusoy C., Zeybel M., et al.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri)

2019

86. Microarray Analysis Indicates Altered Expression Levels of B Cell Genes in Benign Multiple Sclerosis

Turkoglu R., Akbayir E., Sen M., Yilmaz V., Kucukali C., Tuzun E.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri)

2019

87. Serum levels of inflammasome complex factors are suppressed in focal epilepsy patients

Küçükali C. İ., Tüzün E., Ulusoy C. A., Bebek N., Baykal B.

AAN 71st Annual Meeting, Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, ss.92-15, (Özet Bildiri)

2019

88. Serum Levels of Inflammasome Complex Factors are Suppressed in Focal Epilepsy Patients

Yavuz E. N., Tuzun E., Ulusoy C., Kucukali C. I., Bebek N., Baykan B.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri)

2019

89. Co-existence of Multiple Sclerosis and Anti-NMDA Receptor Encephalitis: What We Can Learn From It?

Gulec B., Kurucu H., Bozbay S., Dikmen Y., Sayman H., Tuzun E., et al.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, Amerika Birleşik Devletleri, 4 - 10 Mayıs 2019, cilt.92, (Özet Bildiri)

2019

90. Multiple Skleroz Patofizyolojisinde Perisitlerin Rolü

Küçükali C. İ., Ulusoy C. A., Yılmaz V., Özdemir Y., Tüzün E.

55. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2019, (Yayınlanmadı)

2018

91. Antidepressant effect of ketamine in chronic unpredictable mild stress model: Involvement of nod-like protein inflammasome driven pathway

Aricioglu F., Yalcinkaya C., Ozkartal C. S., Tuzun E., Kucukali C. İ., Kandemir C., et al.

31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, İspanya, 6 - 09 Ekim 2018, cilt.29, (Özet Bildiri)

2018

92. Optik Sinir ve Omurilik Tutulumu olan Multiple Skleroz Hastalarının Sitokin-Kemokin Düzeyi ve Bilişsel Profili

Küçükali C. İ., Yılmaz V., Tüzün E.

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Yayınlanmadı)

2018

93. Multiple Skleroz Patofizyolojisinde Perisitlerin Rolünün Deneysel Allerjik Ensefalomyelit Modelinde İncelenmesi

Küçükali C. İ., Ulusoy C. A., Tüzün E., Özdemir Y.

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Yayınlanmadı)

2018

94. Beningn Multiple Sklerozda Uyku Bozukluklarının Sıklığı ve İlişkili İmmün Sistem Genlerinin Ekspresyon Düzeyleri

Küçükali C. İ., Karadeniz D., Tüzün E.

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Yayınlanmadı)

2018

95. Fokal Epilepsilerde İnflamazomun Rolü

Küçükali C. İ., Ulusoy C. A., Bebek N., Tüzün E., Baykal B.

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Yayınlanmadı)

2018

96. Kronik KriptojenikFokal Epilepsi Olgularında Hastalığa Özgü Aday Otoantijen Yaklaşımı

Küçükali C. İ., Gezen Ak D., Dursun E., Kasap M., Akpınar G., Sezgin M., et al.

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Yayınlanmadı)

2018

97. İdiyopatik İntrakraniyal Hipertansiyonda Antinöronal Membran Antikorlar

Küçükali C. İ., Gezen Ak D., Dursun E., Kasap M., Akpınar G., Baykal B., et al.

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 30 Kasım - 06 Aralık 2018, (Yayınlanmadı)

2018

98. Multipl sklerozda hipotalamus ve pineal beze ait mediyatör düzeylerinin hastalık progresyonu ve motor sistem performansı ile ilişkisi

Akbayır E., Şen M., Arsoy E., ULUSOY C. A., YILMAZ V., TÜZÜN E., et al.

54. Ulusal Nöroloji Kongresi, Türkiye, 1 - 05 Aralık 2018, (Tam Metin Bildiri)

2018

99. Optik sinir ve omurilik tutulumu olan multipl skleroz hastalarının sitokin-kemokin düzeyi ve bilişsel profili

Şen M., Ece A., MERCAN Ö., Arsoy E., YILMAZ V., Gencer M., et al.

54. Ulusal Nöroloji Kongresi, Türkiye, 1 - 05 Aralık 2018, (Tam Metin Bildiri)

2018

100. Bilgisayarlı Kognitif Rehabilitasyonun Benign Multipl Sklerozda Yürütücü İşlevlere Etkisi

Akbayır E., Şen M., ŞANLI E., Arsoy E., Türkoğlu R., TÜZÜN E.

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 01 Aralık 2018 - 06 Eylül 2019, ss.1, (Özet Bildiri)

2018

101. Is the frequency of neuronal autoantibodies higher in patients with bilateral hippokampal sclerosis compared to unilateral ones?

Küçükali C. İ., Tüzün E., Sezgin M., Ulusoy C. A., Bebek N., Sencer N. S., et al.

13th European Congress on Epileptology, Vienna, Avusturya, 26 - 30 Ağustos 2018, (Yayınlanmadı)

2018

102. Circulating B cell subsets in chronic inflammatory demyelinating polyneuropaty

ÖZDAĞ ACARLI A. N., YILMAZ V., Şirin İnan N. G., Soysal A., aysal f., DURMUŞ TEKÇE H., et al.

4th Congress of the European Academy of Neurology, 16 - 19 Haziran 2018, (Tam Metin Bildiri)

2018

103. Computerised cognitive rehabilitation improves executive functions in benign Multiple Sclerosis patients

TÜZÜN E., Arsoy E., Turkoglu R.

4th Congress of the European-Academy-of-Neurology (EAN), Lisbon, Portekiz, 16 - 19 Haziran 2018, cilt.25, ss.563, (Özet Bildiri)

2018

104. Optikospinal multipl sklerozun sitokin profilinin incelenmesi

Şen M., akbayır E., MERCAN Ö., Erdil A., TÜRKOĞLU R., YILMAZ V., et al.

16. Ulusal Sinirbilim Kongresi, Türkiye, 20 - 23 Mayıs 2018, (Tam Metin Bildiri)

2018

105. Parkinson Hastalığında Mikroarray Ekspresyon Verilerinin Biyoinformatik Yöntemlerle İncelenmesi

Küçükali C. İ., Timirci Kahraman Ö., Tüzün E., Ulusoy C. A., Ergen H. A.

Nörodejenerasyon / Nörorejenerasyon Çalıştayı, İstanbul, Türkiye, 4 - 05 Mayıs 2018, (Yayınlanmadı)

2018

106. SEPSİS İLİŞKİLİ AKUT BEYİN DİSFONKSİYONU OLAN HASTALARDA İNFLAMATUAR BELİRTEÇLER İLE KOGNİTİF SONUÇ İLİŞKİSİ

ORHUN G., TÜZÜN E., ERGİN ÖZCAN P., ULUSOY C. A., YILDIRIM E., KÜÇÜKERDEN M., et al.

19.Ulusal Yoğun Bakım Kongresi, Türkiye, 19 - 22 Nisan 2018, cilt.22, (Özet Bildiri)

2018

107. Novel anti-neuronal antibodies in idiopathic intracranial hypertension patients

Tuzun E., Altiokka-Uzun G., Erdag E., Gezen-Ak D., Dursun E., Kucukali C. I., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

2018

108. P015 Association between inflammatory markers and cognitive outcome in patients with acute brain dysfunction due to sepsis

ORHUN G., TÜZÜN E., ERGİN ÖZCAN P., ULUSOY C. A., YILDIRIM E., KÜÇÜKERDEN M., et al.

38th International Symposium on Intensive Care and Emergency Medicine, 20 - 23 Mart 2018, cilt.22, ss.87, (Özet Bildiri)

2017

109. Topiramatın Fare Frenik Sinir-Hemidiyafram Preparatı Üzerine Etkileri

Küçükali C. İ., Yüceer H., Tüzün E.

53. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 24 - 30 Kasım 2017, ss.298, (Özet Bildiri)

2017

110. Kronik İnflamatuar Demiyelinizan Polinöropati’de Periferik Kan B hücre İmmünfenotiplemesi

YILMAZ V., Şirin İnan N. G., Soysal A., aysal f., DURMUŞ TEKÇE H., TÜZÜN E., et al.

53. Ulusal Nöroloji Kongresi, Türkiye, 24 - 30 Kasım 2017, (Özet Bildiri)

2017

111. NEDENİ BELİRLENEMEYEN EPİLEPTİK ENSEFALOPATİLERDE OTOİMMUN ANTİKORLARIN ARAŞTIRILMASI

Tektürk P., Baykal B., Erdağ E., Sezgin M., Küçükali C. İ., Yapıcı Z., et al.

53. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 24 - 30 Kasım 2017, ss.13, (Özet Bildiri)

2017

112. Hafıza B hücre Düzeyi Klinik İzole Sendrumun Multipl Skleroza Dönüşümü için Biyobelirteç Olabilir mi?

TÜZÜN E., AK TURA D., YILMAZ V., Özkan Yaşargün D., TÜRKOĞLU R.

53. Ulusal Nöroloji Kongresi, Türkiye, 24 - 30 Kasım 2017, (Özet Bildiri)

2017

113. Multipl skleroz gelişiminde aday biyomarkerlarin proteomiks analiz yöntemi ile belirlenmesi

TİMİRCİ KAHRAMAN Ö., KARAASLAN Z., KÜÇÜKALİ C. İ., TÜZÜN E., BAYKAL A. T., KÜRTÜNCÜ M., et al.

53. ulusal nöroloji kongres, Türkiye, 24 - 30 Kasım 2017, (Özet Bildiri)

2017

114. Selective inhibition of purinergic 2X7 receptors elicits antidepressant-like effect in chronic mild stress model in rats: role of innate immunity

Aricioglu F., Ozkartal C. S., Bastaskin T., Tuzun E., Kucukali C., Utkan T.

30th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Paris, Fransa, 2 - 05 Eylül 2017, cilt.27, (Özet Bildiri)

2017

115. GABA and microbiota association in multiple sclerosis and neuro-Behcet's disease

Oezguen N., Yalcinkaya N., KÜÇÜKALİ C. İ., Dahdouli M., Hollister-Branton E., Luna R. A., et al.

3rd Congress of the European-Academy-of-Neurology, Amsterdam, Hollanda, 01 Haziran 2017, cilt.24, ss.656, (Özet Bildiri)

2017

116. Prognostic value of adipokines in multiple sclerosis

TÜZÜN E., Duzel B., Turkoglu R., Tamam Y.

3rd Congress of the European-Academy-of-Neurology, Amsterdam, Hollanda, 01 Haziran 2017, cilt.24, ss.416, (Özet Bildiri)

2017

117. The NLRP1 and NLRP3 inflammasomes are activated in multiple sclerosis and clinically isolated syndrome

Turkoglu R., Ozkan-Yasargun D., TÜZÜN E.

3rd Congress of the European-Academy-of-Neurology, Amsterdam, Hollanda, 01 Haziran 2017, cilt.24, ss.415, (Özet Bildiri)

2017

118. Cytokine Production in Myasthenia Gravis

YILMAZ V., OFLAZER P., aysal f., DURMUŞ TEKÇE H., PARMAN F. Y., TÜZÜN E., et al.

13th International Conference on Myasthenia Gravis and Related Disorders, 15 - 17 Mayıs 2017, (Özet Bildiri)

2017

119. MuSK binding peripheral B cells as biomarker for MuSK myasthenia gravis

TÜZÜN E.

13th International Conference on Myasthenia Gravis and Related Disorders, New York, Amerika Birleşik Devletleri, 15 - 17 Mayıs 2017, cilt.1, ss.12, (Tam Metin Bildiri)

2017

120. ŞİZOFRENİ HASTALARI VE KARDEŞLERİNDE KİNÜRENİN YOLAĞI METABOLİTLERİ, VİTAMİN D VE İNFLAMASYON BELİRTEÇLERİNİN KOGNİSYON VE KLİNİK BELİRTİLERLE İLİŞKİSİ

Noyan H., TÜZÜN E., Erdağ E., HAKAN M. T., KÜÇÜKHÜSEYİN Ö., YAYLIM İ., et al.

II. Türkiye in vitro Diyagnostik(IVD)Sempozyumu, İzmir, Türkiye, 10 - 22 Mayıs 2017, ss.1, (Tam Metin Bildiri)

2017

121. Immune Cell Infiltration in CASPR2-Antibody Associated Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

TÜZÜN E., YAVUZ E. N., ERDAĞ E., BAYKAL B.

Neurology, Amerika Birleşik Devletleri, 18 - 22 Nisan 2017, cilt.88, ss.1226, (Özet Bildiri)

2017

122. Nöronal Oto-antikorlarla İlişkili Dirençli Epilepsi Olgularında Otoimmun Tedavi Deneyimi ve EEG Üzerine Etkisi

Sezgin M., Ekizoğlu Turgut E., Tüzün E., Erdağ E., Bebek N., Gürses R. C., et al.

33. Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi, Antalya, Türkiye, 12 - 16 Nisan 2017, ss.104, (Özet Bildiri)

2016

123. Fingolimod Tedavisinin Multipl Skleroz hastalarında periferik kan hücre immünofenotipleri üzerine etkisi

AKÇAY H. İ., ULUSOY C. A., ÇINAR S., YILMAZ V., Türkoğlu R., Altunrende B., et al.

52. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016, ss.30, (Tam Metin Bildiri)

2016

124. Fingolimod Tedavisinin Multipl Skleroz Hastalarında Periferik Kan hücre İmmunufenotipleri üzerine Etkisi

AKÇAY H. İ., ULUSOY C. A., ÇINAR S., YILMAZ V., TÜRKOĞLU R., ALTUNRENDE B., et al.

52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016, (Özet Bildiri)

2015

125. Anti NMDA receptor encephalitis with cancer of unknown primary origin

TÜZÜN E., ÇOBAN A., TÜRKOĞLU R., BİLGİÇ B.

1st Congress of the European-Academy-of-Neurology, 20 Haziran 2015

2016

126. Brain magnetic resonance imaging findings in patients with septic shock

Orhun G., Şentürk E., Ergin Özcan P., Sencer N. S., Ulusoy C. A., Tüzün E.

36th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belçika, 15 - 18 Mart 2016, cilt.20, sa.94, ss.134, (Özet Bildiri)

2016

127. Heat shock proteins in a rat model of pyelonephritis and renal scar

Yılmaz A., Yürük Yıldırım Z. N., Küçük M., Gedikbaşı A., Pehlivanoğlu C., Özlük M. Y., et al.

17th IPNA Congress,, Iguatu, Brezilya, 20 - 24 Eylül 2016, cilt.31, ss.1765-1983, (Tam Metin Bildiri)

2016

128. Detection Of Biomarkers in Cerebrospinal Fluid of Multiple Sclerosis Patients By Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

TİMİRCİ KAHRAMAN Ö., KÜÇÜKALİ C. İ., TÜZÜN E., KÜRTÜNCÜ M., BAYKAL A. T., ERAKSOY M.

X. Annual Congress of the European Proteomics Association, İstanbul, Türkiye, 22 - 25 Haziran 2016, ss.1-2, (Tam Metin Bildiri)

2016

129. The effect of fingolimod treatment on peripheral blood cell immunophenotypes in patients with multiple sclerosis

ULUSOY C. A., ÇINAR S., YILMAZ V., AKÇAY H. İ., Türkoğlu R., GÜNDÜZ T., et al.

International Molecular Immunology & Immunogenetcs Congress (MIMIC-III), Antalya, Türkiye, 27 - 30 Nisan 2016, cilt.4, ss.75, (Tam Metin Bildiri)

2016

130. Different Cognitive Parameters in Bilateral and Unilateral Hippocampal Sclerosis

Yavuz E. N., Bilgic B., Tuzun E., Sencer S., Sencer A., Bebek N., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri)

2016

131. A Proteomics Approach for the Identification of Cerebrospinal Fluid Proteins Associated with Conversion to Multiple Sclerosis

Kurtuncu M., Turkoglu R., Tuzun E., Kucukali C.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri)

2016

132. Switching From Glatiramer Acetate: Comparison of Disease Modifying Treatments

Kurtuncu M., Akcay H. I., Cakar A., Gunduz T., Tuzun E., Eraksoy M.

ACTRIMS Forum, Louisiana, Amerika Birleşik Devletleri, 18 - 20 Şubat 2016, cilt.22, ss.18-19, (Özet Bildiri)

2016

133. Clinical features of patients with relapsing inflammatory optic neuritis

Tuzun E., Cakar A., Akcay H. I., Kurtuncu M., Eraksoy M.

ACTRIMS Forum, Louisiana, Amerika Birleşik Devletleri, 18 - 20 Şubat 2016, cilt.22, ss.20-21, (Özet Bildiri)

2015

134. PİLOMOTOR NÖBETLER VE PSİKOZLA GİDEN TEMPORAL LOB EPİLEPSİLİ OLGUDA İLK KEZ SAPTANAN GABA-A RESEPTÖRÜNE KARŞI OTO-ANTİKORLAR

Sezgin M., Tüzün E., Baysal Kıraç L., Vanlı Yavuz E. N., Bebek N., Gürses C., et al.

51. ULUSAL NÖROLOJİ KONGRESİ , Antalya, Türkiye, 27 Kasım - 03 Aralık 2015, ss.133, (Özet Bildiri)

2015

135. Tümefaktif Multipl Sklerozda Serum İyon Kanalı Antikorları

TÜRKOĞLU R., ÇOBAN A., AKCAN U., ULUSOY C. A., ÇEVİK D., ÖZYURT S., et al.

51. Ulusal Nöroloji Kongresi, Türkiye, 27 Kasım 2015

2015

136. Idiopatik Intrakranial Hipertansiyon Olgularında Serum Nöron Spesifik Enolaz Düzeylerinin Incelenmesi.

ŞAHİN E., SAMANCI B., Samancı Y., Altıokka Uzun G., EKİZOĞLU TURGUT E., İÇÖZ S., et al.

51. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 27 Kasım - 03 Aralık 2015, ss.1, (Tam Metin Bildiri)

2015

137. Parkinson Hastalıgının Etyopatogenesinde Kanser Yollarının Rolü.

Yalçınkaya N., Haytural H., KÜÇÜKALİ C. İ., GÜRVİT İ. H., HANAĞASI H. A., BİLGİÇ B., et al.

7. DETAE Günleri, İstanbul, Türkiye, 11 - 12 Kasım 2015, ss.1, (Tam Metin Bildiri)

2015

138. MUSK INDUCED EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS IS ANTI-MUSK IGG1 INDEPENDENT

Kucukerden M., Huda R., TÜZÜN E., Strait R. T., Finkelman F. D., Trakas N., et al.

American-Association-of-Neuromuscular-and-Electrodiagnostic-Medicine 62nd Annual Meeting, Hawaii, Amerika Birleşik Devletleri, 28 - 31 Ekim 2015, cilt.52, (Özet Bildiri)

2015

139. In vivo, in vitro and behavioural effects of intracerebral injection of neuro-Behcet's disease immunoglobulin and sera to brain parenchyma

ERDAG E., ŞAHİN C., Tuzun E., Kucukali C. I., ARICIOĞLU F.

28th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Amsterdam, Hollanda, 29 Ağustos - 01 Eylül 2015, cilt.25, (Özet Bildiri)

2015

140. Impact of intracerebral neuro-Behcet's disease immunoglobulin injection to brain parenchyma histology and behavioral tests

Erdag E., Sahin C., Aricioglu F., Turkoglu R., Tuzun E.

1st Congress of the European-Academy-of-Neurology, Berlin, Almanya, 20 - 23 Haziran 2015, cilt.22, ss.527, (Özet Bildiri)

2015

141. Investigation of DNA repair genes in patients with obsessive compulsive disorder.

Çelik R., KÜÇÜKALİ C. İ., Bireller E. S., TÜZÜN E., ÇAKMAKOĞLU B.

V. International Congress of Molecular Medicine, İzmir, Türkiye, 20 - 22 Mayıs 2015, ss.1, (Tam Metin Bildiri)

2015

142. Evaluation of Paraoxonase 1 Polymorphisms in Patient with Bipolar Disorder.

ULUSOY C. A., Özden Ö., Güleç H., TÜZÜN E., KÜÇÜKALİ C. İ.

V. International Congress of Molecular Medicine, İzmir, Türkiye, 20 - 22 Mayıs 2015, ss.1, (Tam Metin Bildiri)

2015

143. Effects of GNAS1 T393C and GNB3 C825T polymorphisms on schizophrenia.

Gökçe H. H., KÜÇÜKALİ C. İ., DAŞDEMİR S., TÜZÜN E., ÇAKMAKOĞLU B.

V. International Congress of Molecular Medicine, İzmir, Türkiye, 20 - 22 Mayıs 2015, ss.1, (Tam Metin Bildiri)

2015

144. Chemokine gene variants in schizophrenia.

DAŞDEMİR S., KÜÇÜKALİ C. İ., Bireller E. s., TÜZÜN E., ÇAKMAKOĞLU B.

20th International Conference Association of Psychology & Psychiatry for Adults & Children, Atina, Yunanistan, 18 - 22 Mayıs 2015, ss.1, (Tam Metin Bildiri)

2013

145. Multipl Sklerozda Erken Dönem Serum Sitokin Düzeyleri Değişiminin Uzun Süreli İnterferon Beta1a Kullanım Etkinliği Üzerinde Tahmin Ettirici Rolü Var mıdır

ÇOBAN A., BALCI B., SHUGAİV E., TÜRKOĞLU R., ULUSOY C. A., İÇÖZ S., et al.

49. Ulusal Nöroloji Kongresi, Türkiye, 11 Kasım 2013

2015

146. Reduced serum vitamin D levels in neuromyelitis optica

TÜZÜN E., Küçükhüseyin Ö., KÜRTÜNCÜ M., TURKOGLU R., YAYLIM İ.

EACR Neurological Sciences, İzmir, Türkiye, 25 Nisan 2015, ss.1-2, (Özet Bildiri)

2015

147. Serum antibodies isolated from neuro-Behcet’s disease patients mediate neuronal death and cognitive impairment.

TÜZÜN E., Erdağ E., Şahin C., KÜÇÜKALİ C. İ., KAYA M., KÜRTÜNCÜ M., et al.

AAN 67th Annual Meeting, Vancouver, Kanada, 18 - 25 Nisan 2015, ss.1, (Tam Metin Bildiri)

2013

148. Üveitin Multipl Sklerozun Seyri Üzerine Etkisi

SHUGAİV E., TÜZÜN E., ÇOBAN A., PEHLİVAN M., KÜRTÜNCÜ M., DEMİR G., et al.

49. Ulusal Nöroloji Kongresi, Türkiye, 11 Kasım 2013

2013

149. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., TÜZÜN E., ÇOBAN A., Pehlivan M., KÜRTÜNCÜ M., Demir G., et al.

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

2014

150. Nöromiyelitis Optika ve Otoimmün Ensefalitte Serum Oreksin A düzeyleri

ÇOBAN A., KÜÇÜKALİ C. İ., HAYTURAL H., BENBİR G., ULUSOY C. A., GİRİŞ M., et al.

50. Ulusal Nöroloji Kongresi, Türkiye, 21 Kasım 2014

2014

151. Nöro Behçet Hastalığının Aktif ve İnaktif Dönemlerindeki Gen Ekspresyon Profilleri

UĞUREL E., ŞEHİTOĞLU E., KÜRTÜNCÜ M., TÜZÜN E., SHUGAİV E., ÇOBAN A., et al.

6. DETAE Günleri, Türkiye, 24 Kasım 2014

2014

152. Parkinson Hastalıgı’nın Hayvan Modelinde P13K/AKT Yolagı Ile Mitokondriyal, Oksidatif ve Apoptotik Parametrelerinin Iliskisi.

Yalçınkaya N., Haytural H., Türkoğlu R., KÜÇÜKALİ C. İ., TÜZÜN E.

50. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 21 - 27 Kasım 2014, ss.28-37, (Tam Metin Bildiri)

2014

153. Nöromyelitis Optika ve Otoimmün Ensefalitte Serum Oreksin-A Düzeyleri.

Çoban A., Küçükali C. İ., Haytural H., Benbir Şenel G., Ulusoy C. A., Giriş M., et al.

50. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 21 - 27 Kasım 2014, ss.1, (Tam Metin Bildiri)

2014

154. Beyin Parankimal Histolojisi Üzerine Intraserebral Nöro- Behçet IgG ve Serum Enjeksiyonu Etkisi.

Erdağ E., şahin c., KÜÇÜKALİ C. İ., Arıcıoğlu F., TÜZÜN E.

50. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 21 - 27 Kasım 2014, ss.103, (Tam Metin Bildiri)

2014

155. Anti nöronal Antikora Sahip Hastaları Prognozu

ÇELİK Ş., TÜZÜN E., DEMİR G., ÇOBAN A., İÇÖZ S., BİRDAY E., et al.

50. Ulusal Nöroloji Kongresi, Türkiye, 21 Kasım 2014

2014

156. Investigation of the impact of intravenous injection of mesenchymal stem cells from mouse bone marrow on muscle weakness and immunological parameters in experimental autoimmune myasthenia gravis model

Ulusoy C. A., Kucukerden M., Turan S., Gurkan G., ÖĞÜLÜR İ., AKKOÇ T., et al.

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.195, (Özet Bildiri)

2014

157. A novel predictive factor, sorcin antibody in conversion of radiologically isolated syndrome to multiple sclerosis

Erdag E., Sehitoglu E., Kucukerden M., Orcen A., Tuzun E., Turkoglu R.

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.17-18, (Özet Bildiri)

2014

158. Differential cytokine changes in myasthenia gravis patients with antibodies against AChR and Musk

Yilmaz V., Oflazer P., Aysal F., Durmus H., Poulos K., Parman Y., et al.

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.212-213, (Özet Bildiri)

2014

159. Antibodies to DNA repair proteins in HaNDL patients

Erdag E., Tuzun E., Kurtuncu M., Vural B.

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.59, (Özet Bildiri)

2014

160. Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients

Tuzun E., Ulusoy C. A., Turan S., Orcen A., Yetimler B., Akbas-demir D., et al.

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.228, (Özet Bildiri)

2014

161. Evaluation of Incidence and Clinical Features of Antibody Associated Autoimmune Encephalitis Mimicking Dementia.

Erdağ E., ÇOBAN A., KÜÇÜKALİ C. İ., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H., et al.

Alzheimer’ s Association International Conference, Copenhagen, Danimarka, 12 - 17 Temmuz 2014, ss.1, (Tam Metin Bildiri)

2014

162. A Preliminary Study: The effect of Vitamin D3 on mitotic index of SH-SY5Y Neuroblastoma Cells"

YAYLIM İ., KÜÇÜKHÜSEYİN Ö., ÇAKİRİS A., Haytural H., ÜSTEK D., TÜZÜN E.

17. Workshop on Vitamin D, Chicago, Amerika Birleşik Devletleri, 17 - 20 Haziran 2014, ss.1, (Tam Metin Bildiri)

2013

163. Cerebral white matter lesions in Behcet's disease: neuro-Behcet's disease or multiple sclerosis?

Akman-Demir G., Mutlu M., Kiyat-Atamer A., Shugaiv E., KÜRTÜNCÜ M., Tugal-Tutkun I., et al.

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japonya, 6 - 08 Kasım 2013, cilt.20, ss.948-949, (Özet Bildiri)

2013

164. Mitochondrial carrier 1 (MTCH1) antibodies in neuromyelitis optica patients with or without aquaporin-4 antibodies

Coban A., Cavus F., Ulusoy C., Turan S., Vural B., Turkoglu R., et al.

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japonya, 6 - 08 Kasım 2013, cilt.20, ss.942-943, (Özet Bildiri)

2014

165. Gene expression profiles in neuro Behcet s disease during active and inactive stages

UĞUREL E., ŞEHİTOĞLU E., KÜRTÜNCÜ M., SHUGAİV E., ULUSOY C. A., KÜÇÜKERDEN M., et al.

EFNS-ENS Joint Congress of European Neurology, 31 Mayıs 2014

2014

166. Coexistence of neuromyelitis optica and seizures a case report

SHUGAİV E., ÇOBAN A., KÜRTÜNCÜ M., TÜZÜN E., DEMİR G., ERAKSOY M.

EFNS-ENS Joint Congress of European Neurology, 31 Mayıs 2014

2014

167. Demansı Taklit Eden Antikor Iliskili Otoimmün Ensefalitin Insidansının ve Klinik Özelliklerinin Degerlendirilmesi.

Erdağ E., KÜÇÜKALİ C. İ., TÜZÜN E., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H.

12. Ulusal Sinirbilimleri Kongresi, İstanbul, Türkiye, 28 - 31 Mayıs 2014, ss.1, (Tam Metin Bildiri)

2014

168. Relatively benign course in the long term follow-up of two cases with epilepsy associated with NMDAR-antibody positivity

Kirac L. B., Turgut E. E., TÜZÜN E., Baykan B.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)

2014

169. Gene expression profiles in neuro-Behcet's disease during active and inactive stages

Ugurel E., Sehitoglu E., KÜRTÜNCÜ M., Shugaiv E., ULUSOY C. A., Kucukerden M., et al.

Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, (Özet Bildiri)

2014

170. Evaluation of incidence and clinical features of antibody associated autoimmune encephalitis mimicking dementi

ERDAĞ E., ÇOBAN A., KÜÇÜKALİ C., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H., et al.

Alzheimer’s Association International Conference, 12 Temmuz 2014

2013

171. Aquaporin 1 antikoru Aquaporin 4 Antikoru pozitif olan ve olmayan Nöromyelitis Optica Hastalarında Yeni Saptanan Bir Antikor

ÇOBAN A., TZARTOS J., STERGİOU C., DEMİR G., ZİSİMOPOULOU P., SHUGAİV E., et al.

49. Ulusal Nöroloji Kongresi, Türkiye, 15 Kasım 2013

2013

172. Aquaporin 1 in Turkish Neuromyelitis Optica Patients with and without Aquaporin 4 Antibodies

ÇOBAN A., Tzartos J., Stergiou C., Demir G., Zisimopoluou P., Shugaiv E., et al.

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

2013

173. Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

KÜRTÜNCÜ M., TÜZÜN E., Balcı B., Birday E., ÇOBAN A., Türkoğlu R., et al.

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 Ekim 2013

2013

174. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., Tuzun E., Coban A., Pehlivan M., Kurtuncu M., Tugal-Tutkun I., et al.

29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Danimarka, 2 - 05 Ekim 2013, ss.352, (Özet Bildiri)

2013

175. Amyotrofik Lateral Skleroz ALS da Serum Anti Nöronal Antikorları

TURAN S., ULUSOY C. A., ÇOBAN A., GİRİŞ M., KÜÇÜKERDEN M., TÜRKOĞLU R., et al.

11. Ulusal Sinirbilim Kongresi (11th Turkish Neuroscience Congress), Türkiye, 28 Nisan 2013

2013

176. Serum anti neuronal antibodies in Amyotrophic Lateral Sclerosis

Türkoğlu R., ÇOBAN A., ULUSOY C. A., Giriş M., Turan S., TÜZÜN E., et al.

Twenty-third Meeting of the European Neurological Society, 08 Haziran 2013

2013

177. MTCH1 antibodies in Neuromyelitis Optica patients with or without aquaporin 4 antibodies

ÇOBAN A., Çavuş F., ULUSOY C. A., Turan S., VURAL B., Türkoğlu R., et al.

Twenty-third Meeting of the European Neurological Society, 08 Haziran 2013

2013

178. Ion channel and synapse antibodies for differential diagnosis of chronic neurodegenerative and psychiatric disorders.

Yalçınkaya N., Yalçınkaya N., Haytural H., ULUSOY C. A., Turan S., Küçükerden M., et al.

4th International Medical Students’ Research Congress, İstanbul, Türkiye, 3 - 05 Mayıs 2013, ss.1, (Tam Metin Bildiri)

2013

179. Klinik İzole Sendromdan Klinik Olarak Kesin Multipl Skleroza Dönüşüm Sürecinde MRI Ve Disabilitenin Prediktif Değeri

ARIKANOĞLU A., SHUGAİV E., ÇOBAN A., TÜZÜN E., ERAKSOY M.

6. Nöroimmünoloji Okulu, Türkiye, 28 Şubat 2013

2013

180. Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies

Cavus F., Ugurel E., Sehitoglu E., Woodhall M., Waters P., Ulusoy C., et al.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, cilt.80, (Özet Bildiri)

2013

181. Arterial CNS Involvement in Behcet's Disease

Akman-Demir G., Birday-Shugaiv E., Kurtuncu M., Mutlu M., Barlas-Yesilot N., Tuzun E., et al.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, (Özet Bildiri)

2012

182. Skeletal muscle pathology in the experimental animal model of muscle-specific receptor tyrosine kinase (MuSK) related myasthenia gravis

Ulusoy C., Yilmaz V., Trakas N., Poulas K., Armagan H., Turan S., et al.

11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.51-52, (Özet Bildiri)

2012

183. Switch-associated protein 70 (SWAP 70) antibody levels are associated with clinical relapse in multiple sclerosis

Erdag E., Tuzun E., Akman-Demir G., Ugurel E., Sehitoglu E., Cavus F., et al.

11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, cilt.253, ss.17, (Özet Bildiri)

2012

184. Uveitis in patients with multiple sclerosis

Shugaiv E., KÜRTÜNCÜ M., Mutlu M., Akman-Demir G., Tugal-Tutkun I., TÜZÜN E., et al.

11th International Congress of Neuroimmunology (ISNI), Massachusetts, Amerika Birleşik Devletleri, 4 - 08 Kasım 2012, ss.34, (Özet Bildiri)

2012

185. White Matter Lesions in Behcet's Disease: Neuro-Behcet's Disease or Multiple Sclerosis?

Akman-Demir G., Mutlu M., Kiyat-Atamer A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.

64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, Amerika Birleşik Devletleri, 21 - 28 Nisan 2012, cilt.78, (Özet Bildiri)

2012

186. Elevated Switch-Associated Protein 70 (SWAP70) Antibody Levels during Attacks in Multiple Sclerosis Patients

Erdag E., Ugurel E., Cavus F., Vural B., Kurtuncu M., Eraksoy M., et al.

64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, Amerika Birleşik Devletleri, 21 - 28 Nisan 2012, cilt.78, (Özet Bildiri)

2011

187. Anti-Neuronal and Stress-Induced-Phosphoprotein 1 Antibodies in Neuro-Behcet's Disease

Akman-Demir G., Vural B., Ugurel E., Icoz S., TÜZÜN E., Kurtuncu M., et al.

63rd AAN Annual Meeting, Hawaii, Amerika Birleşik Devletleri, 9 - 16 Nisan 2011, cilt.76, (Özet Bildiri)

2010

188. Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): Could It Be an Autoimmune Disease?

Akman-Demir G., Tuezuen E., KAYA D., Vural B., Ugurel E., Icoez S., et al.

62nd Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 10 - 17 Nisan 2010, (Özet Bildiri)

2009

189. Increased complement activation in MuSK-antibody positive myasthenia gravis patients.

YILMAZ V., TÜZÜN E., OFLAZER P., PARMAN F. Y., DEYMEER F., SARUHAN DİRESKENELİ G.

International Conference on Myasthenia, 1 - 02 Aralık 2009, (Özet Bildiri)

2009

190. MUSK Antikoru Pozitif Myasthenia Gravis’de Artmış Kompleman Aktivasyonu

YILMAZ V., TÜZÜN E., PARMAN F. Y., DEYMEER F., SARUHAN DİRESKENELİ G.

20. Ulusal İmmünoloji Kongresi, Türkiye, 19 - 22 Kasım 2009, (Özet Bildiri)

2008

191. Devic's neuromyelitis optica: An analysis of 47 patients and prognostic implications of NMO IgG status

Akman-Demir G., ERAKSOY M., TÜZÜN E., Jarius S., Icoz S., Kartuncu M., et al.

60th Annual Meeting of the American-Academy-of-Neurology, Illinois, Amerika Birleşik Devletleri, 12 - 19 Nisan 2008, cilt.70, (Özet Bildiri)

2007

192. Clinical and pathological features of anti-NMDAR antibody associated encephalitis

Tüzün E., Rossi J. E., Rosenfeld M. R., Lynch D. R., Dalmau J.

43. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 10 - 15 Kasım 2007, cilt.13, sa.5, ss.18, (Özet Bildiri)

2007

193. Adenylate kinase 5 (AK5) autoimmunity in limbic encephalitis

TÜZÜN E., Rossi J. E., Karner S. F., Centurion A. F., Dalmau J.

59th Annual Meeting of the American-Academy-of-Neurology, Massachusetts, Amerika Birleşik Devletleri, 28 Nisan - 05 Mayıs 2007, cilt.68, (Özet Bildiri)

2007

194. Clinical and Pathollogical analyzis of paraneoplastic anti-NMDA receptor encephalitis in 16 patients

TÜZÜN E., Rossi J. E., Rosenfeld M. R., Lynch D. R., Dalmau J.

59th Annual Meeting of the American-Academy-of-Neurology, Massachusetts, Amerika Birleşik Devletleri, 28 Nisan - 05 Mayıs 2007, cilt.68

2006

195. Functional NR2B and NR2A heteromers of the NMDA receptor are the autoantigens of treatment-responsive encephalitis in patients with ovarian teratoma

Dalmau J., TÜZÜN E., Wu HY W. H., Rossie J. E., Maronski M., Masjuan J., et al.

131st Annual Meeting of the American-Neurological-Association, Illinois, Amerika Birleşik Devletleri, 8 - 11 Ekim 2006, cilt.60, ss.639-640, (Özet Bildiri)

2006

196. Plasma cytokine levels in juvenile myasthenia gravis: 11 patients

Yapici Z., Erdogan H. A., TÜZÜN E., Vildan A., İŞSEVER H., ERAKSOY M.

11th International Congress on Neuromuscular Diseases, İstanbul, Türkiye, 2 - 07 Temmuz 2006, cilt.16, (Özet Bildiri)

2006

197. HLA class II molecules and AChR subunit immunity determine ocular myasthenia gravis susceptibility in HLA transgenic mice

Christadoss P., Bednov A., Saini S., TÜZÜN E., Yang H.

58th Annual Meeting of the American-Academy-of-Neurology, California, Amerika Birleşik Devletleri, 1 - 08 Nisan 2006, cilt.66, (Özet Bildiri)

2006

198. Anti-DAF antibody administration augments the development of ocular myasthenia gravis in HILA-DQ8 transgenic mice

Li F., TÜZÜN E., Saini S. S., Bednov A., Harris C. L., Christadoss P.

131st Annual Meeting of the American-Neurological-Association, Illinois, Amerika Birleşik Devletleri, 8 - 11 Ekim 2006, cilt.60, (Özet Bildiri)

2004

199. Anti-C1q antibody treatment prevents murine myasthenia gravis by reducing IL-5 and IFN-gamma production and neuromuscular junction complement deposition

Christadoss P., TÜZÜN E., Saini S., Yang H.

20th International Complement Workshop, Hawaii, Amerika Birleşik Devletleri, 13 - 18 Haziran 2004, cilt.41, ss.221, (Özet Bildiri)

2004

200. A pilot trial of etanercept in the treatment of steroid-dependent, generalized autoimmune myasthenia gravis

Rowin J., Meriggioli M., TÜZÜN E., Christadoss P.

56th Annual Meeting of the American-Academy-of-Neurology, San-Francisco, Kostarika, 24 Nisan - 01 Mayıs 2004, cilt.62, (Özet Bildiri)

2001

201. Morvan's syndrome: New insights into the mechanisms of thalamic insomnia

Tüzün E.

Journal of Neurological Sciences, İstanbul, Türkiye, 01 Ağustos 2001, cilt.18, ss.1, (Tam Metin Bildiri)

2000

202. Ontogenic development of mammalian sleep-wake cycle: Evidence based on the thalamic immunoreactivity pattern of a patient with Morvan’s syndrome

Tüzün E., Vincent T., Vincent A.

36th National Congress of Neurology, İstanbul, Türkiye, 01 Kasım 2000, ss.73, (Özet Bildiri)

Kitaplar

2025

1. Current Biomarkers in Multiple Sclerosis Treatment

Türkoğlu R. (Editör), Tüzün E. (Editör)

Türkiye Klinikleri Yayınevi, Ankara, 2025

2025

2. Preface

Türkoğlu R. (Editör), Tüzün E. (Editör)

Current Biomarkers in Multiple Sclerosis Treatment, Recai Türkoğlu,Erdem Tüzün, Editör, Türkiye Klinikleri Yayınevi, Ankara, 2025

2025

3. Treatment Response Markers of Flow Cytometry Method in Ocrelizumab Treatment

Akbayır E., Tüzün E. (Editör)

Current Biomarkers in Multiple Sclerosis Treatment, Recai Türkoğlu,Erdem Tüzün, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.10-16, 2025

2025

4. The Predictive Role of Biomarkers in Monitoring Aggressive Multiple Sclerosis

Erol Yıldız R., Tüzün E.

Current Biomarkers in Multiple Sclerosis Treatment, Recai Türkoğlu,Erdem Tüzün, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.31-37, 2025

2024

5. Nörobilimciler için nörobilim

Yemişci Özkan M. (Editör), Karataş Kurşun H. (Editör), Küçükali C. İ. (Editör), Tüzün E. (Editör), Baştan B. (Editör)

Bayçınar, Ankara, 2024

2024

6. IgG4 autoantibodies in the context of IgG4 autoimmunity

Huijbers M. G., Koneczny I. (Editör), YILMAZ V. (Editör), TÜZÜN E. (Editör), Querol L. (Editör), Martinez P. (Editör)

Frontiers Media SA., 2024

2024

7. Neuronal Culture Methods to Study Neuronal Function and Disease

Şen M., Ayşit N., Bay S., Tüzün E.

Current Trends in Neurosciences , Nurcan Orhan,Zeynep Karakaş,Tamer Demiralp, Editör, İstanbul Üniversitesi, İstanbul, ss.127-153, 2024

2024

8. Kanallar ve taşıyıcılar

Şanlı E., Tüzün E.

Nörologlar için nörobilim, Yemişci M,Karataş-Kurşun H,Küçükali Cİ,Tüzün E,Baştan B, Editör, Bayçınar, Ankara, ss.97-113, 2024

2024

9. Sinaptik İletim

Yüceer H., Tüzün E.

Nörologlar için Nörobilim, Yemişci M,Karataş-Kurşun H,Küçükali Cİ,Tüzün E,Baştan B, Editör, Bayçınar, Ankara, ss.77-85, 2024

2024

10. The Experimental Animal Models for the Research of Neuroimmunological Diseases

AKBAYIR E., ULUSOY C. A., Cossins J., TÜZÜN E.

Current Trends in Neurosciences, ORHAN NURCAN, KARAKAŞ ZEYNEP, DEMİRALP TAMER, Editör, Istanbul University Press, İstanbul, ss.37-61, 2024

2023

11. Merkezi sinir sisteminde nöroinflamasyon

Yüceer H., Tüzün E.

Nöroimmünoloji, Yücesan C,Tuncer A,Uzunköprü C, Editör, Türk Nöroloji Derneği, Ankara, ss.51-65, 2023

2022

12. Epilepsi ve status epileptikusta inflamatuar mekanizmalar, biyobelirteçler ve tedavi yaklaşımları

Tüzün E.

Epilepsi ve Farmakoterapisi Klinik ve Nörobiyolojik Yaklaşım, Dervent A,Yılmaz Onat F,altındag E, Editör, Nobel Tıp Kitapevi, İstanbul, ss.1-15, 2022

2021

13. Neuro-Behçet’s Disease

Tüzün E. (Editör), Kürtüncü M. (Editör)

Springer, London/Berlin , London, 2021

2021

14. Nöro-onkoloji

Tüzün E., Hanağası F., Sabancı P. A., Akman-Demir G., Yazıcı J.

İTF Nöroloji e-kitap, A. Emre Öge,Betül Baykan,başar bilgiç, Editör, Nobel Yayın Dağıtım, İstanbul, ss.733-757, 2021

2021

15. Multipl skleroz etiyolojisi

Tüzün E.

Multipl Skleroz, Yeşim Beckmann,Cihat Uzunköprü, Editör, Ema Tıp Kitabevi, İstanbul, ss.15-24, 2021

2021

16. Preface

Tüzün E., Kürtüncü M.

Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment, Erdem Tüzün,Murat Kürtüncü, Editör, Springer-Verlag , London, 2021

2021

17. Neuro-Behçet’s Disease: Epidemiology and Genetics

Yüceer H., Tüzün E.

Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment, Erdem Tüzün,Murat Kürtüncü, Editör, Springer-Verlag , London, ss.1-16, 2021

2021

18. Animal Models of Behçet’s Disease

Yüceer H., Tüzün E.

Neuro-Behçet's Disease: Pathogenesis, Clinical Aspects, Treatment, Erdem Tüzün,Murat Kürtüncü, Editör, Springer-Verlag , London, ss.41-48, 2021

2018

19. İnfeksiyöz ve inflamatuar epilepsiler

Kınay D., Tezer İ., TÜZÜN E.

Epilepsi, Bora İbrahim H, Yeni S Naz, Gürses Candan, Editör, Nobel Yayın Dağıtım, İstanbul, ss.183-222, 2018

2017

20. Nanotechnology-based management of neurological autoimmune diseases

TÜZÜN E.

Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery across the Blood–Brain Barrier, Gürsoy-Özdemir Y, Pehlivan SB, Şekerdağ E, Editör, Elsevier Science, Oxford/Amsterdam , Londra, ss.279-290, 2017

2015

21. Santral sinir sisteminin nörolojik hastalıkları

Çoban A., TÜZÜN E.

Çocukluk ve Adolesan Döneminin Nörolojik Hastalıkları Rehberi, Dervent A, Ayta S, Cokar O, Uluduz D, Editör, Ulusal Nöroloji Derneği, İstanbul, ss.207-213, 2015

2013

22. Miyastenia gravis modeli

Tüzün E., Ulusoy C. A.

Temel ve Klinik Nöroimmünoloji, Karabudak R, Editör, Ada Yayıncılık, İstanbul, ss.165-173, 2013

2013

23. Paraneoplastik nörolojik sendromlar

Altunrende B., Akman-Demir G., Tüzün E.

Temel ve Klinik Nöroimmünoloji, Karabudak R, Editör, Ada Yayıncılık, İstanbul, ss.521-536, 2013

2013

24. Limbik ensefalit

TÜZÜN E.

Temel ve Klinik Nöroimmünoloji, Karabudak R, Editör, Ada Yayıncılık, İstanbul, ss.511-519, 2013

2011

25. İmmünolojik Mekanizmalı Nörolojik Hastalıklar

Şahin H., TÜZÜN E.

Temel Nöroloji, Emre M, Editör, Güneş Yayınları, İstanbul, ss.997-1001, 2011

2011

26. Kanser hastasının nörolojik sorunları

ERKOL G., TÜZÜN E., SİVA A.

Kanser Hastasına Yaklaşım, Molinas Mandel M, Onat H, Editör, Nobel Yayın Dağıtım, İstanbul, ss.275-301, 2011

2011

27. Paraneoplastik Nörolojik Sendromlar

TÜZÜN E.

Temel Nöroloji, Emre M, Editör, Güneş Yayınları, İstanbul, ss.1145-1151, 2011

2010

28. Targeting classical complement pathway and IL-6 in experimental autoimmune myasthenia gravis.

TÜZÜN E., Christadoss P.

Myasthenia Gravis Disease Mechanisms and Immune Intervention, Christadoss P, Editör, Linus Publications, New York, ss.327-351, 2010

2010

29. Pathogenic mechanisms in myasthenia gravis

TÜZÜN E., Vincent A.

Myasthenia Gravis Disease Mechanisms and Immune Intervention, Christadoss P, Editör, Linus Publications, New York, ss.23-39, 2010

2009

30. Neuromuscular Junction Disorders

TÜZÜN E., Vincent A.

Master in Neuroimmunology, Montalban XG, Sastre-Garriga J, Editör, Viguera Editores S.L., Barcelona, ss.275-325, 2009

2009

31. Nöroonkoloji

TÜZÜN E., Akman-Demir G., Yazıcı J.

Nöroloji Ders Kitabı, Öge AE, Baykan B, Editör, -, İstanbul, ss.577-593, 2009

2007

32. Complement associated pathogenic mechanisms in myasthenia gravis

TÜZÜN E., Christadoss P.

Neuroimmunology Research Perspectives, Johansson LM, Editör, Nova Science Publishers, New York, ss.103-129, 2007

Patent

2024

Methods using anti-slc3a2 autoantibodies and slc3a2 for detection of glioma brain tumor from patient serum

Patent

Başvuru Yapıldı, Buluşun Başvuru Numarası: US20240060979A1 , Standart Tescil

2022

GLİOMA BEYİN TÜMÖRÜNÜN HASTA SERUMLARINDAN TESPİTİNE YÖNELİK ANTİ-SLC3A2 OTOANTİKORLARININ VE SLC3A2'NİN KULLANILDIĞI YÖNTEMLER

Patent

Tescil Edildi, Buluşun Tescil No: 2020/21768 , Standart Tescil

2013

Methods and materials for treating autoimmune and/or complement mediated diseases and conditions

Patent

2011

Methods and materials for treating autoimmune diseases and conditions

Patent

Bilimsel Dergilerdeki Faaliyetler

2023 - Devam Ediyor

Psychiatry and Clinical Psychopharmacology

Editörler Kurulu Üyesi

2022 - Devam Ediyor

Journal of Multiple Sclerosis Research

Editörler Kurulu Üyesi

2021 - Devam Ediyor

FRONTIERS IN IMMUNOLOGY

Editörler Kurulu Üyesi

2015 - Devam Ediyor

Nöropsikiyatri Arşivi

Editör

2011 - 2020

EXPERIMED

Baş Editör

Bilimsel Kuruluşlardaki Üyelikler / Görevler

2021 - Devam Ediyor

European Academy of Neurology (EAN)

Üye

2020 - Devam Ediyor

New York Academy of Sciences

Üye

2001 - Devam Ediyor

Nöroimmünoloji Derneği

Yönetim Kurulu Üyesi

2001 - Devam Ediyor

Nöropsikiyatri Derneği

Üye

2000 - Devam Ediyor

Ulusal Nöroloji Derneği

Üye

Bilimsel Yayınlarda Hakemlikler

Mart 2016

Journal of Neurology Neurosurgery Psychiatry

SCI Kapsamındaki Dergi

Ocak 2016

Journal of Neurology

SCI Kapsamındaki Dergi

Ocak 2015

Plos One

SCI Kapsamındaki Dergi

Ocak 2015

Nöropsikiyatri Arşivi

Hakemli Bilimsel Dergi

Ocak 2012

European Journal of Immunology

SCI Kapsamındaki Dergi

Ocak 2012

Journal of Diabetes and its Complications

SCI Kapsamındaki Dergi

Ocak 2012

Journal of Neuroimmunology

SCI Kapsamındaki Dergi

Ocak 2011

Journal of the Neurological Sciences

SCI Kapsamındaki Dergi

Ocak 2011

Vaccine

SCI Kapsamındaki Dergi

Ocak 2010

Neuromuscular Disorders

SCI Kapsamındaki Dergi

Ocak 2010

Epilepsia

SCI Kapsamındaki Dergi

Ocak 2009

Acta Neuropathologica

SCI Kapsamındaki Dergi

Ocak 2008

Headache

SCI Kapsamındaki Dergi

Ocak 2006

European Journal of Neurology

SCI Kapsamındaki Dergi

Ödüller

Aralık 2024

Sözel Bildiri Birincilik Ödülü

Türk Nöroloji Derneği

Ekim 2024

Akademik Performans Kategorisi, 40 Yaş Üstü Ödülü, Sağlık Bilimleri Alanı

İstanbul Üniversitesi

Aralık 2023

Sözel Bildiri İkincilik Ödülü

Türk Nöroloji Derneği

Aralık 2023

Otoimmün Demiyelizan Hastalıkların Ayırıcı Tanısında CCL4L2’nin B Hücre Temelli Biyobelirteç Olarak Değeri

59. Ulusal Nöroloji Kongresi

Kasım 2022

Sözel Bildiri Birincilik Ödülü

58. Ulusal Nöroloji Kongresi

Kasım 2022

Sözel Bildiri Birincilik Ödülü

Türk Nöroloji Derneği

Temmuz 2022

Poster Sunum Ödülü

International League Against Epilepsy (Ilae)

Mayıs 2022

Sözel Bildiri Birincilik Ödülü

Türk Epilepsi İle Savaş Derneği

Aralık 2020

Poster Birincilik Ödülü

Türk Biyokimya Derneği

Kasım 2019

Sözel Bildiri Birincilik Ödülü

Türk Nöroloji Derneği

Ocak 2019

Sözel bildiri ikincilik ödülü

Türk Nöroloji Derneği

Ocak 2018

45.yıl proje ödülleri

Türk Epilepsi İle Savaş Derneği

Kasım 2017

30th ECNP Congress of Applied and Translational Neuroscience CDE Grant

Ecnp Congress

Ocak 2016

Sözel Bildiri Ödülü

Türk Nöroloji Derneği

Eylül 2015

İstanbul Üniversitesi Başarılı Araştırmacı Ödülü

İstanbul Üniversitesi

Eylül 2010

Türk Nöropsikiyatri Derneği Bilimsel Araştırma Ödülü

Türk Nöropsikiyatri Derneği

Haziran 2004

James W. McLaughlin Postdoctoral Award for Excellence in Research on Infection and Immunity

Utmb Galveston

Nisan 1999

Beyin Araştırmaları Derneği Proje Birincilik Ödülü

Beyin Araştırmaları Derneği

Davetli Konuşmalar

Şubat 2025

1st IgG4-TREAT Winter School

Seminer

IgG4-TREAT Consortium-Avusturya

Ekim 2024

9th International Symposium on Neurodegeneration with Brain Iron Accumulation (NBIA)

Konferans

NBIA-Türkiye

Eylül 2022

32nd International Congress of Clinical Neurophysiology

Konferans

Congress of Clinical Neurophysiology-İsviçre

Haziran 2019

FENS Meeting

Konferans

FENS-Sırbistan

Mayıs 2015

31st International Epilepsy Congress

Konferans

International Epilepsy Congress-Türkiye

Mart 2009

International Conference on Myasthenia Gravis

Konferans

International Conference on Myasthenia Gravis-Fransa

Mayıs 2006

MDA Myasthenia Gravis Research Update

Seminer

Muscle Dystrophy Association-Amerika Birleşik Devletleri

Mart 2006

GTCbio’s Modern Drug Discovery & Development Summit

Konferans

GTCbio-Amerika Birleşik Devletleri

Haziran 2005

Annual ANA meeting

Konferans

American Neurology Association (ANA)-Türkiye

Haziran 2005

MDA meeting

Konferans

Muscular Dystrophy Association (MDA)-Amerika Birleşik Devletleri

Nisan 2003

Myasthenia Gravis Foundation of America Scientific Session

Konferans

Myasthenia Gravis Foundation of America-Amerika Birleşik Devletleri

Atıflar

Toplam Atıf Sayısı (WOS): 7393

h-indeksi (WOS): 35

Bilimsel Araştırma / Çalışma Grubu Üyelikleri

2021 - Devam Ediyor

Ean Task Force On Consensus Guidelines For The Management Of Autoimmune Encephalitis

https://www.ean.org/research/ean-guidelines/about-ean-guidelines-for-neurologists/ongoing-guidelines

EAN (European Academy of Neurology), Switzerland

2021 - Devam Ediyor

Nöroonkoloji Çalışma Grubu - Neuro-Oncology Board

https://www.ean.org/home/organisation/scientific-panels/neuro-oncology

EAN (European Academy of Neurology), Austria

2019 - Devam Ediyor

Translasyonel Nörobilim - Translational Neuroscience

https://www.noroloji.org.tr/altbirim/34/translasyonel-norobilim/kosullar/

İstanbul Üniversitesi, Turkey

2000 - Devam Ediyor

Nöroimmünoloji Çalışma Grubu

Yok

İSTANBUL ÜNİVERSİTESİ, Turkey

2019 - 2022